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ABSTRACT 
Over the past few decades, scientists have come to acknowledge the growing 
importance of marine and marine-related resources for new drugs, pesticides and anti-
fouling substances, with over 10,000 metabolites isolated from marine organisms to 
date. In an effort to tap into the pharmaceutical potential of marine fungi in Malaysia, 
selected marine derived endophytic and manglicolous fungi from the coastlines of 
Peninsular Malaysia were investigated for their antibacterial potential. The endophytic 
fungi in this study were isolated from two marine associated plants; Vitex rotundifolia 
L.f. and Ipomoea pes-caprae (L.) R.Br., from the east and west coast of Peninsular 
Malaysia respectively. A total of 13 and 21 endophytic fungi were isolated from V. 
rotundifolia and I. pes-caprae, respectively. The eleven manglicolous fungi strains used 
in this study were of mangrove origin and were obtained from the Institute of Biological 
Sciences (ISB) culture collection. In preliminary experiments, a mycelial plug assay 
was employed to study the antibacterial activities of both endophytic and manglicolous 
fungi. Almost 38.5% of the fungal strains from V. rotundifolia and 47.6% of the fungal 
strains from I. pes-caprae exhibited antibacterial activity against at least one test 
bacteria. Ten or 91% of the manglicolous fungi exhibited antibacterial activity against 
at least one test bacteria. Endophytic fungi from I. pes-caprae displayed higher potential 
for antibacterial activity in comparison to endophytic fungi from V. rotundifolia. 
Minimidochium sp. and Bipolaris sp. displayed antibacterial activity towards five or 
more of the test bacteria. Ten or 91% of the eleven manglicolous fungi displayed 
antibacterial activity. Saccardoella rhizophorae, Henningsomyces sp., Dactylospora 
haliotrepha (ISB003) and MF 28 exhibited promising antibacterial potential. Based on 
the results from the mycelial plug assay, five endophytic and ten manglicolous fungi 
were further investigated using the broth microdilution assay to obtain quantitative 
antibacterial parameters. Saccardoella rhizophorae was chosen for complete chemical 
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analysis of its secondary metabolite profile. Bioactivity-guided fractionation of S. 
rhizophorae crude extract resulted in the isolation and characterization of two fatty 
acids namely palmitic acid and linoleic acid from the n-hexane fraction. Both isolated 
fatty acids exhibited antibacterial activity against gram positive bacteria. Certain fatty 
acids are important constituents of essential oils and fatty acids, such as linoleic acid, 
are important as nutritional supplements. Fatty acids are also essential in the field of 
biodiesel which is fast becoming the preferred alternate to conventional fuel with 
research being performed to identify sustainable sources of biodiesel feedstock. The 
isolation of fatty acids from S. rhizophorae indicates its potential application in the field 
of food technology and biodiesel. Although Malaysia hosts a great diversity of fungi, 
there are very few studies on metabolites of fungal origin, thus this study may prove 
crucial in paving the way towards commercial application of fungal metabolites and 
possibly lead to further discovery of new or novel fungal metabolites with 
pharmacological values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
ABSTRAK 
 
Sejak beberapa dekad yang lalu, ahli sains telah mengakui kepentingan sumber marin di 
dalam kajian untuk ubat-ubatan baru, racun perosak dan bahan-bahan yang mempunyai 
potensi aktiviti biologi. Laporan kaji selidik santifik telah melaporkan lebih kurang 
10,000 metabolit kimia yang telah diasingkan daripada organisma marin terutamanya, 
span, karang lembut, kulat dan bakteria di seluruh dunia. Dalam usaha untuk meneroka 
potensi farmaseutikal daripada kulat marin di Malaysia, kulat marin berasal kulat 
endofitik dan saprofitik dari pantai Semenanjung Malaysia telah dipilih untuk kajian 
selidik potensi antibakteria mereka. Kulat endofitik dalam kajian ini telah diasingkan 
daripada dua tumbuhan marin iaitu; Vitex rotundifolia L.f dan Ipomoea pes-caprae (L.) 
R.Br., dari pantai timur dan pantai barat Semenanjung Malaysia, masing-masing. 
Sebanyak 13 dan 21 kulat endofitik telah diasingkan daripada V. rotundifolia dan I. pes-
caprae masing-masing. Sebelas kulat daripada paya bakau yang dikaji dalam kajian ini 
berasal daripada kayu bakau dan diperolehi daripada koleksi kultur Institut Sains 
Biologi. Dalam percubaan awal, “plug assay” telah digunakan untuk mengkaji aktiviti 
antibakteria kedua-dua jenis kulat. Hampir 38.5% daripada kulat endofitik daripada V. 
rotundifolia dan 47.6% daripada kulat endofitik daripada I. pes-caprae memaparkan 
aktiviti antibakteria terhadap sekurang-kurangnya satu bakteria ujian dalam penskrinan 
awal. Keputusan yang diperolehi menunjukkan bahawa kulat endofitik yang dipencil 
daripada tumbuhan I. pes-caprae memaparkan potensi aktiviti antibakteria yang lebih 
tinggi berbanding dengan kulat endofitik yang dipencil daripada tumbuhan V. 
rotundifolia terutama kulat seperti, Minimidochium sp. dan Bipolaris sp. yang 
memaparkan aktiviti antibakteria terhadap lima atau lebih daripada bakteria yang diuji. 
Daripada sebelas kulat yang diperolehi daripada paya bakau, sepuluh atau 91% daripada 
kulat tersebut memaparkan aktiviti antibakteria yang ketara. Kulat seperti, Saccardoella 
rhizophorae, Henningsomyces sp., Dactylospora haliotrepha (ISB003) dan MF 28 telah 
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memaparkan potensi antibakteria yang memberangsangkan. Berdasarkan keputusan 
antibakteria awal, lima kulat endofitik dan sembilan kulat daripada paya bakau telah  
disiasat secara lanjut melalui “broth microdilution assay” untuk mendapatkan parameter 
antibakteria yang lebih kuantitatif. Saccardoella rhizophorae sejenis kulat saprofitik 
telah dipilih untuk analisis kimia lengkap terhadap profil metabolit sekundernya. 
Pengasingan metabolit berpandu bioaktiviti ke atas ekstrak mentah S. rhizophorae 
menyebabkan pengasingan dan pencirian dua asid lemak iaitu asid palmitic dan asid 
linoleik daripada pecahan n-heksana. Kedua-dua asid lemak yang diasingkan 
mempamerkan aktiviti antibakteria terhadap bakteria gram positif. Asid lemak tertentu 
adalah juzuk penting dalam minyak yang penting dan asid lemak seperti asid linoleik 
penting sebagai pemakanan tambahan. Selain itu, asid lemak yang juga penting dalam 
bidang biodiesel yang kini menjadi alternatif pilihan kepada bahan api konvensional 
dengan penyelidikan yang berterusan sedang dilakukan untuk mengenal pasti sumber-
sumber yang mampan bahan mentah biodiesel. Pengasingan asid lemak dari S. 
rhizophorae menunjukkan aplikasi yang berpotensi dalam bidang teknologi makanan 
dan biodiesel. Walaupun Malaysia menjadi tuan rumah kepada diversiti besar kulat, 
setakat ini hanya terdapat sedikit kajian mengenai metabolit daripada kulat. Oleh 
demikian, kajian ini membuktikan kepentingan halatuju ke arah aplikasi komersil 
metabolit kulat dan mungkin membawa kepada penemuan metabolit kulat baru atau 
novel dengan nilai farmakologi pada masa depan. 
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INTRODUCTION 
 
The marine environment comprises 70% of the Earth’s surface; however taking into 
account the topography of the ocean floor, the actual surface area of the ocean is 
considerably higher. The ocean harbours great biological diversity accounting for more 
than 90% of the whole biosphere (Subramani et al., 2012). This estimation could be in 
fact higher due underestimated oceanic depth which stands at slightly more than 
10,000m in comparison to the vertical rise of land, the Mt. Everest at merely 8848m 
thus suggesting the existence of greater biodiversity in the oceans (Fautin, 2012; 
Manivasagan et al., 2013). However, most reports of natural product discovery stem 
from the terrestrial environment due to the underexplored state of the marine habitat 
(Dias et al., 2012). 
Microorganisms such as bacteria and fungi, have been evolving for the past 3.8 
billion years and are shown to produce more evolved metabolites as a part of their 
defence mechanism thus making them candidates for the production of bioactive natural 
products to be used as drug leads (Joel et al., 2013; Swathi et al., 2013). Scientists’ 
hypothesize that the need of these organisms to adapt and survive in the considerably 
harsh marine environment may have shaped their biochemical pathways into producing 
unique secondary metabolites (Zhou et al., 2014). 
The marine habitat is host to a wide variety of organisms particularly 
microorganisms that are promising sources for the discovery of novel metabolites 
(Manivasagan et al., 2013). Recent years has seen a growing interest in marine derived 
fungi as sources of new or novel metabolites (Zhou et al., 2014). Marine derived fungi 
produce bioactive metabolites with wide range of activities such as anticancer, 
antibacterial, antiplasmodial, antiviral and anti-inflammatory (Ebel, 2012; Duarte et al., 
2012). Interest in marine derived fungi as producers of antibacterial metabolites 
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commenced with the discovery of cephalosporin C by the fungi Cephalosporium 
acremonium in 1940’s (Proksch et al., 2008). Currently, marine derived fungi represent 
a large fraction of antibacterial compound producers in comparison to other microbial 
flora (Bhatnagar et al., 2012). 
Two-thirds of drugs used in the treatment of human diseases over the past 25 
years, have been derived from natural products or derivatives of them (Berkov et al., 
2014). Technological and molecular biology advances have opened up new frontiers in 
natural product research, allowing effective investigation of new leads from Nature 
(Berkov et al., 2014). Hastened human practices and inappropriate use of antibiotics has 
led to an increase in bacterial resistance to clinically used antibiotics often leading to 
failure of conventional antibiotic therapies (Ola et al., 2014; Rao, et al., 2014). This 
scenario further raises the urgency to develop new antibiotics with novel mechanisms of 
action to counter effect the current resistance mechanisms of bacteria (Ola et al., 2014; 
Gomes et al., 2014).  
There is a general lack of information and few studies on bioactive metabolites 
from marine derived fungi from Malaysia. A study by Zainuddin et al. (2010), 
investigated the antimicrobial properties of 152 marine derived fungi from Malaysia and 
successfully  isolated 2,2,7-trimethyl-2H-chromen-5-ol from the marine derived fungi 
Fasciatispora nypae K.D. Hyde, a compound that was never before reported to be 
isolated from nature. The study by Zainuddin et al. (2010) only targeted the bioactivities 
of mangrove fungi; however there are other ecological groups of marine derived fungi 
such as algicolous, arenicolous, endophytic fungi from coastal associated plants and 
others that have yet to be explored in Malaysia.  
Endophytic fungi are known to be excellent sources of a wide array of new 
biologically active metabolites (Debbab et al., 2011; Saleem et al., 2013) with a great 
number of compounds isolated in the past decades (Zhang et al., 2014). However there 
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have only been few reports from Malaysia (Sultan et al., 2011; Tong et al., 2011) on the 
potential of bioactive metabolites of endophytic fungi, all originating from medicinal 
herbs and non-marine associated plants of Malaysia. The marine associated plants, Vitex 
rotundifolia and Ipomoea pes-caprae are usually found as crawlers along the sand 
dunes, which is an area located in the intertidal are, that makes them both excellent 
sources for endophytic fungi. Mangroves are also located in the intertidal zone and are 
known to be host to a great diversity of fungi due to its high carbon recycling rates 
(Sridhar et al., 2012). Manglicolous fungi have been reported to produce a broad variety 
of new and novel bioactive metabolites with significant pharmacological values (Joel et 
al., 2013). Studies on bioactivities of manglicolous fungi from Malaysia are still at its 
initial stages while the bioactivities of fungi from the marine associated plants in the 
present study have not been previously explored in Malaysia. There have been no 
studies on the bioactivities of endophytic fungi from V. rotundifolia, while there was 
only one study (Guo et al., 2012) pertaining to the bioactivity of endophytic fungi from 
I. pes-caprae however this study was not reported from Malaysia. There have also been 
no reports from Malaysia regarding metabolites isolated from the manglicolous fungi in 
the present study. Marine derived fungi from Malaysia may harbour promising potential 
for the discovery of pharmacologically significant metabolites.  
 
Research objectives: 
1. To isolate and identify endophytic fungi from marine associated plants, Vitex 
rotundifolia and Ipomoea pes-caprae using Inter-trancribed spacer (ITS) 
sequence analysis. 
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2. To evaluate the antibacterial activity of endophytic fungi from marine associated 
plants (V. rotundifolia and I. pes-caprae) and manglicolous fungi from 
mangrove decaying materials of Peninsular Malaysia using mycelial plug and 
broth microdilution assay 
3. To isolate and characterize the antibacterial secondary metabolites from the 
manglicolous fungi, Saccardoella rhizophorae by using bioactivity-guided 
fractionation coupled with Nuclear magnetic resonance (NMR) spectroscopy, 
Liquid chromatography-mass spectrometry (LC-MS), Ultra-violet (UV) 
spectroscopy and Infra-red (IR) spectroscopy. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Marine organisms and their potential as producers of natural products  
Nature is known to be a reservoir of compounds with high chemical diversity and 
excellent therapeutic potential (Bhatnagar et al., 2012). Approximately 70% of the 
earth’s surface constitutes water and every life form on earth is believed to have its 
origin in the sea (Haefner, 2003). Some marine biologists go as far as to believe that in 
certain marine ecosystems, the biodiversity can be even higher than what is usually 
observed in tropical rainforests (Haefner, 2003). The search for natural products was 
traditionally limited to plants especially higher terrestrial plants; however over the 
years, the scientific world has become increasingly aware of the vast untapped potential 
of natural products from marine life forms (Ebel, 2012).  
The discovery of natural products from marine sources began in the 1950’s, 
which resulted in the isolation of two nucleosides; spongouridine and spongothymidine 
from the sponge Tectitethya crypta Laubenfels (Oliveira et al., 2012). This pioneering 
discovery led to the synthesis of the anticancer drug Cytarabine, used in the treatment of 
acute myeloid leukemia and the antiviral drug Vidarabine, used in the treatment of 
herpes virus infection (Oliveira et al., 2012). Marine organisms live in an environment 
significantly different from its terrestrial counterparts, thereby suggesting that the 
secondary metabolite profiles of marine organism may differ in terms of its chemical 
structures and pharmacological activities (Lu et al., 2010; Debbab et al., 2013). The 
marine ecosystem is known to be governed by harsh biological, physical and chemical 
parameters which may have given rise to novel metabolic pathways, thus leading to the 
production of chemicals with interesting structures (Oliveira et al., 2012). Moreover, 
compounds from natural resources possess high affinities towards target molecules 
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rendering them as effective drug candidates (Bhatnagar et al., 2012).  Worldwide, over 
10,000 metabolites have been isolated from marine organisms mainly; sponges, soft 
corals, fungi and bacteria (Ebel, 2012). Due to the broad spectrum of chemical 
properties of marine natural products, they are known to exhibit a wide range of 
bioactivities including; antimicrobial, anticancer, anti-tuberculosis, antiviral, anti-
parasitic, anti-helmintic, anti-malarial, anti-protozoal, anti-coagulant, anti-platelet, anti-
inflammatory, anti-diabetic, and antitumor activities (Jones, 2008; Imhoff et al., 2011).  
Over the years, the search for natural products from marine organisms have 
evolved from merely isolation and description of natural compounds, to more intensive 
studies such as the investigation of their biological properties and most importantly, the 
biosynthetic pathways leading to the production of these natural compounds to ensure 
sustained production for pharmaceutical applications (Suyama et al., 2011). A variety of 
marine organisms have been studied for natural products over the years, and they 
include; plants, invertebrates, algae, bacteria, fungi and protozoa (Gul et al., 2005). 
Overall, marine derived fungi are now widely accepted as promising sources for the 
discovery of novel compounds with pharmaceutical properties. According to Bhatnagar 
et al. (2012), marine derived fungi are the major producers of antibacterial compounds 
among marine microbial flora. Keeping in mind the underestimated biodiversity of 
marine derived fungi, we can expect marine derived fungi to play a prominent role in 
the discovery of bioactive chemical compounds, to serve as potential drug candidates in 
line with the growing need of new natural products. 
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2.2 Marine derived fungi 
Fungi are classified as lower eukaryotes and are also known as heterotrophic 
osmotrophs (Dick, 1997). They are incapable of synthesizing their own food but rather 
obtain nutrients directly from dead or living organisms or materials (Dick, 1997). 
Previously mistaken to be associated with the plant kingdom, modern biologists have 
now categorized them into their own kingdom known as “The fifth kingdom”. Fungi 
were known to be diverse some 600 million years ago and have continued diversifying 
to such an extent that they are now classified into numerous groups (Dick, 1997). 
Worldwide, there are about 100,000 known fungal species and around 800 new species 
being named new to science every year (Jones et al., 2012)  
The 1991 hypothesis of having approximately 1.5 million fungal species on 
Earth by Hawksworth et al. (2011) is now considered an underestimate by many 
(Blackwell, 2011). Recent use of molecular methods in the classification of fungi has 
given rise to a new estimate of fungal diversity at about 5.1 million species (Blackwell, 
2011).  Fungi can range from microfungi such as molds and yeasts to macrofungi such 
as mushrooms and truffles. Certain types of macrofungi are considered delicacies and 
thus widely cultivated by humans for food supply. Microfungi can cause positive or 
negative impacts. Some microfungi are considered pathogenic and harmful to humans, 
animals and plants, while others are known to be producers of metabolites and enzymes 
proven beneficial to human life (Bennett, 1998). 
Marine fungi are microorganisms that complete their entire life cycle in the sea 
whereby they can grow and sporulate exclusively in the marine habitat (Kohlmeyer et 
al., 2003; Hooley et al., 2006). According to Kohlmeyer et al. (2003), in a broad 
ecological definition, marine fungi are classified into two groups; obligate marine fungi, 
which are able to grow and sporulate exclusively in a marine habitat and secondly, 
facultative marine fungi, also known as marine derived fungi which are those from 
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freshwater or terrestrial habitat but is able to grow and possibly sporulate in the marine 
environment. Besides that, marine derived fungi can also be categorized based on their 
niche or in other words, the habitats and substrata that they occupy. Kohlmeyer et al. 
(1991) described four ecological groupings of fungi namely; lignicolous, arenicolous, 
algicolous and manglicolous fungi. Lignicolous fungi grow on submerged woody 
material mainly driftwood while arenicolous fungi are associated with sand grains. 
Follicolous fungi are found on leaves immersed or shed in the marine habitat while 
fungi isolated from submerged mangrove parts are called manglicolous fungi. 
Algicolous fungi are specific for fungi that occur on marine algae (Kohlmeyer et al., 
1991).  
Buee et al. (2009) characterized functional ecological groups of fungi by linking 
fungal diversities to their niches in the environment. Currently, there are three 
functional ecological groups of fungi namely; parasitic, saprotrophic and mutualistic 
(Buee et al., 2009). Parasitic fungi are fungi that depend on a host organism for 
nutrition and protection in turn, causing harm to the host organism. On the other hand, 
mutualistic fungi are fungi that are attached to a host organism where both fungi and 
host benefit from this association. Saprotrophic fungi are a group of fungi that are 
normally found on decaying matter such as plants or animals. 
 
2.2.1 Natural products from marine derived fungi 
Soil fungi and terrestrial plants have long been the focus as natural product reservoirs; 
however, chemical compounds isolated from these sources have been known to produce 
repeated chemical structures with common carbon backbones (Ebel, 2012). As the 
requirement for new therapeutic agents is ever increasing, scientists have now shifted 
focus upon diverse sources such as, thermophiles from ocean vents, soils subject to 
extreme radiation, endolithic fungi, marine organisms and endophytes (Jones et al., 
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2008). The 1990’s showed a drastic increase in marine microbial metabolites that 
continues until today, and marine derived fungi from various substrates have been 
recognized as a rich resource of novel bioactive metabolites with potential biomedical 
applications (Zhang et al., 2008a). Figure 2.1 shows the percentage of new compounds 
from marine derived fungi based on the various substrates that they were isolated from. 
Based on Figure 2.1, it is noted that the highest percentage of new compounds were 
from the marine derived fungi isolated from algae, sponges and sediments including 
deep sea at 21%, 19% and 16% respectively.  
Many metabolites from marine derived fungi have shown to possess 
antimicrobial, antifungal, cytotoxic, antitumor, immuno-stimulatory, antiviral and 
kinase inhibitory activity (Wu et al., 2008). Reports suggest that the majority of marine 
natural products have novel pharmaceuticals values (Davidson, 1995; Liberra et al., 
1995; Jensen et al., 2002; Bringmann et al., 2005). The groups of chemical compounds 
of marine fungal origin are divided into seven groups namely; polyketides, alkaloids, 
terpenoids, peptides, prenylated polyketides, shikimates and lipids. According to Figure 
2.2, the majority of marine derived fungi secondary metabolites are from the chemical 
group polyketides and alkaloids groups. Some of the reported secondary metabolites of 
marine derived fungi origin are listed in Table 2.1 while selected chemical compounds 
are shown in Figure 2.3.  
It is believed that due to harsh environmental factors, marine derived fungi are 
expected to produce high numbers of active secondary metabolites with unique 
structures (Vongvilai et al., 2004). A study by Pan et al. (2008) reported the discovery 
of 42 new compounds and 35 known compounds from marine derived fungi isolated 
from South China Sea. To date, more than 500 new natural products have been isolated 
from marine derived fungi (Rateb et al., 2010). The first report of a bioactive natural 
product from a marine derived fungus dates back to the 1940s when cephalosporin C 
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was isolated from the fungus Acremonium chrysogenum Gams collected from a sewage 
outlet in the Mediterranean Sea (Proksch et al., 2008). Cephalosporin C is the precursor 
chemical compound of modern cephalosporin antibiotics (Proksch et al., 2008). 
Existing modern drugs of fungal origin include b-lactam antibiotics, griseofulvin, 
cyclosporine A, taxol, ergot alkaloids, and lovastatin (Suryanarayanan et al., 2009). On-
going research on the secondary metabolite chemistry of marine derived fungi has led to 
the discovery of numerous novel compounds with promising pharmacological potential 
such as those with anti-cancer and anti-microbial properties (Proksch et al., 2008). 
There are numerous marine derived fungi reported to produce compounds with 
interesting bioactivities. One such example is the marine derived fungus Aspergillus sp. 
which has been widely known to produce many novel chemical compounds such as 
azonazine with anti-inflammatory activities, spirotryprostatin with phytoregulating 
activities and the anti-cancer compound, diphenly (Liu et al., 2006; Ebel, 2010; 
Afiyatullov et al., 2012). Kitano et al. (2012), reported the discovery of a new anti-
tumour metabolite, pileotin A from Aspergillus sp isolated from a sea urchin. The 
marine derived fungi Gymnascella sp. has also been widely studied over the years and 
has been known to produce Gymnastatins, Gymnasterones and Dankastatins with 
promising anti-tumour and cytostatic activities (Amagata et al., 1998; Amagata et al., 
2008). Extensive research has also been carried out to explore the antimicrobial 
properties of fungal secondary metabolites to cope with the ever increasing occurance of 
microbial drug resistance. A study by Gallordo et al. (2006), reported the isolation of 
amides of D-allo and L-isoleucine derivative with antibacterial and antifungal properties 
from the marine derived fungi Acremonium furcatum. A recent study by Caballero et al. 
(2013) reported the production of toluquinol, a strong inhibitor of angiogenesis thus 
making this compound a promising drug candidate for further evaluation to treat cancer 
and other angiogenesis-related conditions. 
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Figure 2.1: Percentage of new compounds from marine derived fungi with respect to 
the fungi source and substrates (Ebel, 2012) 
 
 
 
 
 
 
 
 
 
Figure 2.2: Percentage of new compounds from marine derived fungi with respect to 
their chemical grouping (Ebel, 2012) 
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Table 2.1: Secondary metabolites from selected marine derived fungi 
Fungi identified New compound Bioactivity Reference 
Penicillium sp. Penicillazine 
 
Cephalosporolides H-
I 
Biverlactones A-D 
Sorbifuranones A-C 
Sorbicillinoid 
Antibacterial Iwatsuki et al., 
2011 
Li et al., 2007 
 
Bringmann et al., 
2010 
Penicillium 
citrinum 
Benzopyranones 
Isochroman 
Anthraquinone-
citrinin derivatives 
Citrin derivatives 
Penicitrinols C-E 
Antimicrobial 
Antimicrobial 
Antimicrobial 
 
Anticancer 
Anticancer 
Khamthong et al., 
2012 
 
 
Chen et al., 2011 
Penicillium 
aurantiogriseum 
Verrucisidinol 
Verrucosidinol acetate 
Antimicrobial 
Antimicrobial 
Yu et al., 2010a 
Penicillium 
commune 
Comazaphilones A-F Antimicrobial, 
Anticancer 
Gao et al., 2011 
Xylaria sp. Xyloallenolide A 
Xyloketals A-H 
 Lin et al., 2001 
Liu et al., 2006 
Paecilomyces sp. Paeciloxanthone Antibacterial, 
Anticancer 
Wen et al., 2008 
Eutypella scoparia 7,8-dihydroxy-3,5,7-
trimethyl-8,8a-
dihydro-1H-
isochromen-6(7H)-
one 
6-(hydroxymethyl)-
2,2-dimethyl-3,4-
dihydro-2H-
chromene-3,4-diol 
Anticancer 
 
 
 
 
Anticancer 
Li et al., 2012 
Stysanus-like sp. Hypoxylin A-B  Wang et al., 2005 
Tryblidiopycnis sp. Chloro-monoterpene  Huang et al., 2006 
Guignardia sp. Vermistatin Anticancer, 
Antifungal 
Xia et al., 2007 
Ascochyta sp. Ascochytatin 
Ascosalipyrrolidinone 
A 
Ascospiroketals A-B 
Antibacterial 
Antimicrobial 
Kanoh et al., 
2008a 
Zygosporium sp. Sulfoalkylresorcinol Antibacterial Kanoh et al., 
2008b 
Phomopsis sp. Phomolide B Antibacterial Du et al., 2008 
Nodulisporium sp. Nodulisporacid A Antimalarial Kasettrathat et al., 
2008 
Chaetomium sp. Chaetoxanthone B 
 
Chaetominedione 
Antimalarial, 
Antiprotozoal 
Anticancer 
Pontius et al., 
2008a 
 
Abdel-Lateff, 
2008 
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Table 2.1, continued 
 
 
Chaetomium 
globosum 
Chaetoglobosin Fex 
Cytoglobosins A-G 
Anti-inflammatory 
Anticancer 
Dou et al., 2011 
Cui et al., 2010 
Aspergillus 
insulicola 
Azonazine Anticancer Wu et al., 2010 
Aspergillus 
sulphureus 
Decumbenone C Anticancer Zhuravleva et al., 
2012 
Aspergillus 
carbonarius 
8’-O-
Demethylnigerone 
8’-O-
Demethylisonigerone 
Anti-tuberculosis 
 
Anti-tuberculosis 
Zhang et al., 
2008a 
Periconia sp. Macrosphelide M 
Peribysin J 
Xanthine oxidase 
inhibition 
Yamada et al., 
2007 
Aigialus parvus Aigialomycins A-E 
 
Hypothemycin 
Aigialone 
Aigialospirol 
Antimalarial, 
Anticancer 
Anticancer 
Anticancer 
Anticancer 
Isaka et al., 2002 
 
 
Vongvilai et al., 
2004 
Exophiala sp. Circumdatin I Ultraviolet 
protecting 
Zhang et al., 
2008b 
Lignincola laevis 7-hydroxyergosterol Anticancer Abraham et al., 
1994 
Monodictys 
putredinis 
Monodictysin C 
Monodictyochromes 
A-B 
Monomeric xanthones 
Anticancer 
Anticancer 
 
Anticancer 
Krick et al., 2007 
Pontius et al., 
2008b 
Verruculina enalia Enalin A Antimicrobial, Anti-
diabetic 
Lin et al., 2002 
Halorosellinia 
oceanica 
2-hexylidene-3-
methylsuccinic acid 
Cytochasin 
5-carboxymellein 
 
Halorosellins A-B 
 
Hypoxylin A-B 
Sesquiterpenoid 
lactone 
Anticancer, 
Antimalarial 
Anticancer 
Anticancer, 
Antimalarial 
Antimalarial, 
Antimycobacterial 
Chinworrungsee et 
al., 2001 
 
 
 
Chinworrungsee et 
al., 2002 
Acremonium sp. Acremolides A-D 
Lipodepsipeptides 
Unknown Ratnayake et al., 
2008 
Acremonium 
striatisporum 
Diterpenic altrosides Anticancer Afiyatullov et al., 
2000 
Acremonium 
furcatum 
Amides of D-allo 
Amides of L-
isoleucine 
Antimicrobial 
Antimicrobial 
Gallardo et al., 
2006 
Acremonium 
strictum 
Acremolin 
Acremostrcitin 
Anticancer 
Antibacterial 
Julianti et al., 2012 
Julianti et al., 2011 
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Table 2.1, continued 
 
 
Gymnascella sp. Gymnastatins Q-R 
Dankasterone 
Dankastatins A-B 
Gymnasterone 
Anticancer 
Anticancer 
Anticancer 
Anticancer 
Amagata et al., 
2008 
 
Amagata et al., 
1998 
Gymnascella 
dankaliensis 
Gymnastatins A-C 
Gymnastatins F-H 
Anticancer 
Anticancer 
Numata et al., 
1997 
Amagata et al., 
2006 
Aspergillus sp. Diphenyl ether 
Pileotin 
Anticancer Liu et al., 2006 
Kitano et al., 2012 
Aspergillus 
fumigatus 
Spirotryprostatin Phytoregulating  Afiyatullov et al., 
2012 
Fusarium sp. Fusaranthraquinone 
Fusarnaphthoquinones 
A-C 
Fusarone 
Antimicrobial, 
Antimycobacterial, 
Antimalarial, 
Anticancer 
Trisuwan et al., 
2010 
Deuteromycete sp. Deuteromycols A-B 
Benzofuranoids 
Antibacterial 
Antibacterial 
Nawwar et al., 
2010 
Phoma herbarum Arthropsadiol C 
 
Massarilactone H 
Neuraminidase 
inhibitory  
Neuraminidase 
inhibitory 
Zhang et al., 2012 
Botryotinia sp. Botcinin Anti-diabetic Kim et al., 2012 
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Ascochytatin 
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Nodulisporacid A 
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Figure 2.3: Secondary metabolites from selected marine derived fungi 
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Macrosphelide M 
 
1-Deoxyrubralactone  
 
Cephalosporolides I 
 
 
 
 
 
Figure 2.3: Secondary metabolites from selected marine derived fungi (continued) 
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Figure 2.3: Secondary metabolites from selected marine derived fungi (continued) 
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2.2.2 Antibacterial compounds from marine derived fungi and their mechanisms 
The first antibacterial compound isolated from an obligate marine fungi was 
cephalosporin C from the fungi Cephalosporium acremonium (now named Acremonium 
chrysogenum) (Bugni et al., 2004). Cephalosporin C is the precursor molecule that led 
to the development of modern day cephalosporins that are used in the treatment of 
infections caused by Gram positive and Gram negative bacteria (Liu et al., 2011). 
Cephalosporins belong to the beta lactam class of antibiotics similar with penicillin, in 
which they possess the beta-lactam ring (Liu et al., 2011). Cephalosporins are 
bacteriocidal in their mode of action, whereby they interfere with the synthesis of the 
bacterial cell wall (Liu et al., 2011). The proper formation of the cell wall is essential 
for the growth of the bacteria and peptidoglycan is an important component in the cell 
wall that provides stability through its cross-linked latticework structure (Singh et al., 
1999). Beta-lactam antibiotics generally inhibit the completion of the cross-links by the 
membrane bound transpeptidase enzyme thus killing the bacteria (Singh et al., 1999).  
The majority of new compounds from marine derived fungi are polyketides, 
which also encompasses the antibiotic class macrolides (Ebel, 2012). There have been 
reports on the isolation of antibacterial macrolides from marine derived fungi (Isaka et 
al., 2002; Shiomi et al., 2002). Macrolides are a group of drugs with the presence of the 
macrolide ring and possesses bacteriostatic activities (Shiomi et al., 2002). Macrolides 
are protein synthesis inhibitors, whereby they inhibit the biosynthesis of bacterial 
protein by binding to the large ribosomal subunit, close to the peptidyl transferase 
center thus preventing the formation of peptide bonds during protein elongation (Tenson 
et al., 2003). Alkaloids are the second major fraction of new metabolites from marine 
derived fungi (Ebel, 2012) with reports that certain alkaloids produced by these 
organisms possesss antibacterial activities (Li et al., 2006; Du et al., 2012). Studies 
have reported that antibacterial alkaloids exert its antibacterial activity by inhibiting the 
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transpeptidase enzyme sortase A, thus interrupting bacterial cell wall formation (Mayer 
et al., 2013). Marine derived fungi are also known to produce antibacterial diterpenes, a 
type of terpene (Gao et al., 2011). Although the mechanism of action of diterpenes from 
marine derived fungi have not been extensively studied upon, Ghosh et al. (2013) stated 
that diterpenes with antibacterial activities usually exert their action by causing 
significant bacterial cell membrane damage leading to cell leakage. 
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2.3 Manglicolous and endophytic marine derived fungi as potential natural 
product reservoirs  
2.3.1 Manglicolous fungi 
Mangroves are wetland forests located along the intertidal areas of estuarine sea coasts 
and river mouths in tropical and subtropical parts of the world (Logesh et al., 2012). It 
is believed that 25% of the world’s tropical coastlines across 112 countries, covering an 
approximate area of 150,000-181,000 km
2
 are dominated by mangroves (Sridhar et al., 
2012). The mangroves of Malaysia ranks 6
th
 largest in the world with a total coverage 
area of 6458.5 km
2
, of which 1097.95 km
2
 is in Peninsular Malaysia and 5360.55 km
2
 is 
located in East Malaysia (Spalding et al., 2010). Mangroves are known to be one of the 
most productive ecosystems with intense carbon recycling, thus making them excellent 
harbors of fungi lifeforms (Arfi et al., 2012).  
Manglicolous fungi can be classified into five main groups namely; terrestrial, 
phylloplane, parasites, saprobes and endophytes (Sridhar et al., 2012). Manglicolous 
fungi are commonly found on submerged areas of mangroves, growing on substrates 
such as wood, leaf, seagrass, sediments, soil, sand, algae, coral and calcareous materials 
and they are considered the second largest group of marine fungi (Hyde, 1990).  
The role of fungi in the ecosystem of the mangrove is considered vital as they 
act as decomposers of organic matter (Sridhar et al., 2012). The first manglicolous 
fungus was reportedly isolated from Australia by Cribb et al. (1955). All major fungi 
taxa namely; Ascomycota, Basidiomycota, Deuteromycota, thraustochytrids and lower 
fungi, can be found in the tropical and sub-tropical mangroves (Jones et al., 1997). The 
unique characteristics of the mangroves such as semi-saline surroundings with periodic 
flooding, supports an array of diverse microorganisms with the ability to produce novel 
compounds due to their interactions with their habitat (Amrani et al., 2012).  
21 
 
Marine derived fungi associated with mangrove plants such as Rhizophora 
mucronata, Rhizophora apiculata and Avicenna officinalis have been reported to 
produce new and and novel compounds beneficial to medicine and agrochemicals 
(Bhimba et al., 2011; Rukachaisirikul et al., 2012). Pan et al. (2008) and Li et al. (2010) 
reported that the mangrove habitat along the South China Sea coastline has served as a 
reservoir for marine derived fungi with novel secondary metabolites. 
 
2.3.2 Host plant and endophytic fungi 
Plant scientists believed that there may be an unaccounted number of organisms known 
as endophytes that reside within the inter-cellular spaces of plant tissue (Strobel, 2003). 
Endophytes are defined as microorganisms (bacteria or fungi) that reside inside the 
tissues of an otherwise healthy plant also known as the host plant (Strobel, 2003). The 
symbiotic relationship between an endophytic fungi and its host plant holds a major role 
in structuring plant communities by affecting colonization, competition, coexistence and 
soil nutrient dynamics (Borges et al., 2009). During this symbiotic relationship, neither 
the host plant nor the fungi is harmed in any way. The fungi benefits by gaining 
protection and nutrients from the plant, in return the fungi produces certain secondary 
metabolites that benefits the host plant and protects it from pathogens and herbivores 
(Kusari et al., 2012).  
Scientists have come up with a theory that links these long term host-endophyte 
interactions to the development of specialized genetic systems in the endophytes to 
facilitate the transfer of information from host plant to endophyte. This way, there is an 
exchange of biochemical pathways allowing the endophytes to produce compounds 
similar or common to their host plant (Borges et al., 2009). These secondary 
metabolites, harbors diverse therapeutic activities applicable in medicine and there have 
been instances where the fungi is able to produce certain chemical compounds similar to 
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its host; a known example is the compound taxol, originally isolated from the Pacific 
Yew tree which was also isolated from the endophytic fungi Taxus andreanae (Radic et 
al., 2012). Studies have reported that in comparison to novel compounds from soil 
microflora, 51% of compounds isolated from endophytic fungi were previously 
unreported (Strobel, 2003). Radic et al. (2012) stated that the number of secondary 
metabolites reported from endophytic fungi is larger than that from any other 
endophytic microorganism. However, this may also be due to the frequency of isolation 
of endophytic fungi from plants (Radic et al., 2012). 
According to Yu et al. (2010b), in order to obtain endophytic fungi prone to 
producing novel compounds, there are several criterias to consider when selecting the 
endophyte host plant namely; plants in areas of high biodiversity, plants in harsh or 
challenging habitats, plants surrounded by pathogen infected plants, plants with 
traditional medicinal values and lastly plants occupying a certain ancient land mass.   
Research shows that there are over 300,000 plant species on earth, and it is 
estimated that there may be one or more endophytic fungi residing in each individual 
plant. However over the one million species of endophytic fungi estimated, only a small 
fraction has been described and recorded (Yu et al., 2010b). With regards to the 
estimated abundance of plant endophytic fungi yet to be explored and the ever 
increasing number of novel and interesting compounds isolated from these fungi, it is 
justified that these group of fungi can be untapped reservoirs of unique and biologically 
potent compounds with high commercial potential (Shiono et al., 2011; Cheng et al., 
2012). 
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2.4 Bacterial resistance and nosocomial infections 
More than 30% of the world’s populations are likely affected by bacterial infections 
with roughly two million fatalities recorded each year (Monaghan et al., 2006). 
Antibiotic resistance is fast emerging as a threat to the success of medical interventions 
of health care, at local, national and even global dimensions thereby creating clinical 
and therapeutic challenges to human health (Monaghan et al., 2006). When 
continuously exposed to antibiotic compounds especially in the hospital environment, 
bacteria that are generally considered as normal human flora tend to develop significant 
antibacterial resistance to the antibiotics (Grundmann et al., 2011). Most of these 
bacteria are truly opportunistic pathogens, thus the segment of society most vulnerable 
are usually the young, elderly and immune-compromised individuals (Grundmann et al., 
2011). The European Centre for Disease Prevention and Control (ECDC) rated 
antimicrobial resistance as one of the major infectious disease threats in Europe due to 
increasing levels of multidrug-resistance bacteria. A study by Zaidi et al. (2005), 
reported that 70% of hospital acquired neonatal infections could not be treated 
successfully with the drug regimen recommended by the World Health Organization 
(WHO). The development of new antibacterial agents against these multidrug-resistant 
bacteria is therefore regarded as crucial to public health need (Moran et al., 2011). 
Nosocomial infection is defined as an infection acquired in the hospital by a patient 
whose illness upon admission was independent of the infection. The timeline of 
infection is within 48 hours of hospital admission, 3 days of discharge or 30 days of 
surgery (Inweregbu et al., 2005). The WHO reported that at any one time, over 14 
million people worldwide suffer from complication due to nosocomial infections. 
Nosocomial infections occur worldwide affecting both developed and poor countries 
causing significant burden to both patient and public health (World Health 
Organization, 2002; Centers for Disease Control, 2013)  
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2.4.1 Characteristics of test bacteria and their relation to nosocomial infections 
2.4.1.1 Staphylococcus aureus 
Staphylococcus aureus are Gram positive, non-motile, catalase positive, spherical 
shaped bacterium (cocci) (Hait, 2012). Upon microscopic examination, these 
microorganisms appear either in pairs, short chains or in a bunch like grape cluster 
(Hait, 2012). This bacterium is commonly found in soil, water, air, and also possess the 
ability to live in humans and animals (Hait, 2012). They are one of the most resistant 
non-spore-forming human pathogens which are able to survive in dry states for long 
(Hait, 2012).  
Research has shown that approximately 20% if the human population carry this 
bacterium in their nasal cavity (Weidenmaier et al., 2012). Although commonly acting 
as a commensal, this bacterium can also evolve into a human pathogen triggering a wide 
range of acute and chronic diseases (Weidenmaier et al., 2012). Staphylococcus aureus 
is the predominant agent associated with staphylococcal food poisoning; where they 
produce enterotoxins that are fast acting and usually is not destroyed by the heat 
introduced during cooking of contaminated food (Gadepalli et al., 2009).  
Staphylococcus aureus is the most frequently isolated microorganism in skin 
and soft tissue infections (SSTIs), which is the common cause of morbidity in 
hospitalized patients around the world (Gadepalli et al., 2009). However the 
development of antimicrobial resistance has further complicated treatment management 
of these infections (Gadepalli et al., 2009).  Some of of the other diseases associated 
with this bacterium are; toxic shock syndrome, pneumonia, postoperative wound 
infection and nosocomial bacteremia (Hait, 2012).  
Staphylococcus aureus is fast becoming resistant to standard commercial 
antibiotics with the emergence of methicillin-resistant S. aureus (MRSA) and 
vancomycin-resistant S. aureus (VRSA) (Joo et al., 2012). Reports show that MRSA is 
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the main cause of healthcare associated infection with a record number of two to fifty-
three million human carriers worldwide and a mortality rate of about 20% (Joo et al., 
2012). 
 
2.4.1.2 Bacillus cereus 
Bacillus cereus is a Gram positive, motile, rod-shaped bacterium with haemolytic 
activity and is able to form heat resistant endospores (Tallent, 2012). They are classified 
as saprobes and are thus widespread in the environment, commonly found in soil and 
plants (Tallent, 2012). The main disease associated with B. cereus is food poisoning 
caused by the necrotic enterotoxin produced by this bacterium when contaminated food 
are consumed (Lee et al., 2009; Tallent, 2012). Although cooking can kill the 
bacterium, the toxin might still be active (Tallent, 2012). 
There are two ways this bacterium can induce food poisoning, firstly the 
production of toxins in the intestine when contaminated food is ingested and secondly, 
B. cereus can also produce a different kind of toxin in contaminated food especially in 
starchy foods like rice (Tallent, 2012). The toxins produced by this bacterium are also 
responsible for invasive infections such as panopthalmitis, pneumonia, endocarditis, 
meningitis or septicaemia, especially in immunocompromised patients (Dubouix et al., 
2005). Bacillus cereus has been listed as one of the foodborne microorganisms of public 
health significance and foodborne illnesses (Lee et al., 2009).  
 
2.4.1.3 Bacillus subtilis 
Bacillus subtilis is a Gram positive, catalase positive, rod-shaped bacterium that is able 
to form tough, protective endospores (Bridier et al., 2012). This bacterium is commonly 
found in the soil and is rarely associated with human infections in contrary to B. cereus 
(Bridier et al., 2012). However, recent research by Bridier et al. (2012), reported the 
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isolation of an antimicrobial resistant B. subtilis from an endoscope washer-disinfector 
in the hospital environment. The B. subtilis strain isolated in the study by Bridier et al. 
(2012) was able to produce a thick immersed biofilm with specific protruding structures 
and displayed protective characteristics towards S. aureus. The finding by Bridier et al. 
(2012) could serve to prove that although never once thought to be pathogenic, B. 
subtilis may be emerging as a causal agent in nosocomial infections and may in fact 
aggravate the effects primarily caused by other nosocomial pathogens. 
 
2.4.1.4 Micrococcus luteus 
Micrococcus luteus is a Gram positive, spherical (cocci) bacterium that are commonly 
found on the human skin and mucosal membranes of otherwise healthy individuals and 
have been rarely associated as human pathogens (Oprica, 2009). Although considered to 
be part of the normal flora of the skin, M. luteus is still noted as a contaminant when 
isolated from clinical specimens (Oprica, 2009). This bacterium is an opportunistic 
pathogen normally affecting immune-compromised individuals causing diseases such as 
bacteraemia and sepsis, endocarditis, pneumonia, peritonitis, central nervous system 
infection, and traumatic and post-operative endophthalmitis (Miller et al., 2007). In the 
hospital environment, this bacterium has been closely associated with indwelling 
intravenous lines and dialysis among others (Altuntas et al., 2004). 
 
2.4.1.5 Enterococcus faecalis 
Enterococcus faecalis is a Gram positive, catalase-negative, spherical and ovoid 
bacterium that usually occurs singly, in pairs or in chains (Zhang et al., 2012). 
Enterococcus faecalis is usually a commensal in human and animal gastrointestinal 
tracts and thus usually recovered from faeces and clinical specimens (Zhang et al., 
2012). This bacterium is an opportunistic pathogen and is able to tolerate harsh 
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conditions producing virulence factors such as, cytolysin/hemolysin and adhesins 
among others (Gil et al., 2009). The toxin cytolysin produced by some E. faecalis 
strains display both haemolytic and bactericidal activities, which upon ingestion, may 
cause diarrhoea, cramps, nausea, vomiting, fever and chills in otherwise healthy 
individuals; thus giving this bacterium an added advantage to survive in extreme 
conditions and eliminate competition (Zhang et al., 2012). The people most likely to 
suffer serious problems are usually those with underlying illnesses and immune-
compromised individuals (Zhang, et al., 2012).  
The emergence of vancomycin-resistant and multi-drug resistant enterococci 
strains poses a global threat to human health and may possess serious impact on human 
healthcare (Gil et al., 2009). In the hospital environment, this bacterium has been 
reported to be the frequent cause of endocarditis, bacteraemia, urinary and wound 
infections (Gil et al., 2009). Furthermore, studies by Stuart et al. (2006) reported that E. 
faecalis is the main cause of asymptomatic, persistent endodontic infections ranging 
from 24% to 77%. 
 
2.4.1.6 Escherichia coli 
Escherichia coli is a Gram negative, rod-shaped bacterium predominantly found as a 
commensal in the human gut (Wu et al., 2012). Although commonly associated as 
normal intestinal flora, there are six pathogenic groups namely; entero-toxigenic E. coli 
(ETEC), entero-pathogenic E. coli (EPEC), entero-hemorrhagic E. coli (EHEC), entero-
invasive E. coli (EIEC), entero-aggregative E. coli (EAEC), and diffusely adherent E. 
coli (DAEC) (Feng, 2012). ETEC has been known to cause travellers’ diarrhoea with 
the World Health Organization (WHO) attributing 380,000 deaths each year, mainly 
among children (Feng, 2012). Infantile diarrhoea is usually associated with EPEC with 
mortality rates ranging from 25% to 50% (Feng, 2012). One of the more harmful E. coli 
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strain is the EHEC which produces Shiga toxins (Feng, 2012). Infections of EHEC can 
range from mild diarrhoea to more severe diseases such as haemorrhagic colitis causing 
severe abdominal cramps and bloody diarrhoea which may progress to life-threatening 
complications such as, thrombotic thrombocytopenia purpura (TTP) (Feng, 2012). The 
use of antibiotics for EHEC infections has proven to have more harm than benefits with 
speculation that the antibiotics lyse EHEC cells thus releasing more Shiga toxin into the 
infected host (Feng, 2012). EIEC is on the other hand a less harmful strain commonly 
causing mild bacillary dysentery with the Centre’s for Disease Control and Prevention 
(CDC) listing a death rate of zero for infections by this bacterium (Feng, 2012).  
Escherichia coli is also a common pathogen associated with nosocomial urinary 
tract infections (UTIs) (Bonkat et al., 2011). The emergence of extended-spectrum beta-
lactamase E. coli, a strain resistant to all penicillins, first-, second- and third generation 
cephalosporin sans aztreonam has become an on-going problem in the hospital 
environment (Bonkat et al., 2011). 
 
2.4.1.7 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a Gram negative, monoflagellated, rod-shaped bacterium 
that are commonly found in the soil, water and also on humans and animals (Iversen et 
al., 2008). It is an opportunistic pathogen and usually affects immune-compromised 
individuals (Iversen et al., 2008). This bacterium is one of the leading causes of 
nosocomial infections, whereby almost 10% of hospital acquired infections are caused 
by P. aeruginosa and is ranked among the top ten causes of bacteraemias in hospitals 
(Iversen et al., 2008).  
Pseudomonas aeruginosa are known to be associated with several hospital 
acquired infections ranging from urinary tract infection, respiratory and central nervous 
system infections to ear, eye, bone, and skin infections (Iversen et al., 2008; Bilavsky et 
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al., 2013). A severe complication associated with this bacterium is blood stream 
infections which carries a mortality rate ranging from 18% to 39% (Suarez et al., 2009). 
Pseudomonas aeruginosa has been notoriously known to acquire and develop resistance 
to most standard antibiotics thus increasing the mortality rates of its infections (Suarez 
et al., 2009). 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Collection, isolation and identification of marine derived fungi 
3.1.1 Endophytic fungi of marine associated host plants 
The two marine associated plants chosen in this study were, Vitex rotundifolia and 
Ipomoea pes-caprae as shown in Figure 3.1. Vitex rotundifolia was collected from Kijal 
Beach, Terengganu (east coast, Peninsular Malaysia), while the plant I. pes-caprae was 
collected from Port Dickson Beach, Negeri Sembilan (west coast, Peninsular Malaysia).  
Vitex rotundifolia, commonly known as Beach Vitex, is an exotic deciduous 
woody shrub that does not grow high but rather forms thick patches on the soil (Maddox 
et al., 2007). Beach Vitex can reach one to two inches high and around twelve inches in 
diameter but their stem runners can grow up to 60 inches long (Maddox et al., 2007). 
This fast growing woody vine is able to tolerate the harsh conditions of beach sand 
dunes whereby, they can tolerate the drough conditions of the sand on the beach as well 
as the salt spray from the ocean (Maddox et al., 2007). Beach Vitex is native to 
Malaysia, Indonesia and Hawaii, but is also found in China, Taiwan, Japan, India, Sri 
Lanka, Mauritius, Australia and the Pacific Islands (Maddox et al., 2007). 
Ipomoea pes-caprae is a pantropical, perennial, trailing vine with pick flowers 
(Devall, 1992). It known to be a widely distributed beach plant, forming wide and thick 
continuous mats on the beach sand dunes mostly in the tropical and subtropical areas in 
the world (Devall, 1992). 
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Figure 3.1: Photographs of endophytic fungi host plants. A and B: V. rotundifolia; C 
and D: I. pes-caprae 
 
3.1.1.1 Collection and isolation of marine derived endophytic fungi 
Whole plant materials were excised using clean scissors and placed in sterile polythene 
bags and transported back to the laboratory within four hours for analysis. Samples 
were washed with distilled water to remove surface sand and debris. The leaves and 
stem of the plant were then cut into standard 6 mm sizes and surface sterilized using a 
regimen of, 70% ethanol for two minutes followed by 4% bleach for one minute after 
which they were treated again with 70% ethanol for one minute and finally rinsed thrice 
in distilled water.  
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The surface sterilized plant materials were then placed on potato dextrose agar 
(PDA) and incubated at 37°C. The agar was observed daily for mycelia sporulation; 
germinating mycelia was then transferred to fresh media using a fine needle to obtain 
pure fungi cultures. The cultures were then transferred to agar slant and stored at 8°C 
until further use. The identification of the endophytic fungi was done using molecular 
methods as elaborated further in this dissertation. 
 
3.1.2 Manglicolous fungi 
The manglicolous fungi strains used in this study were obtained from the Institute of 
Biological Science (ISB) culture collection. All fungi strains were from the mangrove 
habitats of Peninsular Malaysia. The manglicolous fungi were maintained on PDA 
supplemented with 25 ppm marine salt.  
 
Table 3.1: List of manglicolous fungi in the present study 
Fungi Culture collection number 
Corollospora maritima Werderm. ISB007 
Dactylospora haliotrepha (Kohlm. & E.   
  Kohlm.) Hafellner 
ISB001 
Dactylospora haliotrepha  ISB002 
Dactylospora haliotrepha  ISB003 
Dactylospora haliotrepha  ISB004 
Fusarium sp. ISB008 
Henningsomyces sp. ISB009 
MF 28 ISB010 
Saccardoella rhizophorae K.D. Hyde ISB011 
Verruculina enalia (Kohlm.) Kohlm. &  
  Volkm.-Kohlm. 
ISB005 
Verruculina enalia  ISB006 
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3.2 Molecular identification of endophytic marine derived fungi 
3.2.1 Deoxyribonucleic acid (DNA) extraction from marine derived endophytic fungi 
Extraction of DNA was carried out using the “Plant Mini DNeasy Kit” from Qiagen. 
Firstly the samples were homogenized using a mortar and pestle. Secondly, 400 µl of 
Lysis buffer and 4 µl of RNase A were added to the samples, after which the samples 
were vortexed and incubated for ten minutes at 65°C. Next, 130 µl Precipitation Buffer 
was added and mixed with the sample, followed by 5 minutes incubation period on ice. 
The lysate was then centrifuged for five minutes at 14,000 rpm. The lysate was further 
pipetted into a QIAshredder Spin Column placed in a 2ml collection tube and 
centrifuged for two minutes at 14, 000 rpm. The flow-through was then transferred into 
a new tube without disturbing the pellet and 1.5 volumes of Washing Buffer was added 
and mixed. About 650 µl of the mixture was then transferred into a DNeasy Mini spin 
column placed in a 2ml collection tube and centrifuged for one minute at 9, 000 rpm. 
The flow through was discarded. The spin column was then transferred into a new 2 ml 
collection tube and 500 µl of Washing Buffer was added followed by centrifugation for 
one minute at 9000 rpm. The flow through was discarded and another 500 µl of 
Washing Buffer was added followed by centrifugation for two minutes at 14, 000 rpm. 
The spin column was then transferred to a new 2 ml centrifuge tube. Lastly, 100 µl of 
Elution Buffer was added for elution and incubated for five minutes at room 
temperature (15-25°C) and centrifuged for one minute at 9, 000 rpm. 
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3.2.2 Preparation of agarose gel 
The agarose used in this study was 10 % agarose which was prepared by dissolving 1 g 
of agarose powder in 100 ml of distilled water. The slurry mixture was then heated in a 
microwave until it turned clear. The mixture was then left to cool for about ten minutes, 
after which 5 µl of the staining dye Cyber Safe was added and mixed well. The agarose 
mixture was then poured into the gel blocks and left to solidify.  
 
3.2.3 Preparation of Tris-acetate-EDTA (TAE) buffer 
The TAE buffer was prepared by adding 40 ml of the 25 times TAE stock buffer with 
960 ml of distilled water to obtain 1000 ml of TAE buffer.  
 
3.2.4 Preparation of Tris-EDTA (TE) buffer 
TE buffer was made from 1 M stock of Tris-Cl at pH 7.5 and 500 mM stock of EDTA 
at pH 8.0. To make 1 litre of TE buffer, 10 ml 1 M Tris-Cl at pH 7.5 was added with 2 
ml of 500 mM EDTA at pH 8.0. The mixture was then topped up with 988 ml of 
distilled water to obtain a total of 1 litre TE buffer. 
 
3.2.5 Preparation of primer working solution 
The concentration of the primer stock for both ITS 4 and ITS 5 was 100 µM. The 
concentration in the Polymerase Chain Reaction (PCR) mixture should be 0.5 µM. 
Therefore a primer working solution of 25 µM was prepared by adding 12.5 µl of 
primer stock and 37.5 µl of TE buffer to obtain 50 µl of primer working solution.  
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3.2.6 Polymerase chain reaction (PCR) 
The PCR reaction mixture consisted of 25 µl of PCR mix from QIAGEN, 1 µl of ITS 4 
primer, 1 µl of ITS 5 primer, 2 µl of template DNA and 21 µl of RNase free water. The 
mixture was then placed into the thermal cycler and for initial amplification, PCR 
reaction mixtures were denatured for 5 minutes at 96°C, followed by 35 PCR cycles for 
30 seconds at 95°C, 30 seconds at 52°C, and 90 seconds at 72°C. The final extension 
step was at 72°C for 10 minutes. This cycle was programmed for 35 reactions.  
After the PCR, the resultant products were runned on the agarose gel submerged 
in TAE buffer solution in a gel electrophoresis tank. The electrophoresis was runned at 
100 Volt for 30 minutes. The presence of a distinct thick band indicated a successful 
PCR run. The PCR products were then sent for PCR clean-up and DNA sequencing to 
First Base Laboratories Sdn. Bhd for direct sequencing using the same primers. 
 
3.2.7 Alignment of DNA sequences using MEGA 5.0 and Basic Local Alignment 
Search Tool (BLAST) 
The ITS 1 and 2 DNA sequences of endophytic fungi were aligned using the MEGA 5.0 
software and the BLAST program at the US National Centre for Biotechnology 
Information (NCBI), (http://www.ncbi.nlm.gov/) was employed for nucleotide sequence 
analysis and database searches to identify the putative genus or species of the fungi. The 
nucleotide sequences of the endophytic fungi strains were aligned against their 
respective test strains to further confirm their match and thus validating the 
identification.  
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3.3 Preliminary screening of marine derived endophytic and manglicolous fungi 
using the plug assay method 
The preliminary screening for antibacterial activity of endophytic and manglicolous 
fungi was carried out using a mycelial plug assay method as described by Hoskisson et 
al. (2001), Ezra et al. (2004) and Zainuddin et al. (2008).  
Prior to the bioassay, the fungi isolates were cultured on potato dextrose agar 
(PDA) without antibiotic supplements for one week at 37°C. The test bacteria used 
comprised of both Gram positive and negative strains. The Gram positive bacteria used 
were, Staphylococcus aureus Rosenbach MTCC 96 (ATCC 9144), Bacillus subtilis 
(Ehrenberg) Cohn. (ATCC 6051), Bacillus cereus Frankland and Frankland (ATCC 
11778), Micrococcus luteus (Schroeter) Cohn (ATCC 49732) and Enterococcus faecalis 
(Andrewes and Horder) Schleifer and Kilpper-Balz (ATCC 29212). The Gram negative 
bacteria used were Escherichia coli (Migula) Castellani & Chalmers MTCC 443 
(ATCC 25922) and Pseudomonas aeruginosa (Schroeter) Migula (ATCC 27853). The 
test bacteria were provided by the Microbiology Department, University of Malaya and 
were maintained on Luria Broth (LB) agar at 4°C.  
To inoculate the test bacteria, a few colonies were picked using a sterile 
inoculation loop and transferred to a universal bottle containing Mueller Hinton broth 
(MHB) and shaken well. A bacterial suspension of each test bacteria was prepared 
according to the concentration of the 0.5 McFarland standard. The 0.5 McFarland 
standard was prepared by adding 0.5 ml of 1.174% (wt/vol) barium chloride dehydrate 
(BaCl22H2O) solution to 99.5 ml of 1% (vol/vol) sulphuric acid. The absorbance of the 
0.5 McFarland standard was checked using a spectrophotometer set at a wavelength of 
625 nm. A sterile cotton swab was dipped into the adjusted test bacterial suspension and 
slightly pressed against the inside wall of the tube to remove excess fluid. This cotton 
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swab was then used to swab the entire surface of the LB agar. The agar plates were 
divided into four sections and 6 mm agar plugs was cut out from each section of the 
agar plate to form wells. A 6 mm plug of fungal mycelia was then taken from the edge 
of an actively growing fungal culture to replace the well in the agar plates inoculated 
with the test bacteria. The plates were then incubated at 37°C for 24 hours. The 
diameter of the zone of inhibition was measured in millimetre (mm) and a zone of 
inhibition of 8 mm in diameter or higher is taken as a positive response (Zainuddin et 
al., 2008). The experiment was conducted in triplicates. All preparative procedures of 
media are attached as Appendix 1. 
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3.4 Determination of minimum inhibitory concentration (MIC) values of marine 
derived endophytic and manglicolous fungi extracts 
The marine derived endophytic and manglicolous fungi strains which demonstrated 
promising antibacterial activity in the plug assay was further investigation through the 
broth microdilution assay. This was done to obtain quantitative results from the 
qualitative results obtained from the plug assay, thus further asserting the antibacterial 
activity exhibited by these fungi strains. 
 
3.4.1 Extraction of fungal secondary metabolites 
The fungi isolates were grown on sterile PDA in Petri plates for 14-30 days at 25°C. 
Active growing fungi mycelium was then cut into 6 mm plugs and three of those 
mycelial plugs were added into conical 250 ml flasks containing potato dextrose broth 
(PDB) and the flasks were incubated at 25°C under shaken phase of 120 rpm for thirty 
days. After the incubation period, the fungal biomass was separated by filtration. The 
filtrate was then extracted with equal volumes of ethyl acetate (EA) (1:1). The organic 
EA layers were then combined and evaporated to dryness using a rotary evaporator at 
25°C. The resulting crude obtained was weighed and stored at -20°C prior to use. 
 
3.4.2 Preparation of p-Iodonitrotetrazolium violet (INT) and antibiotics 
To prepare INT, 0.4 mg was dissolved in 1 ml of distilled water. As for antibiotics 
chloramphenicol and penicillin, 2.0 mg of powder was dissolved in 1 ml of distilled 
water with respect to each antibiotic. Both solutions were stored at -4°C prior to use. 
Preparative procedures of chemicals are attached as Appendix 1. 
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3.4.3 Preparation of bacterial suspension 
The bacterial suspension was prepared according to the 0.5 McFarland standard. Firstly, 
three to five isolated colonies were taken from a pure 24-hour bacterial culture at 37°C 
on the MHA medium with a sterile inoculation loop and inoculated into a sterile Falcon 
tube containing 3 ml of MHB solution. The suspension was shaken well and the 
absorbance value was adjusted between 0.08-0.10 at 625 nm wavelength using a 
spectrophotometer. At this adjusted absorbance value, the bacterial concentration would 
be 1×10
8 
cfu/ml similar to a 0.5 McFarland standard as mentioned in sub-chapter 3.3 
above. The bacterial suspension was then diluted to 1×10
6 
cfu/ml in order to achieve the 
final concentration of 5×10
5 cfu/ml after the addition of 50 μl of bacterial suspension 
into the well. 
 
3.4.4 Preparation of crude stock 
Forty milligrams of each extract was dissolved in 1% Dimethyl sulfoxide (DMSO) to 
obtain a concentration of 10 mg/ml of stock solution. The solution was sonicated to 
ensure homogeneity. The solution was then filtered using 0.45 μm syringe filter into a 
sterile eppendorf tube and kept at -20°C. 
 
3.4.5 Bioassay using broth microdilution method 
A sterile 96-well plate was labelled under aseptic conditions as shown in Figure 3.2. 
Firstly, 100 μl of Mueller-Hinton broth (MHB) was added to the wells at each corner of 
the plate, labelled blue in Figure 3.2 to serve as sterility control. The wells labelled pink 
acted as growth control, containing 50 μl MHB and 50 μl bacteria. The wells labelled 
green acted as negative control, containing 75 μl MHB and 25 μl extract. Fifty 
millilitres of MHB was added to all the wells in column 2-11, and 50 μl of different 
fungi extracts in 1% DMSO were pipetted into the first row of the 96 well plate 
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(Column 2-7). Two-fold serial dilutions were performed using a multichannel 
micropipette. Wells in columns 2 to 8 contained the same fungi extracts but with 
dilutions, 2.0, 1.0, 0.50, 0.25, 0.125, 0.063, 0.031 and 0.016 mg/ml while wells in 
column 9 to 11 contained 50 µl of antibiotic with dilutions, 2.0, 1.0, 0.50, 0.25, 0.125, 
0.063, 0.031 and 0.016 mg/ml. Finally 50μl of bacterial suspension (1×106 cfu/mL) was 
added to each tested wells and growth control to achieve a final concentration of 5×10
5 
cfu/ml. The 96 well plates were put on the orbital shaker for 10 minutes and then 
incubated at 37ºC for 24 hours.  
After 24 hours, 20 μl of INT were added into each of the wells, and placed on 
the orbital shaker for 10 minutes, and then incubated at 37ºC for 30 minutes. The 
changes in colour were then observed. The wells that remained colourless or clear 
meant that the extract was active against the bacteria while the wells that observed pink 
colour meant that there were bacteria present and thus indicating that the extract was 
inactive againt the bacteria. The lowest concentration of the extract at which there was 
no colour changes in the well was taken as the MIC value. The assay was carried out in 
triplicates to ensure the accuracy of results.  
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A                                                                     
B                                                                    
C                                                                    
D                                                                    
E                                                                    
F                                                                    
G                                                                    
H                                                                    
 
       1         2         3         4         5        6        7         8         9        10      11       12 
  
 Sterility control (100 µl MHB) 
 Growth control (50 µl MHB + 50 µl bacterial suspension) 
 Negative control (25 µl fungi extracts + 75 µl MHB) 
 Positive control (50 µl antibiotic + 50 µl bacterial suspension) 
 50 µl fungi extracts and 50 µl MHB were added to first well then diluted 50µl 
from first well to second well and so on until the last well, 50 µl of extracts were then 
discarded, after dilution, 50 µl bacteria suspension was added. 
 Two-fold serial dilutions 
 
Figure 3.2: Illustration of the 96 well plate used in broth microdilution assay 
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3.5 Chemical analysis of ethyl acetate crude extract (EAS) of Saccardoella 
rhizophorae  
3.5.1 Extraction of crude fungal extract for fractionation 
The fungi, S. rhizophorae was grown in 3 L of PDB supplemented with 25 ppm of 
marine salt. The culture was incubated at a temperature of 25°C for 15 days at an 
agitation rate of 100 rpm. At the end of the incubation, the broth was filtered, separating 
the fungal mass and broth solution. The broth solution was partitioned with equal 
volumes of EA and the resulting organic layer was separated. The fungal mass was 
dried and extracted with EA at a ratio of 1g of dried fungal mass: 10 ml of EA. Both EA 
extracts from the broth solution and the dried fungal mass was pooled together and 
evaporated to dryness. The resulting dried EAS of S. rhizophorae was then stored at -
4°C prior to use. 
 
3.5.2 Solvent sequential extraction 
The dried EAS of S. rhizophorae was partitioned by sequential extraction using solvents 
of increasing polarity starting with, n-hexane, dichloromethane and methanol. The dried 
EAS of S. rhizophorae was first soaked in n-hexane at a ratio of 1 g: 10 ml solvent and 
shaken in an orbital shaker for 7 hours. The solvent mixture was filtered using Whatman 
filter paper to separate the solution from undissolved solids and the resulting solution 
was evaporated to dryness. The remaining undissolved solids on the filter paper were 
then dried and soaked dichloromethane following the same procedure. This was 
repeated with the methanol. The last solvent methanol resulted in no undissolved solids. 
This partitioning procedure afforded a total of three fractions; n-hexane (HS), 
dichloromethane (DS) and methanol (MS) fractions. 
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3.5.3 Column chromatography 
Column chromatography was carried out using silica gel (Merck 230-400 mesh ASTM). 
The ratio of the silica gel to sample loaded was approximately 30:1. The silica was 
made into a slurry using dichloromethane before packing into the glass column. The 
sizes of glass column used in the experiment were of various dimensions as it depended 
on the weight of crude extract and partially purified fractions. Antibacterial test on 
fractions HS, DS and MS showed that only two of the three fractions (HS and DS) 
displayed antibacterial activity. Therefore, bioassay-guided fractionation was carried out 
on fractions HS and DS. To obtain sub-fraction, HS fraction was dissolved in n-hexane 
and subjected to column chromatography using a gradient solvent system of 100% n-
hexane,  90% n-hexane: 10% EA, 85: 15, 80: 20, 75: 25, 70: 30, 65: 35, 60: 40, 55: 45, 
50: 50, 100% EA and 100% acetone. To obtain sub-fractions, DS fraction was dissolved 
in dichloromethane and was fractionated using a gradient solvent system of 100% 
dichloromethane, 95% dichloromethane: 5% EA, 90: 10, 85: 15, 80: 20, 75: 25, 70: 30, 
65: 35, 60: 40, 55: 45, 50: 50, 100% EA and 100% acetone. Individual column fractions 
were combined according to their TLC profiles.  
 
3.5.4 Preparative thin layer chromatography (TLC) 
Preparative TLC was carried out on Merck 60 F254 silica gel plates. Standard 
chromatograms of sub-fractions were prepared by applying a small drop of the sub-
fraction to a silica gel TLC plate and developing it using different solvent systems, to 
improve separation under saturated conditions. Separated bands were detected by UV-
light at 254nm and 365 nm. Upon optimization of the solvent system, the sub-fractions 
were further purified using the same solvent system. The purity of the compound 
isolated was confirmed by observing their respective NMR spectra. 
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3.5.5 Structure elucidation of the isolated secondary metabolite 
3.5.5.1 Nuclear magnetic resonance spectroscopy (NMR) 
Structures were elucidated mainly using one and two dimensional Nuclear magnetic 
resonance (NMR) techniques and Liquid chromatography-mass spectrometry (LC/MS). 
NMR spectra of extracts and pure compounds were recorded using JEOL ECA 400 
MHz and JEOL LA 400 MHz NMR spectrometers in chloroform D1 (CDCl3) as a 
solvent and tetramethysilane as internal standard. The observed chemical shifts (δ) 
values were recorded in ppm. 
 
3.5.5.2 Liquid chromatography-mass spectroscopy (LCMS) 
The Liquid chromatography-mass spectrum-Ion trap-Time of flight (LC-MS-IT-TOF) 
spectra were recorded on a Ultra-fast liquid chromatography (UFLC) Shimadzu Liquid 
Chromatograph with a SPD-M20A diode array detector coupled to a IT-TOF The IT-
TOF was operated in positive ion electrospray mode. 
 
3.5.5.3 Infra-red spectroscopy 
Infrared light is the region of the electromagnetic spectrum with longer wavelength and 
lower frequency in comparison to visible light. Different molecules absorb specific 
frequencies of infrared light with respect to their structure thus this spectroscopic 
technique is used in the identification and study of chemicals. IR spectra were recorded 
using a Perkin-Elmer Spectrum 400 FT-IR Spectrometer.  
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3.5.5.4 Ultraviolet-visible spectroscopy 
Ultraviolet-visible (UV) light is light in the visible and adjacent near-ultraviolet and 
near-infrared regions of the electromagnetic spectrum. UV spectroscopy is used in the 
determination and quantification of chemical based on their different absorption 
energies. UV-visible spectrum was recorded using a Shimadzu 1650 PC UV-Vis 
Spectrophotometer. 
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Figure 3.3: Schematic protocol of isolation of the bioactive metabolite by bioassay 
guided fractionation from S. rhizophorae 
 
S. rhizophorae grown in PD broth for fifteen days (3 L) 
 
Fermented broth filtered using vacuum pump 
Mycelia and filtrate extracted with EA; three times 
EAS dried using rotary evaporator (900 mg) 
Antibacterial assay 
 
Dried EAS sequentially partitioned with three solvents (n-hexane, 
dichloromethane and methanol) 
Antibacterial assay- Fraction HS and DS active  
 
Fractionation of HS and DS by column chromatography 
HS (seven sub-fractions) DS (seven sub-fractions) 
Antibacterial assay 
 
Isolation of palmitic and linoleic 
acid from sub-fraction 2 and 3 
respectively confirmed by NMR 
Compounds too minute for 
further investigation 
Antibacterial assay 
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3.6 Chemicals, media & kits 
The chemicals and media used in this study are listed in Table 3.2. 
Table 3.2: List of chemicals and media 
Chemicals/Media Manufacturer 
Acetone 
Dichloromethane 
Ethyl acetate 
Methanol   
n-hexane    
p-Iodonitrotetrazolium violet (INT)  
Mueller-Hinton agar (MHA)  
Mueller-Hinton broth (MHB)   
Luria-Broth (LB) agar   
Potato Dextrose agar (PDA)  
Potato Dextrose broth (PDB)   
Chloroform-D1    
Silica gel 60    
TLC Silica gel 60  
Agarose  
TAE Buffer  
Tris (hydroxymethyl) aminomethane 
hydrochloride  
Ethylenedinitrilotetraacetic acid (EDTA) 
PCR Master mix 
DNeasy® Plant Mini kit   
Systerm Chem AR 
Systerm Chem AR 
Systerm Chem AR 
Systerm Chem AR 
Systerm Chem AR 
R&M Marketing, Essex, U.K 
Oxoid LTD, Basingstoke 
Oxoid LTD, Basingstoke 
Merck 
Difco 
Difco 
Merck 
Merck 
Merck 
NextGene 
Bio Basic Inc 
Merck 
 
Merck 
QIAGEN 
QIAGEN 
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3.7 Instruments and Labware 
The instruments and labware used in this study are listed in Table 3.3. 
Table 3.3: List of intruments and lab ware 
Instruments/Lab ware Manufacturer 
Autoclave machine 
Beaker 
Bunsen burner 
 
Conical flask 
Spectrophotometer 
Freezer 
Refrigerator 
Laminar flow hood 
Electronic balance 
Rotary evaporator 
Schott bottle 
Measuring cylinder 
Sterile swab 
Flat-bottom polysterene 96 well plate 
Syringe 
Parafilm 
UV Illuminator 
UV Spectrophotometer 
 
IR Spectrometer 
 
Orbital shaker 
Eppendorf tubes 
Membrane filter 
Micropipette 
Capillary tube 
TLC glass chamber 
Glass column  
Test tube 
Glass dropper 
Glass vial 
NMR tube  
NMR 
 
LCMS 
HR-ESI-MS 
 
 
Fume Hood 
TOMY 
GQ 
CAMPINGAZ, Kolon International Corp, 
Korea 
Bomex 
Eppendorf 
Fischer Scientific
TM
 
WELTEX, Refrigeration & Equipment 
ESCO 
Sartorius 
BUCHI 
DURAN® 
NORMAX 
NA 
NUNC 
BD 
PECHINEY Plastic Packaging, Chicago, 
IL 
Perkin-Elmer Spectrum 400 FT-IR 
Spectrometer 
Shimadzu 1650 PC UV-Vis 
Spectrophotometer 
WiseShake®, Wisd 
Axygen® scientific 
Minisart® Sartorius 
Transferpette® 
NA 
NA 
NA 
NA 
NA 
NA 
Schott Duran 
JEOL (JEOL Ltd., Tokyo, Japan) ECA 
400 MHz 
Shimadzu 
Thermo Instrument (Thermo Fisher 
Scientific, Bremen, Germany) LTQ 
XL/LTQ Orbitrap Discovery system 
Cole-Parmer 
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Table 3.3, continued 
 
 
 
Instruments/lab ware Manufacturer 
Round bottom flask 
Filter paper 
Centrifuge 
Vortex 
Electrophoresis gel tank and adapter 
Water bath  
BUCHI 
Whatman®, Schleicher & Schuell 
Eppendorf 
LMS Co, LTD 
CS 
WiseTherm, Wisd 
NA: not applicable 
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CHAPTER 4 
RESULTS 
 
4.1 Endophytic fungi strains from marine associated plants 
4.1.1 Endophytic fungi from Vitex rotundifolia and Ipomoea pes-caprae 
A total of 34 endophytic fungi were isolated from both marine associated plants 
including thirteen from V. rotundifolia and twenty-one strains from I. pes-caprae. The 
thirteen endophytic fungi strains identified from V. rotundifolia comprised of seven 
genera/species of fungi. Based on Table 4.1, six strains were identified to species level, 
while six were identified to genus level. The twenty-one strains from I. pes-caprae, 
were comprised of fifteen genera/species of fungi. Alignment of ITS DNA sequences 
are attached in Appendix 2. As shown in Table 4.1, five strains were identified to its 
species level while fifteen strains were identified to genus level. The photographs of 
selected endophytic fungi strains from isolated from V. rotundifolia and I. pes-caprae 
are shown in Figure 4.1 and 4.2 respectively. Certain species/genera of endophytic fungi 
occured in each plant whereby they were of the same species/genus but could be 
different strains as suggested by their differing GenBank accession numbers as shown 
in Table 4.1. Overlapping strains isolated from V. rotundifolia were Cochliobolus 
eragrostidis (two strains), Curvularia sp. (two strains), Nemania primolutea (two 
strains) and Phoma sp. (three strains). Overlapping strains from I. pes-caprae were 
Bipolaris sp. (four strains), Dothideomycete sp. (two strains) and Phoma sp. (two 
strains). Endophytic fungi strains such as Phoma sp. and Guignardia mangiferae 
appeared common to the two marine associated plants as they were isolated both from 
V. rotundifolia as well as I. pes-caprae. 
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Table 4.1: Putatively named endophytic fungi from the marine associated plants V. 
rotundifolia and I. pes-caprae  
 
Fungi Plants 
V. 
rotundifolia 
GenBank 
accession 
I. pes-
caprae 
GenBank 
accession 
Bipolaris sp. -  ++++ GU017499.1 
HQ631009.1 
JX960589.1  
JX949177.1 
Clasdosporium 
 cladosporioides (Fresen.) 
 G.A. de Vries 
-  + EU497957.1 
Cochliobolus eragrostidis 
 (Tsuda & Ueyama) Sivan. 
++ JN943412.1 
JN943448.1 
-  
Cochliobolus lunatus R.R. 
 Nelson & F.A. Haasis 
-  + GQ169765.1 
Colletotrichum hippeastri 
 Yan L. Yang, Zuo Y. Liu, 
  K.D. Hyde & L. Cai 
-  + JX010293.1 
Colletotrichum sp. -  + JN390940.1   
Curvularia sp. ++ GQ184733.1 
HQ631061.1 
-  
Dothideomycete sp. -  ++ HQ631008.1 
JQ759890.1 
Fungal endophyte sp g88 -  + HM537063.1 
Fungal sp. ARIZ B233 + FJ612966.1 -  
Fusarium equiseti (Corda) 
 Sacc. 
-  + EU595566.1 
Guignardia mangiferae A.J. 
 Roy 
+ KC686598.1 
 
+ EU273524.1 
Letendraea helminthicola 
 (Berk & Broome) Weese 
+ JQ026217.1 -  
Minimidochium sp. -  + HQ630974.1 
Montagnulaceae sp. -  + KC291642.1 
Myrothecium sp. -  + HQ631067.1 
Nemania primolutea Y.M. 
 Ju, H.M. Hsieh & J.D. 
Rogers 
++ EF026121.1 
KC845930.1 
-  
Paecilomyces sp. + HQ631041.1 -  
Penicillium sp. -  + JQ889696.1 
Phoma sp. +++ HQ630963.1 
JN207285.1 
JQ388280.1 
 
++ HQ630963.1 
JQ388280.1 
Pleosporales sp. -  + HQ631015.1 
Xylaria sp. -  + EF423534.1 
 “-“ = represents absence of strain 
“+” = represents presence and number of strains 
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A B  
C  D  
E  F  
 
 
 
Figure 4.1: Photographs of selected endophytic fungi isolated from V. rotundifolia on 
PDA. A: G. mangiferae; B: Phoma sp.; C: L. helminthicola; D: C. eragrostidis; E: 
Paecilomyces sp.; F: Fungal sp. ARIZ B233 
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A  B  
C  D  
E  F  
 
 
 
Figure 4.2: Photographs of selected endophytic fungi isolated from I. pes-caprae on 
PDA. A: C. cladosporioides; B: Dothideomycete sp.; C: Phoma sp.; D: Bipolaris sp.; E: 
F. equiseti; F: Colletotrichum sp. 
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4.2 Antibacterial activity of marine derived fungi based on plug assay 
4.2.1 Antibacterial activity of endophytic fungi from Vitex rotundifolia and Ipomoea 
pes-caprae 
Table 4.2 shows the results obtained from the antibacterial activity screening of the 34 
endophytic fungi using the plug assay method. As shown in Table 4.2, five of the 
thirteen isolated endophytic fungi strains from V. rotundifolia displayed antibacterial 
activity against at least one test bacteria while ten of the twenty-one isolated endophytic 
fungi strains from I. pes-caprae displayed antibacterial activity against at least one test 
bacteria. Results obtained showed that eight and eleven fungi strains from V. 
rotundifolia and I. pes-caprae respectively did not exhibit antibacterial activity against 
any of the test bacteria. The endophytes from V. rotundifolia displayed selective 
antibacterial activity towards only Gram positive bacteria namely; Staphylococcus 
aureus, Bacillus cereus and Bacillus subtilis. Two fungi strains exhibited antibacterial 
activity against S. aureus, five strains against B. cereus and four strains against B. 
subtilis. The fungi strains from V. rotundifolia which displayed the broadest spectrum of 
antibacterial activity which was against three test bacteria were; Paecilomyces sp. and 
Curvularia sp.  
As for the endophytic fungi strains from I. pes-caprae, eight of fungi strains 
exhibited antibacterial activity against S. aureus, seven against B. cereus, six against B. 
subtilis, eight against Micrococcus lutues, one against Enterococcus faecalis, three 
against Escherichia coli, and one against Pseudomonas aeruginosa. The broadest 
spectrum of antibacterial activity was exhibited by Bipolaris sp. (HQ631009.1) which 
was against six out of the seven test bacteria comprising of both Gram positive and 
negative test bacteria. Although most of the endophytic fungi strains from I. pes-caprae 
displayed antibacterial activity against Gram positive bacteria, some of the fungi strains 
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were potent against Gram negative bacteria such as; Dothideomycete sp. (HQ631008.1) 
exhibited antibacterial activity against P. aeruginosa and fungi strains Minimidochium 
sp., Bipolaris sp. (HQ631009.1), and Penicillium sp. exhibited antibacterial activity 
against E. coli. A sample of the zones on inhibition demonstrated by the fungi through 
the plug assay is shown in Figure 4.3. The diameter of zones of inhibition values are 
attached as Appendix 3. 
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Table 4.2: Preliminary antibacterial activities of endophytic fungi from the marine associated plant V. rotundifolia and I. pes-caprae against seven 
bacterial strains 
 
Fungi V. rotundifolia I. pes-caprae 
GenBank accession 
number 
Activity GenBank accession 
number 
Activity 
Bipolaris sp. - - GU017499.1 
HQ631009.1 
 
JX960589.1 
JX949177.1 
NA 
SA(G), BC(G), BS(M), 
EF(G), ML(G), EC(W) 
NA 
BS(M), ML(G) 
C. cladosporioides - - EU497957.1 NA 
C. eragrostidis JN943412.1 
JN943448.1 
NA 
BC(G), BS(G) 
- - 
C. lunatus - - GQ169765.1 NA 
C. hippeastri  - - JX010293.1 NA 
Colletotrichum sp. - - JN390940.1   NA 
Curvularia sp. GQ184733.1 
HQ631061.1 
SA(G), BC(G), BS(G) 
NA 
- - 
Dothideomycete sp. - - HQ631008.1 
 
JQ759890.1 
SA(M), BC(M), ML(M), 
PA(W) 
NA 
Fungal endophyte sp g88 - - HM537063.1 NA 
Fungal sp. ARIZ FJ612966.1 NA - - 
F. equiseti  - - EU595566.1 SA(G), BC(G), BS(G), 
ML(G) 
G. mangiferae  KC686598.1 
 
BC(G), BS(G) EU273524.1 NA 
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Table 4.2, continued 
 
 
    
L. helminthicola  JQ026217.1 NA - - 
Minimidochium sp. - - HQ630974.1 SA(W), BC(W), BS(W), 
ML(M), EC(W) 
Montagnulaceae sp. - - KC291642.1 SA(G), BC(G), BS(G), 
ML(G) 
Myrothecium sp. - - HQ631067.1 SA(W), BC(W), BS(W) 
N. primolutea  EF026121.1 
KC845930.1 
NA 
NA 
- - 
Paecilomyces sp. HQ631041.1 SA(G), BC(G), BS(G) - - 
Penicillium sp. - - JQ889696.1 SA(W), BC(W), EC(W) 
Phoma sp. HQ630963.1 
JN207285.1 
JQ388280.1 
NA 
BC(W) 
NA 
HQ630963.1 
JQ388280.1 
ML(W) 
SA(M), ML(M) 
Pleosporales sp. - - HQ631015.1 NA 
Xylaria sp. - - EF423534.1 NA 
NA: No activity towards any test bacteria  
SA: Staphylococcus aureus; BC: Bacillus cereus; BS: Bacillus subtilis; EF: Enterococcus faecalis; ML: Micrococcus luteus; EC: Escherichia coli; PA: Pseudomonas aeruginosa 
(W): Weak activity; (M): Moderate activity; (G): Good activity 
Activities were classified as: 8 mm to 9 mm: weak activity; 10 mm to 11 mm: moderate activity;  > 11 mm: good activity 
The diameter of plug well: 6 mm  
Experiment carried out in triplicates  
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A  B  
Figure 4.3: Photographs of inhibition zone in plug assay. A: Zone inhibition of 
antibacterial activities of Bipolaris sp. and Montagnulaceae sp. B: Zone inhibition of 
antibacterial activities of Phoma sp. and Paecilomyces sp. 
 
4.2.2 Antibacterial activity of manglicolous fungi 
Table 4.3 shows the preliminary antibacterial activities exhibited by the manglicolous 
fungi in the present study when assessed through the plug assay method. Out of the total 
eleven fungi strains, ten displayed antibacterial activity against at least one test bacteria. 
Only Fusarium sp. did not exhibit antibacterial activity towards any of the test bacteria. 
Certain manglicolous fungi used in the present investigation belonged to the same 
species but are different strains because they were isolated frm different locations, such 
as the fungi strains; Dactylospora haliotrepha (4 strains) and Verruculina enalia (two 
strains) fungi strains. Staphylococcus aureus was the test bacteria most susceptible to 
the antibacterial potential of the manglicolous fungi with nine out of eleven 
manglicolous fungi exhibiting antibacterial activities against this bacterium. Most of the 
antibacterial activity displayed by the manglicolous fungi in this study was skewed 
towards Gram positive bacteria with only one manglicolous fungi, S. rhizophorae active 
against the Gram negative E. coli. The test bacteria most susceptible to the antibacterial 
potential of S. rhizophorae displayed promising potential with antibacterial activity 
against five test bacteria. 
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Table 4.3: Preliminary antibacterial activity of manglicolous fungi against seven test bacteria 
 
Fungi Bacterial strains tested 
S. aureus B. cereus B. subtilis M. luteus E. faecalis E. coli P. aeruginosa 
Corollospora  
  maritima 
NA M M NA NA NA NA 
D.  haliotrepha    
  (ISB001) 
M NA M NA NA  NA NA 
D.  haliotrepha  
  (ISB002) 
M NA M NA NA NA NA 
D.  haliotrepha  
  (ISB003) 
G G G M NA NA NA 
D.  haliotrepha  
  (ISB004) 
G G G NA NA NA NA 
Fusarium sp. NA NA NA NA NA NA NA 
Henningsomyces sp. G G G M NA NA NA 
MF 28 G G G NA NA NA NA 
S.  rhizophorae G G G G NA W NA 
V. enalia  
  (ISB005) 
M G G NA NA NA NA 
V. enalia  
  (ISB006) 
M G M NA NA NA NA 
NA: No activity; (W): Weak activity; (M): Moderate activity; (G): Good activity 
Activities were classified as: 8 mm to 9 mm: weak activity; 10 mm to 11 mm: moderate activity;  > 11 mm: good activity 
The diameter of plug well: 6 mm  
Experiment carried out in triplicates  
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4.3 Minimum inhibitory concentration (MIC) values of marine derived fungi crude 
extracts obtained through broth microdilution assay 
4.3.1 MIC values of endophytic fungi crude extracts  
The five most promising endophytic fungi strains; Minimidochium sp., Paecilomyces 
sp., Curvularia sp. (GQ184733.1), Montagnulaceae sp. (KC291642.1) and Bipolaris sp. 
(HQ631009.1) were selected for further antibacterial assessment through the broth 
microdilution assay. As shown in Table 4.4, most of the fungi extracts inhibited the 
growth of Gram positive bacteria. None of the five fungi extracts were potent against P. 
aeruginosa while B. cereus was the only bacterial strain susceptible to the antibacterial 
activities of all of the five extracts. The extract of Paecilomyces sp. showed promising 
antibacterial potential with low MIC values of 0.250 mg/ml and below against five of 
the test bacteria. On the other hand, the extract of Bipolaris sp. was the only one to 
exhibit good antibacterial activity against E. coli with a low MIC of at 0.250 mg/ml in 
comparison to Montagnulaceae sp. 
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Table 4.4: Minimum inhibitory concentration (MIC) values of endophytic fungi crude extracts in mg/ml  
 
Endophytic 
Fungi 
Bacteria 
S. aureus B. cereus B. subtilis E. faecalis M. luteus P. aeruginosa E. coli 
Minimidochium 
 sp. 
2.000±0 1.000±0 1.000±0 2.000±0 1.000±0 NA NA 
Paecilomyces sp.  0.125±0 0.063±0 0.125±0 0.250±0 0.250±0 NA NA 
Curvularia sp. 
 (GQ184733.1) 
NA 2.000±0 1.000±0 NA NA NA NA 
Montagnulaceae 
 sp. 
 (KC291642.1) 
2.000±0 0.500±0 NA NA 1.000±0 NA 1.000±0 
Bipolaris sp. 
 (HQ631009.1) 
0.500±0 0.250±0 NA NA 0.500±0 NA 0.250±0 
Mean ± standard deviation, n=3; NA: no activity 
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4.3.2 MIC values of manglicolous fungi crude extracts 
The MIC values of manglicolous fungi crude extracts were determined using the broth 
microdilution assay method (Figure 4.4) and results obtained are shown in Table 4.5. 
All the ten selected manglicolous fungi displayed antibacterial activity against at least 
one test bacteria.  From the results, most of the fungi displayed antibacterial activity 
against Gram positive bacteria. The fungi strains potent against Gram negative bacteria 
were S. rhizophorae and the unidentified fungi strain, MF28 which displayed activity 
against E. coli.  
There were four strains of D. haliotrepha that were investigated in this study. 
According to the results obtained, the fungi strains ISB001 and ISB002 possessed 
similar activities whereby both exhibited antibacterial activity against the bacteria S. 
aureus and B. cereus. Among all four strains, the D. haliotrepha strain ISB003 
exhibited the widest range of antibacterial activity which was against four of the seven 
test bacteria namely; S. aureus, B. cereus, B. subtilis and M. luteus. The D. haliotrepha 
strain ISB004 displayed an MIC value of 1.0 mg/ml against S. aureus, B. cereus and 
Bacillus subtilis. There were two strains of the fungi V. enalia that were investigated in 
the present study. Both fungi strains displayed similar antibacterial activities, being 
effective against S. aureus, B. cereus and B. subtilis at an MIC value of 1.0 mg/ml.  
The fungi strain S. rhizphorae was chosen for further investigation and chemical 
analysis because it was the only manglicolous fungi that exhibited the broadest 
spectrum of antibacterial activity against five out of the seven test bacteria comprising 
of four Gram positive bacteria; S. aureus, B. cereus, B. subtilis, M. luteus and 1 Gram 
negative bacteria namely E. coli. In addition, the crude extract (EAS) of S. rhizphorae 
exhibited MIC values of 0.500 mg/ml and lower against test bacteria inhibited by its 
actions. Although crude extracts from fungi such as, Henningsomyces sp. and D. 
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haliotrepha (ISB003) also exhibited low MIC values, proving to possess promising 
potential, none of these fungal crude extracts were active against Gram negative 
bacteria, which is why S. rhizophorae was chosen for further analysis. Although the 
crude extract of MF 28 also exhibited antibacterial activity against E. coli, its MIC 
value was higher (less potent)  in comparison to the MIC value of the crude extract of S. 
rhizophorae. 
 
A  B  
Figure 4.4: Photographs of colour changes indicating MIC values in broth 
microdilution assay. A: MIC of MF28 extract, B: MIC of S. rhizophorae extract 
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Table 4.5: Minimum inhibitory concentration (MIC) values of manglicolous fungi crude extracts in mg/ml  
 
Manglicolous 
Fungi 
Bacteria 
S. aureus B. cereus B. subtilis E. faecalis M. luteus P. aeruginosa E. coli 
 
S. rhizophorae 
 
0.5000±0 
 
0.2500±0 
 
0.0521±0.02 
 
NA 
 
0.5000±0 
 
NA 
 
0.5000±0 
MF 28 1.0000±0 1.0000±0 0.2500±0 NA NA NA 2.0000±0 
Henningsomyces 
 sp. 
0.2500±0 1.0000±0 0.4167±0.15 NA 1.0000±0 NA NA 
C. maritima NA 0.2500±0 0.2500±0 NA NA NA NA 
D. haliotrepha 
 (ISB001) 
0.5000±0 NA 1.0000±0 NA NA NA NA 
D. haliotrepha 
 (ISB002) 
0.5000±0 NA 1.0000±0 NA NA NA NA 
D. haliotrepha 
 (ISB003) 
0.1250±0 0.1250±0 0.0625±0 NA 0.5000±0 NA NA 
D. haliotrepha 
 (ISB004) 
1.0000±0 1.0000±0 1.0000±0 NA NA NA NA 
V. enalia  
 (ISB005) 
1.0000±0 1.0000±0 1.0000±0 NA NA NA NA 
V. enalia 
 (ISB006) 
1.0000±0 1.0000±0 1.0000±0 NA NA NA NA 
Mean ± standard deviation, n=3; NA: no activity 
65 
 
4.4 Sub-fractions from ethyl acetate crude extract (EAS) of Saccardoella 
rhizphorae obtained through bioassay guided fractionation 
4.4.1 EAS of Saccardoella rhizophorae  
A total weight of 900 mg of crude EA extract (EAS) were obtained from the larger 
extraction scale of, 3 L of S. rhizophorae (Figure 4.5) fermentation broth partitioned 
with equal volumes of EA. The dried EAS obtained was dark brownish in colouration. 
 
 
Figure 4.5: Photograph of 15 day old S. rhizophorae cultured on PDA media 
 
4.4.2 Fractions of EAS 
Three fractions were obtained through solvent partitioning using three solvents in order 
of increasing polarity from EAS of S. rhizophorae, affording fractions, HS, DS, and 
MS. The weight and colour of each fraction are shown in Table 4.6. The fraction with 
the highest weight was the DS fraction with a total weight of 320 mg while the other 
two fractions had lower weight in comparison with 235 mg and 110 mg from the MS 
and HS fractions respectively. 
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Table 4.6: Colour and dry weight of HS, DS and MS fractions 
 
Fungi Fraction Colour of 
fraction 
Dry weight of 
fraction (mg) 
Saccardoella 
 rhizophorae 
HS Yellow 110 
DS Dark brown 320 
MS Brownish black 235 
 
 
4.4.3 Column chromatography fractionation of HS and DS fractions 
4.4.3.1 Sub-fractions of HS fraction 
Column fractionation of the HS fraction obtained from the solvent partitioning afforded 
43 fractions. The 43 fractions obtained were further pooled into seven sub-fractions 
based on the similarity of the TLC profiles for each fraction. The weight and appearance 
of the sub-fractions obtained are shown in Table 4.7.1. Sub-fractions 2, 3 and 4 had 
significantly higher weights at, 51.1 mg, 24.5 mg and 20.3 mg respectively in 
comparison to the other 4 sub-fractions. Sub-fraction 1 had the lowest weight at 5 mg. 
 
Table 4.7.1: Weight and appearance of sub-fractions from HS fraction 
  
Sub-fraction Weight (mg) Appearance 
1 5 Oily, light greenish yellow 
2 51.1 Oily, light orange brown 
3 24.5 Oily, light greenish 
4 20.3 Oily, light yellow 
5 5.5 Oily, almost colorless 
6 5.6 Oily, very light yellow 
7 7.9 Oily, medium brown 
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4.4.3.2 Sub-fractions of DS fraction 
Column fractionation of the DS fraction obtained from the solvent partitioning, afforded 
70 fractions in total. The 70 fractions obtained were further pooled into seven sub-
fractions based on the similarity of the TLC profiles for each fraction. The weight and 
appearance of the sub-fractions obtained are displayed in Table 4.7.2. Sub-fractions 4, 5 
and 7 had the highest weight at 92.1 mg, 76.2 mg and 47.2 mg respectively. The other 
sub-fractions had considerably lower weight in comparison. 
 
Table 4.7.2: Weight and appearance of sub-fractions from DS fraction 
Sub-fraction Weight (mg) Appearance 
1 20.1 Light yellowish 
2 10.9 Light brownish 
3 12.1 Light brownish 
4 92.1 Dark brown 
5 76.2 Dark brown 
6 10.2 Blackish 
7 47.2 Blackish 
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4.5 Antibacterial activity of Saccardoella rhizophorae extracts 
4.5.1 MIC values of solvent partition fractions  
The MIC values of the three fractions obtained from the solvent partitioning extraction 
are shown in Table 4.8. Out of the three fractions, the HS fraction exhibited the most 
promising antibacterial activity against six out of seven test bacteria, comprising of both 
Gram positive and negative namely; S. aureus, Bacillus cereus, B. subtilis, E. faecalis, 
M. luteus and E. coli. The DS fraction exhibited antibacterial activity against five out of 
the seven test bacteria all of which comprised of Gram positive bacteria. The MS 
fraction displayed no antibacterial activity towards any of the test bacteria in this study. 
From the results obtained, the DS fraction had lower MIC values towards the bacteria 
against which they exhibited antibacterial activity whereby all MIC values recorded 
were 0.125 mg/ml and below.  
 
Table 4.8: Minimum inhibitory concentration (MIC) values of HS, DS and MS 
fractions in mg/ml 
Bacteria Fractions 
 HS DS MS 
 
S. aureus 
 
2.0000±0 
 
0.1250±0 
 
NA 
B. cereus 0.2500±0 0.0313±0 NA 
B. subtilis 0.1250±0 0.0156±0 NA 
E. faecalis 1.0000±0 0.1250±0 NA 
M. lutues 0.5000±0 0.0625±0 NA 
P. aeruginosa NA NA NA 
E. coli 2.0000±0 NA NA 
Mean ± standard deviation, n=3; NA: no activity 
 
4.5.2 MIC values of the sub-fractions from the HS fraction  
The MIC values of the sub-fractions from the HS fraction are shown in Table 4.8.1. The 
sub-fractions that displayed antibacterial activity towards the most number of bacterial 
strains were sub-fractions 2, 3 and 7, all of which exhibited antibacterial activity against 
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at least three of the seven test bacteria. Sub-fraction 2 exhibited antibacterial activity 
against B. cereus, E. faecalis and M. luteus. Sub-fraction 3 exhibited antibacterial 
activity against S. aureus, B. cereus and B. subtilis while sub-fraction 7 exhibited 
antibacterial activity against S. aureus, B. cereus and E. faecalis. The other 4 sub-
fractions exhibited activity against two or less test bacteria with sub-fraction 1, 4 and 6 
effective against only one test bacteria. Sub-fraction 1 exhibited antibacterial activity 
against E. faecalis, while sub-fractions 4 and 6 exhibited antibacterial activity against B. 
cereus. The bacterium most susceptible to the action of the sub-fractions from HS 
fraction was B. cereus whereby, all the sub-fractions except sub-fraction 1 were active 
against this bacterium. Sub-fractions 1, 2 and 7 were active against E. faecalis while 
sub-fractions 3 and 7 were active against S. aureus and sub-fractions 3 and 5 displayed 
activity against B.subtilis. Only sub-fraction 2 exhibited antibacterial activity against M. 
luteus. None of the 7 sub-fractions possessed antibacterial activity against the Gram 
negative test bacteria namely, P. aeruginosa and E. coli. Although sub-fraction 7 
exhibited the lowest MIC values in comparison to the remaining six sub-fractions, the 
constituents in sub-fraction 7 could not be further elucidated due its low quantity as 
previously stated in Table 4.7.1. All the MIC values recorded by the sub-fractions of HS 
fraction were 0.5 mg/ml and below. 
 
4.5.3 MIC values of the sub-fractions from the DS fraction 
The MIC values of the sub-fractions of the DS fraction are shown in Table 4.8.2. The 
sub-fractions from the DS fraction exhibited antibacterial activity only towards the 
Gram positive test bacteria with no activity exhibited against E.coli and P. aeruginosa 
including the Gram positive E. faecalis. Out of the seven sub-fractions obtained from 
further fractionation of the DS fraction, sub-fractions 4 and 5 displayed antibacterial 
activity against the most number of test bacteria whereby these two sub-fractions were 
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active against S. aureus, B. cereus, B. subtilis and M. luteus. Based on results obtained, 
the bacterium M. luteus was the most susceptible towards the actions of the sub-
fractions of DS fraction whereby five out of the seven sub-fractions were active against 
this bacterium. However due to minute amounts of the sub-fractions of DS fraction no 
further chemical analysis was possible. This may be undertaken in future studies.
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Table 4.8.1: Minimum inhibitory concentration (MIC) values of sub-fractions of HS fraction in mg/ml  
Sub-fraction Bacteria 
S. aureus B. cereus B. subtilis E. faecalis M. luteus P. aeruginosa E. coli 
1 NA NA NA 0.5000±0 NA NA NA 
2 NA 0.2500±0 NA 0.2500±0 0.5000±0 NA NA 
3 0.5000±0 0.2500±0 0.2500±0 NA NA NA NA 
4 NA 0.5000±0 NA NA NA NA NA 
5 NA 0.5000±0 0.5000±0 NA NA NA NA 
6 NA 0.5000±0 NA NA NA NA NA 
7 0.2500±0 0.0313±0 NA 0.0625±0 NA NA NA 
Mean ± standard deviation, n=3; NA: no activity 
 
Table 4.8.2: Minimum inhibitory concentration (MIC) values of sub-fractions of DS fraction in mg/ml  
Sub-fraction Bacteria 
S. aureus B. cereus B. subtilis E. faecalis M. luteus P. aeruginosa E. coli 
1 NA NA NA NA 0.2500±0 NA NA 
2 NA NA NA NA 0.5000±0 NA NA 
3 NA NA NA NA NA NA NA 
4 0.5000±0 0.5000±0 0.1250±0 NA 0.5000±0 NA NA 
5 0.2500±0 0.2500±0 0.0625±0 NA 0.2500±0 NA NA 
6 NA NA NA NA 0.2500±0 NA NA 
7 NA NA NA NA NA NA NA 
Mean ± standard deviation, n=3; NA: no activity 
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4.5.4 MIC values of metabolites from Saccardoella rhizophorae 
Sub-fractions 2 and 3 from the HS fraction were chosen for further chemical analysis 
based on their promising antibacterial potential against the most number of test bacteria 
as well as their low MIC values of not more than 0.500 mg/ml. Linoleic acid was 
isolated from sub-fraction 2 while palmitic acid was isolated from sub-fraction 3 of the 
HS fraction. The MIC values of the metabolites from S. rhizophorae; linoleic acid and 
palmitic acid are shown in Table 4.9. Comparing the MIC values of the linoleic acid in 
relation to the pool from which it was isolated from, the sub-fraction 2 of the HS 
fraction was active against B. cereus, E. faecalis and M. luteus however, linoleic acid 
exhibited antibacterial activity towards S. aureus and B. subtilis. As for palmitic acid 
which was isolated from sub-fraction 3 of the HS fraction, the pure compound palmitic 
acid displayed similar antibacterial activity with the sub-fraction from which it was 
isolated from except the additional exhibition of antibacterial activity against M. luteus 
which was not in sync with its sub-fraction. Both linoleic and palmitic acid, exhibited 
selected antibacterial activity directed towards only the Gram positive test bacteria. 
Overall, both linoleic and palmitic acid did not exhibit excellent antibacterial against the 
test bacteria activity in comparison to the standard antibiotics used in this study, with 
the lowest MIC at 0.250 mg/ml and highest at 1.000 mg/ml. 
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Table 4.9: Minimum inhibitory concentration (MIC) of pure compounds in mg/ml 
Metabolites Bacteria 
S. aureus B. cereus B. subtilis E. faecalis M. luteus P. aeruginosa E. coli 
Palmitic acid 0.500±0 0.250±0 0.250±0 NA 0.500±0 NA NA 
Linoleic acid 1.000±0 NA 0.500±0 NA NA NA NA 
Penicillin 0.004±0 0.063±0 0.063±0 0.500±0 0.125±0 0.500±0 0.125±0 
Chloramphenicol 0.031±0 0.016±0 0.016±0 0.500±0 0.016±0 0.125±0 0.008±0 
Mean ± standard deviation, n=3; NA: no activity 
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4.6 NMR spectroscopic data of metabolites from Saccardoella rhizophorae 
 
 
 
Linoleic acid      Palmitic acid 
Figure 4.6: Structure of linoleic acid and palmitic acid 
 
Linoleic acid, also known as cis-9, cis-12-octadecadenoic acid was isolated from sub-
fraction 2 of the HS fraction while, palmitic acid, or n-hexadecanoic acid was isolated 
from sub-fraction 3 of the HS fraction. Palmitic acid was isolated as light yellowish 
powder while linoleic acid was isolated as light yellowish oil. Linoleic acid is a known 
polyunsaturated fatty acid while palmitic acid is a known saturated fatty acid. Figures 
3.6 shows the structure of linoleic acid and palmitic acid after determination using 
1
H 
and 
13
NMR spectra that were recorded in deuterated chloroform (CDCl3) using FT-
NMR Lambda 400 MHz and mass spectrum on HP 6890 Series Mass Selective 
Detector. The moleculer formula of linoleic acid and palmitic acid was obtained as 
C18H32O2 and C16H32O2 respectively. The 
1
H and 13C NMR 400Hz data for linoleic 
acid are tabulated in Table 4.10 while Table 4.11 shows the 
1
H and 13C NMR 400Hz 
data for palmitic acid. The 
1
H NMR and 13C NMR spectrums for linoleic acid are 
displayed in Figure 4.7a and 3.7b respectively. The 2-dimensional NMR spectrums for 
linoleic acid are attached as Appendix 4. As for palmitic acid, the 
1
H and 13C NMR 
spectrums are displayed in Figure 4.8a and 3.8b respectively. The 2-dimensional NMR 
spectrums for palmitic acid are attached as Appendix 5.  
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Table 4.10: The 
1
H and 13C NMR 400Hz data of linoleic acid 
 
Position δHa δC 
1  180.7 
2 2.35 t (7.8) 34.3 
3 1.64 m 24.8 
4 1.31-1.38 m
b
 29.2
e 
5 1.31-1.38 m
b
 29.3
e 
6 1.31-1.38 m
b
 29.3
e 
7 1.31-1.38 m
b
 29.5
e 
8 2.04-2.09 m
b
 27.4
d 
9 5.30-5.42 m
b
 130.2
f 
10 5.30-5.42 m
b
 128.1
g 
11 2.78 t (6.0) 25.8 
12 5.30-5.42 m
b
 128.3
g 
13 5.30-5.42 m
b
 130.4
f 
14 2.04-2.09 m
b
 27.3
d 
15 1.31-1.38 m
b
 29.8
e 
16 1.31-1.38 m
b
 22.8
c 
17 1.31-1.38 m
b
 31.7
c 
18 0.90 t (7.3) 14.1 
aCoupling constants (J) in Hz are indicated in parentheses 
bOverlapping signals 
c,d,e,f,gChemical shifts are interchangeable 
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Figure 4.7a: The 
1
H NMR 400 Hz of linoleic acid in CDCl3 (ppm) 
77 
 
 
 
Figure 4.7a: The 
1
H NMR 400 Hz of linoleic acid in CDCl3 (ppm) (continued) 
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Figure 4.7a: The 
1
H NMR 400 Hz of linoleic acid in CDCl3 (ppm) (continued) 
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Figure 4.7b: The 13C NMR 400 Hz of linoleic acid in CDCl3 (ppm) 
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Figure 4.7b: The 13C NMR 400 Hz of linoleic acid in CDCl3 (ppm) (continued) 
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Figure 4.7b: The 13C NMR 400 Hz of linoleic acid in CDCl3 (ppm) (continued) 
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Table 4.11: The 
1
H and 13C NMR 400Hz data of palmitic acid 
Position δHa δC 
1  180.2 
2 2.35 t (7.3) 22.9 
3 1.64 m 32.2 
4 1.26 m
b 
29.3
c 
5 1.26 m
b
 29.3
c 
6 1.26 m
b
 29.5
c 
7 1.26 m
b
 29.5
c 
8 1.26 m
b
 29.6
c 
9 1.26 m
b
 29.6
c 
10 1.26 m
b
 29.7
c 
11 1.26 m
b
 29.7
c 
12 1.26 m
b
 29.8
c 
13 1.26 m
b
 29.9
c 
14 1.26 m
b
 24.9
d 
15 1.26 m
b
 34.3
d 
16 0.89 t (6.4) 14.3 
aCoupling constants (J) in Hz are indicated in parentheses 
bOverlapping signals 
c,dChemical shifts are interchangeable 
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Figure 4.8a: The 
1
H NMR 400 Hz of palmitic acid in CDCl3 (ppm) 
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Figure 4.8b: The 13C NMR 400 Hz of palmitic acid in CDCl3 (ppm) 
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Figure 4.8b: The 13C NMR 400 Hz of palmitic acid in CDCl3 (ppm) (continued) 
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4.7 Mass spectrometry data of metabolites from Saccardoella rhizophorae 
The mass of linoleic acid was obtained as 280.2402 with mass of negative ions (M-H)
-
 
at 279.233 and mass of positive ions (M+H)
+
 at 281.2475. The mass of palmitic acid 
was obtained as 256.2402 with mass of negative ions (M-H)
-
 at 255.233 and mass of 
positive ions (M+H)
+
 at 257.2475. The LCMS spectrums of linoleic acid and palmitic 
acid are shown is Figure 4.9a and 3.9b respectively. 
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Figure 4.9a: LCMS spectrum of linoleic acid 
(M-H)
- 
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Figure 4.9b: LCMS spectrum of palmitic acid 
(M-H)
- 
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4.8 Infrared (IR) spectroscopy data of metabolites from Saccardoella rhizophorae 
Infrared (IR) spectrum of linoleic acid is shown in Figure 4.10a while the IR spectrum 
of palmitic acid is shown in Figure 4.10b. Both linoleic acid and palmitic acid are 
chemically classified as carboxylic acids which give them both similar stretch and 
bending patterns. Both IR spectrums have characteristic O-H stretch from 3300 to 2500 
cm
-1
. The normal ranges of stretches and bends for functional groups in carboxylic acids 
are; C=O stretch at 1760 to 1690 cm
-1
, C-O stretch at 1320 to 1210 cm
-1
, O-H bend at 
1440 to 1395 cm
-1
 (Max et al., 2004). Based on the IR spectrum of linoleic acid in 
Figure 4.10a, there is strong O-H stretch from 3300 to 2500 cm
-1
 with C=O stretch at 
1747.32 cm
-1
, O-H bend at 1325.25 cm
-1
, and C-O stretch similarly at 1325.25 cm
-1
. As 
for the IR spectrum of palmitic acid in Figure 4.10b, there is a strong O-H stretch  from 
3300 to 2500 cm
-1
 with C=O stretch at 1713 cm
-1
, O-H bend at 1411.07 and 1378.28 
cm
-1
 and C-O stretch at 1212.17, 1260.87 and 1276.75 cm
-1
.  
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Figure 4.10a: IR spectroscopy data of linoleic acid 
 
 
Figure 4.10b: IR spectroscopy data of palmitic acid 
1747.32 
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4.9 Ultraviolet (UV) spectroscopy data of metabolites from Saccardoella 
rhizophorae 
The UV absorbances of bioactive compounds are shown in Figures 3.11a and 3.11b. 
The UV absorbance data of linoleic acid is displayed in Figure 4.11a while the data for 
palmitic acid is shown in Figure 4.11b. The standard absorbance range of absorbance 
for carboxylic acids is usually at 200 to 210 nm (Weishaar et al., 2003). Both linoleic 
acid and palmitic acid exhibited maximum absorbance at 206 and 204 nm respectively, 
thus justifying that they are indeed carboxylic acids. 
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Figure 4.11a: UV spectroscopy data of linoleic acid 
 
 
Figure 4.11b: UV spectroscopy data of palmitic acid 
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CHAPTER 5 
DISCUSSION 
 
5.1 Significance of molecular methods in the identification of endophytic fungi 
from Ipomoea pes-caprae and Vitex rotundofolia 
Endophytic fungi are commonly described as fungi that completes at least a part of their 
life cycle inside plant tissues without causing any harm to the host plant (Linnakoski et 
al., 2012). Some reports have also suggested the possibility of endophytic fungi having 
evolved from pathogens having latent phases within their life cycles thus justifying as to 
why these fungi do not cause harm to their host plants (Linnakoski et al., 2012). The 
identification and diversity studies of fungi were traditionally carried out based on the 
morphological characteristics of the sexual and asexual fruiting bodies of the fungi. 
Pang et al. (2005) however debated that this mode of identification alone is insufficient 
due to reasons such as, inability of some fungi to grow in culture especially under 
laboratory conditions, different sporulation rates, multiple life cycle forms and also the 
difficulties in distinguishing species with similar morphologies. This is where molecular 
techniques came to play an essential role towards a more reliable method of fungal 
identification. Keeping the above statements in addition to the absence of fruiting 
bodies in consideration, the endophytic fungi isolated in the present study were 
identified using molecular techniques. 
 Prior to this study, there have been no reports of endophytic fungi isolated from 
the leaves of V. rotundifolia. Studies by Khan et al. (2012) have only reported plant 
growth promoting endophytic fungi from the roots of V. rotundifolia. As for I. pes-
caprae, there have been reports such as the one from Beena et al. (2000) in which the 
endophytic fungi from the roots of I. pes-caprae were investigated. The only endophytic 
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fungus reported from the leaves of I. pes-caprae is Fusarium oxysporum (Guo et al., 
2013). Thus overall, there has been minimal work done to investigate the diversity of 
endophytic fungi from the leaves of V. rotundifolia and I. pes-caprae. 
The 1940’s marked the start for the study of fungal genetics due to the nature of 
fungal genes that made them ideal models (Hooley et al., 2006). According to Hooley et 
al. (2006), fungal diversity in marine habitats can be assessed by performing PCR of 
repetitive DNA sequences, in particular sequences that encodes small or large ribosomal 
subunits and their associate ITS regions. Anderson et al. (2007) reported that the last 
decade has seen a marked progress in fungal ecology due to the use of molecular 
methods to analyse the variation of sequences within rRNA genes and their associated 
spacer regions. Fungal diversity in natural environments can be assessed using certain 
molecular techniques namely; denaturing gradient gel electrophoresis (DGGE), 
temperature gradient gel electrophoresis (TGGE), single-strand conformation 
polymorphism (SSCP), terminal restriction fragment length polymorphism (T-RFLP), 
amplified rDNA restriction analysis (ARDRA), amplified ribosomal intergenic spacer 
analysis (ARISA) and cloning (Pang et al., 2005). However most of the techniques 
mentioned above are more suitable when the sample in concern is a mixture of fungi 
strains usually involving direct environmental samples.  
The objective of the present study was to identify the endophytic fungi strains to 
the level of its genus based on the database, therefore only the ITS region was analysed. 
Polymerase chain reaction (PCR) was employed to amplify and further compare the 
sequences of the ITS region incorporating the 5.8S rRNA fungal gene to identify the 
endophytic fungal isolates. The ITS primers work well on DNA from individual 
organisms thus making this technique possible as all the fungal strains in the present 
study were pure cultures (Prewitt et al., 2008). The rRNA genes are a multi-copy gene 
family that are arranged in tandem repeats where each major repeat contains coding 
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regions of the primary rRNAs and non-coding spacer regions. In ecological studies of 
fungi, the genes encoding 18S rRNA and 25/28S rRNA, and the ITS regions 
incorporating the 5.8S rRNA gene are the target regions within the rRNA gene cluster 
normally studied upon (Anderson et al., 2007). In comparison to other rRNA gene 
clusters, the ITS region is extremely variable and have evolved at a slow pace thus 
allowing the detection of a higher number of phylotypes (Prewitt et al., 2008). Although 
highly conserved within most species but the ITS region is variable between species 
thus making it suitable in taxonomy studies (Prewitt et al., 2008). The forward ITS 5 
and reverse ITS 4 primers in the present study were to target the ITS regions flanking 
the 5.8S rRNA, similar to studies by Guo et al. (2003). According to Toju et al. (2012), 
primers designed for ITS analysis should match the sequences of 99% of fungal lowest 
taxonomic units (LTUs) to enable a thorough and unbiased DNA barcoding. Both 
primers ITS 5 and ITS 4 exhibits broad coverage of fungal lowest taxonomic units 
(LTUs) with the coverage of ITS 4 as broad as that of any other primer including new 
and improvised primers (Nikolcheva et al., 2004). Nikolcheva et al. (2004) reported that 
the forward primer ITS 5 is capable of amplifying all Fungi thereby justifying the 
choice of this primer in the present study. 
When compared to other primers, the ITS primers provided higher hit rates for 
fungal sequences in BLAST searches due to the abundance of ITS data in the GenBank 
(Pang et al., 2005; Arnold, 2007). However the limitations with using the ITS data as a 
tool for identification is that its accuracy is limited to comparing distantly related 
organisms (Lamothe et al., 2002). Therefore in phylogenetic studies of fungi, generally 
more than one gene is studies upon in determining the identity and relatedness of fungi 
strains.  There have also been studies that indicate the ITS data alone is insufficient for 
identifications due to the fact that some fungi are not represented in the GenBank and 
therefore fungi strains may be misidentified due to the lack this lack of taxonomic 
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information (Arnold, 2007). A study by Prewitt et al. (2008) on the phylogenetic of 
wood decay fungi reported that the ITS sequence alone could not resolve the 
differentiation between certain species of basidiomycetes. Studies such as those by Ho 
et al. (2012) employed the analysis of sequences from two different genes to obtain a 
more accurate identification of endophytic fungi strains. However in this study we 
merely focused on basic identification as the objective of this study was more towards 
investigation of the bioactivity of the fungi thereby justifying the use of only one gene 
in the identification of the fungi.  
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5.2 Antimicrobial susceptibility testing of marine derived fungi extracts 
The disk diffusion test is usually the gold standard by the Clinical and Laboratory 
Standards Institute (CLSI) in qualitative antimicrobial susceptibility testing. This 
technique relates the diameter of zone of growth inhibition around antibiotic disks to the 
susceptibility of the isolates tested. The plug assay technique by Hoskisson et al. (2001) 
and Ezra et al. (2004) was chosen due to its inexpensive and fast approach to detect the 
antibacterial bioactivity of both marine derived manglicolous and endophytic fungi. In 
the present study, the plug assay technique served as a primary method to downstream 
the large amount of fungi isolates to achieve a systematic way of identifying the fungi 
isolates with promising antibacterial activity for further analysis. This assay requires no 
prior extraction of fungal secondary metabolites which eliminated the time and 
consumables consumed in doing so. However, this assay has its own share of 
disadvantages such as; the antibacterial activity results obtained are only qualitative and 
not quantitative measurements (Zainuddin et al., 2008). This is because the plug assay 
only assesses the mere exhibition of antibacterial activity without taking into account 
the concentration of the fungi extracts as a parameter in the display of antibacterial 
activity.  
The plug assay does not employ the need for prior extraction of fungal 
secondary metabolites thus there is no way of ensuring the presence and concentration 
of secondary metabolites secreted on the medium. There may be a possibility that the 
fungi that exhibited no antibacterial activity in the plug assay, may exhibit antibacterial 
activity when cultured in broth under specific conditions and their secondary 
metabolites extracted with appropriate solvent systems and then further tested, similar 
to studies by Zainuddin et al. (2008). To ensure that the fungal culture media did not 
influence the antibacterial activity displayed by the fungi, the exchange of a plug of 
sterile PDA instead of fungal culture was used as the negative control in the plug assay. 
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The seven test bacteria used in this study comprised of five Gram positive and two 
Gram negative bacteria. All the bacterial strains chosen were known causes of 
nosocomial infections affecting the medical world. Test bacteria were also chosen based 
on four criterias’ such as Gram negative or positive, morphology, endospore and non-
endospore forming bacteria, enterobacteriaceae and non-enterobacteriaceae. These 
criteria served as a tool towards understanding if the antibacterial activity displayed by 
the fungi were selective towards or against a given morphological or physiological trait 
of the test bacteria. Focusing on the first criteria, the Gram positive bacterial strains 
consisted of Staphylococcus aureus, Bacillus cereus, Bacillus subtilis, Micrococcus 
luteus and Enterococcus faecalis while the Gram negative bacterial strains consisted of 
Escherichia coli and Pseudomonas aeruginosa. Taking into account of the second 
criteria which is morphology, the test bacteria were selected based on their shapes. S. 
aureus, M. lutues, E. faecalis and E. coli are all spherical/cocci shaped while B. cereus, 
B. subtilis, P. aeruginosa are rod shaped bacteria. Thirdly in terms of endospore 
formation, only B. cereus and B. subtilis are endospore forming bacteria while the other 
five are non-endospore forming bacteria. Lastly, as for bacteria from the 
enterobacteriaceae family, the bacterium E. coli belongs to this family. 
One of the earliest techniques of antimicrobial susceptibility testing was the 
macrobroth method. This technique provides quantitative results but one of the principal 
disadvantages of this method is that it is rather tedious and requires the use of large 
amounts of reagents and space. The miniature version of the macrobroth method is the 
broth microdilution technique by Eloff, (1998) which is carried out in 96 well plates and 
requires relatively smaller amounts of reagents and space in comparison. Another 
advantage of the broth microdilution method is that this technique can also be 
performed using both manual and automated systems whereby hundreds of 96 well 
trays can be prepared from a single master set of dilutions in a short period of time 
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(Jorgensen et al., 2009). The broth microdilution assay was used to screen the 
antibacterial activity of EA crude extracts of selected marine derived fungi in the 
present study. This assay required prior extraction of the secondary metabolite crude 
from the fungi using EA. Ethyl acetate was chosen as the solvent of extraction mainly 
due to its high polarity index of 3.9 but yet with a solubility of 8.7% in water. Due to 
fact that the sample to be extracted was fermentation broth which is aqueous, the 
solvent of choice needed to be able to extract both polar and non-polar chemical 
compounds while at the same time be non-soluble in water to achieve clear separation 
and partition. The solvent EA has been a favoured solvent in the extraction of fungal 
secondary metabolites as reported in similar studies by Han et al. (2009) and Kjer et al. 
(2010). 
In the broth microdilution assay, the extraction of sterile PDB broth with EA 
served as a negative control to prove that the bioactivity displayed was only with 
respect to the fungal secondary metabolites and not the constituents of the broth. From 
the results obtained, the sterile broth extract showed no antibacterial activity against all 
test bacteria. The antibiotics chloramphenicol and penicillin G served as positive 
controls in this bioassay. The antibiotics in this study possessed two varying 
antibacterial mechanisms. Penicillin G is a β-lactam antibiotic that inhibits the 
formation of peptidoglycan cross-links in the bacterial cell wall while chloramphenicol 
acts as a protein synthesis inhibitor. This study employed two different antibiotics as 
controls as not all bacterial strains are susceptible to one class of antibiotic and thereby 
the use of only one antibiotic may provide a false assumption that the bacterial strain is 
antibiotic resistant when in actual fact, the bacterial cell does not provide suitable target 
for the action of the antibiotic used. 
The broth microdilution technique was employed to obtain a more quantitative 
data of the antibacterial activities of marine derived fungi based on preliminary analysis 
100 
 
results through the plug assay. Although the disc diffusion assay has always been a 
favoured choice in antimicrobial susceptibility testing, this assay is only a semi-
quantitative assay in comparison to the broth microdilution assay which is more 
quantitative (Domig et al., 2007).  
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5.3 Endophytic fungi as producers of bioactive metabolites  
The two host plants in the present study have not been fully exploited in terms of their 
endophytic fungi. There have been no studies on the bioactivities of endophytic fungi 
from the plant V. rotundifolia while there was only one study pertaining to the 
bioactivity of endophytic fungi from I. pes-caprae. A study by Guo et al. (2012) 
reported the isolation of exopolysaccharide from the endophytic fungus F. oxysporum 
isolated from the plant I. pes-caprae. However the study mentioned above was not 
related to antibacterial bioactivity from the endophytic fungi. Other than that, no other 
reports have been published from studies on the bioactivity of endophytic fungi from 
these 2 plants.  
Strobel et al. (2003) stated that the rationale behind endophytic fungi host 
selection for bioactivity studies should be based on, firstly the uniqueness of the host’s 
environment such as harsh environments that require specific survival strategies and 
secondly, plants that possess an ethno botanical history. Endophytic fungi isolated from 
plants exploited for their medicinal values have been known to produce interesting 
compounds with profound activities (Suryanarayan et al., 2009). Both the marine 
associated plants chosen in this study namely; V. rotundifolia and I. pes-caprae, have 
been reported to be exploited as herbal remedies in traditional medicine which could 
have played an important role in the display of their antibacterial activities. 
The seed of V. rotundifolia has been reported to be used for cold remedies and 
headaches by the Japanese and Chinese; it is used as a raw material for Chinese 
traditional medicine. Some diterpenoids and sesquiterpenoids have been obtained from 
this plant as well as some insecticidal substances (Kawazoe et al., 1999). A study by 
Ono et al. (1998), reported the discovery of 7 phenolic compounds with strong 
antioxidant activities as well as the isolation of a new labdane-type diterpene glycoside 
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from V. rotundifolia. In Korea, this plant is well known as “Man Hyung Ja” and is used 
by natives against headaches related to upper respiratory infection as well as various 
allergic diseases (Shin et al., 2000). The analgesic properties of V. rotundifolia have 
also been reported and scientists have isolated polymethoxyflavonoid, a compound with 
the ability to inhibit proliferation of lymphocyte and the growth of some cancer cell 
lines (Ko et al., 2000).  
The plant I. pes-caprae in the present study also has well known ethnobotanical 
history where the genus Ipomoea from the Convolvulaceae family is a known source of 
complex resin glycosides with interesting bioactivities. I. pes-caprae is used as an 
herbal drug in Mexico mainly in the treatment of kidney complaints, digestive 
disorders, hypertension, arthritis, rheumatism, skin infections and other inflammatory 
conditions. Furthermore, nine compounds have been isolated from I. pes-caprae with 
antibacterial activity (Martinez et al., 2010). Umamaheshwari et al. (2012) reported that 
this plant has also been widely explored for its antioxidant, analgesic, anti-inflammatory 
and good anti-nociceptive properties.  
The endophytic fungi from V. rotundifolia; C. eragrostidis (JN943448.1), 
Curvularia sp. (GQ1874733.1), G. mangiferae (KC686598.1), Paecilomyces sp. and 
Phoma sp. (JN207285,1) only displayed antibacterial activity against three of the seven 
test bacteria namely; S. aureus, B. cereus and B. subtilis. None of the endophytic fungi 
from V. rotundifolia exhibited antibacterial activity against the Gram negative bacteria 
in this study. This concludes a rather narrow range of antibacterial activity by the 
endophytic fungi from V. rotundifolia as the activity recorded covered only Gram 
positive bacteria. Results showed that the endophytic fungi isolated from the plant I. 
pes-caprae possessed prominent activity with broad spectrum against both Gram 
positive and negative bacteria compared to the endophytic fungi strains from V. 
rotundifolia.  
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This study reported that 20% and 3.33% of endophytic fungi from I. pes-caprae 
exhibited antibacterial activity against the Gram negative bacteria E. coli and P. 
aeruginosa respectively. Based on reports published, I. pes-caprae has been reported to 
possess antibacterial activity while no reports of antibacterial activity has been studied 
or reported from V. rotundifolia. Therefore the broad spectrum of antibacterial trait 
displayed by the plant I. pes-caprae could have been trait inherited by the endophytic 
fungi isolated from the plant. In a more recent report, Radic et al. (2012) and Kusari et 
al. (2012) characterized endophytic fungi as a “treasure chest of antibacterial 
substances”; further stressing that they possess the ability to produce same or similar 
bioactive compounds as the fungi’s host plant.  
The hypothesis of endophytic fungi being able to synthesize similar compounds 
as their host plants was initiated by the discovery of the revolutionary anticancer drug 
paclitaxel (taxol), from the endophytic fungi Taxomyces andreanae in 1993 (Stierle et 
al., 1993). Taxol was previously isolated from the Pacific yew tree. Although the report 
by Stierle et al. (1993) is still regarded baseless by some scientists, there have been 
other reports where the active compound previously known to originate from a 
particular plant, is found to be also produced by the endophytic fungi of the same plant. 
For instance, the cerebral stimulant and vasodilator vincamine which was isolated from 
the plant Vinca minor was also isolated from the endophytic fungi of V.minor (Yin et 
al., 2011). Another such report was the isolation of rhein, an antimicrobial and 
antitumor compound known to be from the Chinese medicinal plant Rheum palmatum 
L. from the endophytic fungi of the same plant (You et al., 2013). Thus these findings 
further support the hypothesis that the activities demonstrated by the endophytic fungi 
from I.pes-caprae may be influenced by the antibacterial activities that this plant is 
known to possess. 
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Over the years, the studies on fungal secondary metabolites were based mainly 
on random activity screening. Recently, scientists have adopted a systematic approach 
in the discovery of metabolites of fungal origin with proven benefits to human life. 
According to Schulz et al. (2002) fungi that occupy certain ecological niche and possess 
characteristic metabolic interactions with their surrounding environment, may possess a 
greater potential for the synthesis of novel compounds. In line with the statement by 
Schulz et al. (2002), the collection site of I. pes-caprae, which is the west coast, 
Peninsular Malaysia, could have also played a role to influence the antibacterial activity 
exhibited by the endophytic fungi isolated from the plant; as justified by Agusa et al. 
(2005) stating that the Straits of Malacca (west coast, Peninsular Malaysia) is subjected 
to higher pollution rates due to industrialization and urbanization besides being the 
major shipping hub of the country. Studies by Yap et al. (2002) stated that the sediment 
samples analyzed from the west coast of Peninsular Malaysia reported high levels of 
heavy metal contamination; further justifying the high pollution rates in the stated area.  
Overall, the antibacterial activity displayed by the endophytic fungi was found 
to be more pronounced against Gram positive in comparison to Gram negative bacteria. 
This finding is in line with other studies by Tong et al. (2011) and Buatong et al. 
(2011). Studies have shown that Gram negative bacteria are more resistant to 
antimicrobials due to the presence of the outer membrane permeability barrier which 
acts as a barrier to limit the influx of antimicrobials to their targets in the bacterial cell 
(Poole, 2001). Furthermore, Gram negative bacteria belonging to the Enterobacteriaceae 
family (eg: E. coli) have been proven as serious threats in nosocomial infections due to 
their spread of resistance (Paterson, 2006). Bacteria from the Enterobacteriaceae family 
have been reported to produce enzymes such as Extended Spectrum Beta Lactamase 
(ESBL) which are able to break down many commonly used antibiotics; which justifies 
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the resistance displayed by E. coli in this study with none of the only 20% of the 
endophytes from I. pes-caprae were active against this bacterium. 
The ability of endophytic fungi to produce the same types of compounds as its 
host plant may provide an alternative strategy towards the sustainable production of 
certain pharmacologically important substances without exploiting or affecting the 
biodiversity of plants and in the same time reducing the market cost of the product. 
Besides this, fungi can be commercially cultivated under optimized fermentation 
conditions thereby leading to continuous and reproducible compounds. This is more 
effective than harvesting the same compounds from its host plant as the production of 
such compounds is dependent on the host’s environment and as such the quantities and 
quality of compounds produced by the plant may differ according to different 
environments (Kusari et al., 2012). 
Certain endophytic fungi isolates in the present study exhibited promising 
antibacterial potential and may therefore be potential candidates for the discovery of 
new and novel antibacterial compounds. Endophytic fungi especially the ones isolated 
from the plant I. pes-caprae namely; Minimidochium sp. and Bipolaris sp. should be 
further analysed to elucidate their bioactive compounds through bioassay guided 
fractionation coupled with NMR studies. 
 
5.3.1 Endophytic fungi and their antimicrobial activities 
A number of endophytic fungi strains isolated in this study have also been reported 
from previous studies. The antimicrobial activities of these fungi have also been stated 
in several studies which may further justify the activities similar isolates exhibited in 
this study. From the 34 endophytic fungi isolated from both plants in this study, the 
fungi strain most commonly found was Phoma sp. consisting of almost 14.7% of the 
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endophytic fungi. Fungi from the genus Phoma are usually characterized as 
phytopathogens with the ability to cause losses in commercial crops (Liu et al., 2003). 
Although usually isolated from the terrestrial habitats, Phoma sp. has also been isolated 
from the marine environment such as from marine microbial mats in the Bahamas (Liu 
et al., 2003). Goldring et al. (2012) reported the isolation of Phoma sp. from the shell of 
a crab, Chionoecetes opilio. The fungi Phoma sp. gained prominence with the discovery 
of phomactins, which are a novel group of terpenoid platelet activating factor 
antagonists with potential use in the treatment of inflammatory diseases and organ 
transplant rejection (Goldring et al., 2006). In culture, Phoma sp. has been known to 
produce a diverse array of secondary metabolites such as the isolation of the 
antimicrobial compound 2-hydroxy-6-methylbenzoic acid from the endophytic Phoma 
sp. from the plant Taraxacum mongolicum (Zhang et al., 2013). Hoffman et al. (2008) 
reported the identification of the chemical compound phomodione with potent 
antibacterial activities against S. aureus from Phoma sp. However only three out of the 
five Phoma sp. strains in this study displayed antibacterial activity towards test bacteria 
and the Phoma sp. strain (JQ388280.1) from I. pes-caprae was the only one among the 
rest of its kind to demonstrate activity against S. aureus. 
The second most common isolated endophytic fungi in this study were Bipolaris 
sp. comprising of almost 11.8% of all isolated endophytic fungi. All the strains were 
isolated from the plant I. pes-caprae with none from V. rotundifolia. Out of the four 
Bipolaris sp. strains, two of them exhibited antibacterial activity with one strain with 
promising and wide spectrum activity against 85% of test bacteria in this study. The 
genus Bipolaris has been notoriously known as a plant pathogen due to their ability to 
produce mycotoxins and phytotoxins that in various instances are detrimental towards 
plants. Although mostly known for their role as plant pathogens, Bipolaris sp. has also 
been reported to produce biologically active metabolites as in studies by Arunpanichlert 
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et al. (2012), whereby a dimeric chromanone and a phthalide with antimicrobial and 
antioxidant activities was isolated from a strains of Bipolaris sp. derived from the 
seagrass, Halophila ovalis. While the Bipolaris sp. strain in this present study displayed 
broad spectrum antibacterial activity against both Gram positive and negative bacteria, 
the strains used in the study by Arunpanichlert et al. (2012) only managed to exhibit 
activity against the Gram positive bacteria S. aureus. These findings possess certain 
similarities to the present study whereby the Bipolaris sp. with promising antibacterial 
activities in this study was also derived from a marine associated plant. This also serves 
to prove that although the fungi Bipolaris sp. may not be exclusive to the terrestrial 
habitat and may be found in the marine environment as well. 
The endophytic fungi Myrothecium sp. in this study displayed promising 
antibacterial activities against Gram positive bacteria. This fungus was previously 
reported to possess antifungal activities which led to the isolation of antifungal 
trichothecenes (Liu et al., 2005). A study by Pervez et al. (2012) found the fungi 
Myrothecium sp. to possess good in-vitro antimicrobial activities against human 
pathogens such as Salmonella typhi, Klebsiella pneumonia, B. cereus, including the 
Gram negative E.coli while in comparison, the same fungi strain in the present study 
was solely potent against Gram positive bacteria. Research by Garcia et al. (2012) 
reported the display of broad spectrum of antibacterial activity from the endophytic 
fungi Cochliobolus sp. isolated from the plant Sapindus saponaria L. However in the 
present study the Cochliobolus eragrostidis strain displayed a more narrow range of 
antibacterial activity targeted more towards Gram positive bacteria while Cochliobolus 
lunatus exhibited no activity. One of the 2 Dothideomycete sp. isolated from I.pes-
caprae demonstrated potent antibacterial activity even managing to inhibit the 
bacterium P. aeruginosa. Previous studies by Rhoden et al. (2012) have also reported 
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antibacterial activities by Dothideomycete sp.; the difference being that the strain used 
in their study was isolated from a terrestrial medicinal plant.  
Some of the other strains with a wide range of antibacterial activity covering at 
least 3 test bacteria were Paecilomyces sp., Montagnulaceae sp., Fusarium equiseti, 
Minimidochium sp., Penicillium sp. and Curvularia sp. Curvularia sp. have been known 
to produce haloperoxidase which is an enzyme with antimicrobial properties and has 
also been considered as a potential candidate for the development of surface 
disinfectants (Hansen et al., 2003). Furthermore there have also been reports on 
antifungal activities from Curvularia sp. (Zhang et al., 2011). There have been no 
reports on the antibacterial or antimicrobial activities from the fungi Montagnulaceae 
sp. and Minimidochium sp. Some of the endophytic fungi strains with reported 
antibacterial activity in previous studies have displayed no such activities in the present 
study. For instance the strain Clasdosporium cladosporioides in the present study 
exhibited no antibacterial activity towards any of the test bacteria but a study by Wang 
et al. (2007) stated the isolation of the antimicrobial compound brefeldin A from this 
genus. Another similar study by Ding et al. (2008) also reported the isolation of 
antimicrobial metabolites with antibacterial activities against Gram positive and 
negative bacteria from Clasdosporium sp. that was found to be associated with the red 
algae Porphyra yezoensis. Another instance where this fungus was isolated from the 
marine habitat is as reported in Qi et al. (2009) in which Clasdosporium sp. was isolated 
from mangrove seawater and was reported to possess antibacterial activities against 
fouling bacteria. There have been several reports where the fungi Clasdosporium sp. has 
been isolated as endophytic fungi especially from medicinal plants such as studies by, 
Powthong et al. (2012), Vaz et al. (2012) and Wang et al. (2007) which is similar to the 
present study as the C. cladosporioides strain obtained was from the plant I.pes-caprae 
which also is known for its medicinal values as elaborated earlier. Fusarium equiseti is 
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a fungus usually reported from the terrestrial environment however Llamas et al. (2008) 
reported the isolation of this fungal strain from fluvial channels and sea beds from the 
south eastern coast of Spain. Though there has been no report of bioactivity from 
marine derived F. equiseti, Shiono et al. (2013) stated the isolation of the antimicrobial 
compound fusaequisin from an endophytic fungi F. equiseti that was isolated from a 
medicinal plant. Furthermore there have also been reports of cytotoxic compound 
isolated from F. equiseti (Morrison et al., 2001). 
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5.4 Manglicolous fungi as promising natural product reservoirs  
Around 90.91% of the manglicolous fungi in this study exhibited antibacterial activity 
against at least one test bacteria with the highest activity recorded against the Gram 
positive bacteria, B. subtilis, S. aureus and B. cereus at 90.91%, 81.82% and 72.73% 
respectively. This selective antibacterial activity displayed by the manglicolous fungi 
against Gram positive bacteria is similar to studies by Buatong et al. (2011) which 
reported high activity by manglicolous fungi towards the Gram positive S.aureus but 
minimal activity and lack of activity against the Gram negative E. coli and P. 
aeruginosa respectively.  
The manglicolous fungi displayed no antibacterial activity against E. faecalis 
and P. aeruginosa while the lowest percentage was recorded against E. coli at 18.18%. 
Studies have shown that Gram negative bacteria are more resistant to antimicrobials due 
to the presence of the outer membrane permeability barrier which acts as a barrier to 
limit the influx of antimicrobials to their targets in the bacterial cell (Poole, 2001). 
Furthermore, Gram negative bacteria belonging to the Enterobacteriaceae family (eg: E. 
coli) have been proven as serious threats in nosocomial infections due to their spread of 
resistance (Paterson, 2006). Bacteria from the Enterobacteriaceae family have been 
reported to produce enzymes such as Extended Spectrum Beta Lactamase (ESBL) 
which are able to break down many commonly used antibiotics thus providing a 
probable justification to the lack of activity exhibited by the fungal extracts towards E. 
coli. 
Many marine derived fungi have been reported to be able to produce secondary 
metabolites with interesting bioactivities, some with selective activity and other with 
broad spectrum of activities. Studies have reported fungi such as Verruculina enalia and 
Corollospora maritima with the potential to produce antibacterial compounds. Liberra 
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et al. (1998) reported the isolation of a novel antibacterial agent, corollosporine from 
the marine derived fungi C. maritima. Corollosporine is an antibiotic with phthalide 
activity against S. aureus and B. cereus (Neumann et al., 2006). Research by Lin et al. 
(2002) isolated the metabolites enalin A and B from the mangrove derived fungi 
V.enalia which was isolated from salt lake in the Bahamas. Therefore the antibacterial 
activities displayed by the fungi V. enalia and C. maritima in this study, could have 
been due to the presence of the reported antibacterial compounds known to be produced 
by these strains. 
Li et al. (2010) claimed that the mangrove on the South China Sea coast plays 
host to an abundant diversity of marine derived fungi that may be an important source 
of new and novel metabolites with interesting bioactivities. Recently, the research of 
natural products from marine derived fungi experienced a boost when a group of 
Chinese researchers’ uncovered the immensely large fungal diversity in the unique 
mangrove habitats on the tropical island of Hainan (Ebel, 2012). Ebel, (2012) stated that 
only 6% of all new compounds from marine derived fungi originated from mangrove 
derived fungi. This suggests that though the fungal diversity in mangrove habitats is 
vast, they have yet to be fully explored for their bioactive metabolites. 
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5.5 Effect of culture conditions in the production of fungal secondary metabolites 
Culture conditions of fungi have been proven to modulate the types and physiochemical 
properties of secondary metabolites produced, thus altering the levels and intensity of 
their bioactivity as stated in studies by Ramos et al. (2011), Sood, (2011) and Kang et 
al. (2013). A study by Ramos et al. (2011) reported differential bioactivity displayed by 
the same fungal strain with differing incubation times and carbon and nitrogen sources.  
In the present study, the antibacterial activities of all marine derived fungi were 
firstly evaluated using the plug assay which did not require the extraction of secondary 
metabolites. Two different growth media namely; PDA and CMA was used. Based on 
optimization testing, the fungi grown on PDA demonstrated better antibacterial activity 
compared to the same fungi grown on CMA. In accordance to Moss, (1984) and 
Jennings, (1995), PDA has been characterized as a simple media suitable for the 
production of fungal secondary metabolites. Several studies on bioactive fungal 
secondary metabolites have also reported the use of PDA as their primary fungal media 
(Guo et al., 2006; Varughese et al., 2012). Therefore the types of media used can 
influence the bioactivity exhibited by the fungi in this study. 
According to Bhadury et al. (2006), the syntheses of most fungal secondary 
metabolites are modulated by the polyketide synthase (PKS) and nonribosomal peptide 
synthethase (NRPS) pathways. Research has shown that the manipulation in 
fermentation and post genomic technologies may play a prominent role in the 
expression of these gene clusters thereby influencing the amount and types of secondary 
metabolites produced by the fungi (Bhadury et al., 2006). These reports serve to prove 
that the difference in culture conditions determines the secondary metabolites produced 
by a fungus. 
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The culture conditions of the manglicolous fungi were manipulated in terms of, 
incubation time and shaken or stationary phase for optimization purposes. In this 
present study, incubation times of 10, 15 and 20 days were experimented for 
optimization. Based on findings, fungi cultured with an incubation period of 10 days or 
less displayed no antibacterial activity while an incubation period of 20 days showed 
neither significant increase nor decrease in antibacterial activity displayed. The results 
of this optimization are not shown in this write up. Deduke et al. (2012) stated that due 
to the fact that fungal secondary metabolites are not required in primary metabolism, 
their synthesis may be triggered when the nutrients become limited and growth slows 
down. After optimization of incubation timing, fungi mycelia and fermentation broth 
were harvested after 15 days of incubation for secondary metabolite extraction.  
In a bid to mimic the physiochemical characteristics of their natural 
environment, all manglicolous fungi in the present study were grown in broth 
supplemented with salt at a concentration of 25 parts per million (ppm) similar to the 
stated salinity of the surroundings from which they were isolated, and incubated under 
agitation phase. Based on experimental optimization, the ideal culture phase for these 
fungi was found to be the agitation phase of 100 rpm. A recently report by Kusari et al. 
(2012) stated that altering fermentation parameters such as media type, aeration, 
temperature, pH, agitation and harvest points may influence the production of 
biologically active metabolites in fungi. Thereby this may serve as a justification for 
optimal antibacterial activity display of the fungi when cultured at a salt concentration 
of 25 ppm and the agitation phase of 100 rpm. 
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5.6 Antibacterial potential of Saccardoella rhizophorae 
A strain of S. rhizophorae was selected from the panel of manglicolous fungi strains 
used in this study for further chemical analysis of its secondary metabolites. This 
selection was based on the fact that the crude extract of this fungus displayed activity 
against five out of the seven test bacteria with promising activity against the Gram 
negative E. coli at a MIC of 500µg/ml. Furthermore all the MIC values recorded by the 
crude extract of S. rhizophorae were 500µg/ml and below suggesting promising 
antibacterial potential. 
 Mangrove derived fungi has been a focal point of study since a group of Chinese 
researchers’ isolated numerous significant and new metabolites from this group of fungi 
(Huang et al., 2008). Li et al. (2010) stated that the importance of the mangrove forest 
on the South China Sea for the discovery of new bioactive chemical compounds as 
many novel compounds have been reported from this area. The fungi S. rhizophorae 
also originates from the mangrove bordering the South China Sea. 
 The strain S. rhizophorae was isolated from the driftwood of the mangrove tree 
Rhizophora apiculata. Previous studies by Sahoo et al. (2009) stated the isolation of the 
fungi Clasdosporium herbarum, Fusarium moniliforme, Cirrenalia basiminuta and 
Halophytophthora vesicular from the dead leaves of R.apiculata with pectinolytic, 
proteolytic and amylolytic activities. Rukachaisirikil et al. (2012) isolated endophytic 
fungi from R. apiculata with antibacterial and antifungal activity. Based on these 
reports, there may be promising pharmacological potential yet to be fully explored in 
the fungi found to be associated with R. apiculata and that is what this study intends to 
uncover. Mangrove plants are constantly subjected to the harsh surroundings of the 
mangrove forest such as high salinity and tidal flushes and thus these plants have been 
known to have developed special morphological and physiological characteristics as an 
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adaptation strategy (Wu et al., 2008). Therefore the fungi found to be associated with 
these plants are also subjected to such harsh and extreme conditions thereby generating 
the possibility that these fungi may possess the capability to generate certain survival 
strategies such as secondary metabolites. 
In this study we employed small scale cultivation of fungi to obtain their 
secondary metabolites which led to the isolation of two compounds mainly comprising 
of fatty acids with antibacterial activities. Numerous studies such as Lin et al. (2008), 
Klaiklay et al. (2012), Rukachaisirikul et al. (2012) and Amrani et al. (2012) have 
reported the isolation of more than at least five compounds from a single mangrove 
derived fungi. Therefore the cultivation method used in this study could have led to the 
small scale of discovery with respect to this study.  
According to Bhadury et al. (2006), large scale cultivation of marine fungi using 
bioreactor technologies is crucial to ensure optimal production of important fungal 
secondary metabolites. The maintenance of standard culture parameters during the 
entire course of cultivation ensures optimal production of secondary metabolites in 
terms of quantity and quality. Since the cultivation of fungi in this study was carried out 
in lab conditions, there could have been slight differences in culture conditions from 
time to time therefore leading to the discovery of only two major metabolites from S. 
rhizophorae. 
The efficacy of antibiotics against bacteria primarily depends on the 
antimicrobial susceptibility of the bacteria in concern. The MIC values of antibiotics 
penicillin G and chloramphenicol against test bacteria tabulated against antimicrobial 
susceptibility interpretive criteria as obtained from The European Committee on 
Antimicrobial Susceptibility Testing (EUCAST), 2013, is showed in Table 5.1. Based 
on MIC values of penicillin G, all test bacteria except E.coli can be characterized as 
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resistant strains while based on the MIC values of chloramphenicol, E. coli is a 
susceptible strain, P. aeruginosa and E. faecalis are resistant strains while S. aureus, B. 
cereus, B. subtilis and M. luteus are intermediate strains. The resistant trait displayed by 
P. aeruginosa and E. faecalis may justify the lack of activity exhibited of the pure 
compounds towards this two bacterial strains. Both linoleic and palmitic acid did not 
exhibite antibacterial activity towards E. faecalis which can be justified due to resistant 
trait displayed by this bacterium against both chloramphenicol and penicillin G; 
however the other four Gram positive bacterial strains are characterized as intermediate 
strains according to the MIC values of chloramphenicol thus rendering them more 
susceptible to the antibacterial action of the pure compounds. 
 
Table 5.1: Comparison of MIC values of antibiotics against test bacteria towards 
antimicrobial susceptibility interpretive criteria (adapted from EUCAST, 2013) 
 
Bacteria Antibiotic MIC of 
Test 
bacteria 
(µg/ml) 
Antimicrobial susceptibility 
interpretive criteria (values in µg/ml) 
Susceptible Intermedia
te 
Resistant 
S. aureus Penicillin 3.91 ≤0.12  ≥0.25 
Chloramphenicol 31.25 ≤8 16 ≥32 
E. coli Penicillin 125 ≤16 32-64 ≥128 
Chloramphenicol 7.81 ≤8 16 ≥32 
P. aeruginosa Penicillin ≥250 ≤64  ≥128 
Chloramphenicol 125 ≤8 16 ≥32 
E. faecalis Penicillin ≥250 ≤8  ≥16 
Chloramphenicol ≥250 ≤8 16 ≥32 
B. cereus Penicillin 62.5 ≤8  ≥16 
 Chloramphenicol 15.63 ≤8 16 ≥32 
B. subtilis Penicillin 62.5 ≤8  ≥16 
 Chloramphenicol 15.63 ≤8 16 ≥32 
M. luteus Penicillin 125 ≤8  ≥16 
 Chloramphenicol 15.63 ≤8 16 ≥32 
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5.6.1 Bioactive metabolites of Saccardoella rhizophorae  
 Most studies on the identification of fungal metabolites such as Huang et al. (2006), 
Isaka et al. (2009) and Klaiklay et al. (2012), report the use of column chromatography 
to fractionate the crude fungal extract. However in the present study, solvent 
partitioning was used to further fractionate the EA crude fungal extract of S. 
rhizophorae (EAS) prior to column chromatography to ease the separation and isolation 
of the active. Since EA generally extracts out most of the secondary metabolites from 
the fermentation broth of the fungi, solvents of differing polarities were used to perform 
a preliminary separation of secondary metabolites based on polarity. Results obtained 
showed that out of the three fractions, the n-hexane (HS) and dichloromethane (DS) 
fractions exhibited antibacterial activity while the methanol (MS) fraction did not 
exhibit any antibacterial activity. This concludes that the active compounds in the 
fungal extract are of lesser polarity thus they are able to dissolve in solvents with lower 
polarities as the solvents n-hexane and dichloromethane are lower in polarity in 
comparison to the relatively polar solvent methanol. 
 Based on the display of antibacterial activities, sub-fractions 2 and 3 of the HS 
fraction were further subjected to separation via multiple TLC profiling which led to the 
isolation two fatty acids, both eluted using solvent system, n-hexane: ethyl acetate, 
75:25. The fatty acid cis-9, cis-12-octadecadenoic acid (linoleic acid), a polyunsaturated 
fatty acid was isolated from sub-fraction 2 while the other fatty acid, n-hexadecanoic 
acid (palmitic acid) was isolated from sub-fraction 3. Both the fatty acids isolated are 
long chain fatty acids which are rather non-polar in nature thus justifying why they were 
isolated from the non-polar HS fraction.  
Linoleic acid exhibited antibacterial activity towards S. aureus and B. subtilis 
while the sub-fraction from which linoleic acid was derived from exhibited antibacterial 
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activity against B. cereus, E. faecalis and M. luteus. The exhibition of antibacterial 
activity by linoleic acid is lower than its unpurified subfraction which could be due to 
the synergistic effect (Pereira et al., 2014) between linoleic acid and the elements in the 
unpurified subfraction, thereby increasing the antibacterial effect of the subfraction. 
This may explain the higher potency of the subfraction in comparision to the pure 
compound. Palmitic acid exhibited antibacterial activity against S. aureus, B. cereus, B. 
subtilis and M. luteus while the subfraction from which palmitic acid was derived from 
exhibited antibacterial activity only against S. aureus, B. cereus, B. subtilis. The 
exhibition of antibacterial activity by palmitic acid was greater than its subfraction 
which could be due to the antagonistic effect (Oshiro et al., 2008) between palmitic acid 
and the elements in the unpurified subfraction thereby increasing the antibacterial 
potency of the purified palmitic acid. This may explain the higher potency of the pure 
compound in comparison to the unpurified subfraction. 
Palmitic acid exhibited antibacterial activity against most of the Gram positive 
bacterial strains in this study namely; S. aureus, B. cereus, B. subtilis and M. luteus; 
while linoleic acid exhibited antibacterial activity only against S. aureus and B. subtilis. 
The lipo-polysaccharide (LPS) layer of Gram negative bacteria prevents the penetration 
of hydrophobic oils and their accumulation in the bacterial cell membrane (Bajpai et al., 
2013). Thus, since fatty acids are known to be hydrophobic in nature, the selective 
permeability of the LPS layer can justify the lack of antibacterial activity exhibited by 
both fatty acids against the Gram negative bacteria used in the present study.  
According to Zheng et al. (2005), fatty acids have been long used as food 
additives to prevent and inhibit the growth of microorganisms. Certain fatty acids have 
been known to display antibacterial activities such as in studies by Huang et al. (2011), 
which reported the antibacterial activity of palmitic acid against oral microorganisms. 
Even the fatty acid linoleic acid has been reported to possess antibacterial activities 
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against S. aureus in studies by Dilika et al. (2000) which is similar to the present study 
in which linoleic acid displayed an MIC of 0.5mg/ml against S. aureus. Furthermore, 
linoleic acid was found to be able to inhibit the bacterial enoyl-acyl carrier protein 
reductase which is an important component in bacterial fatty acid synthesis thus also 
inhibiting the growth of the bacteria. Besides being known for its antibacterial activity, 
fatty acids have also been explored in the field of cancer drug discovery. A study on 
metabolites from the marine fungi Trichoderma sp. by Kandasamy et al. (2012) 
reported the isolation of linoleic acid which was found to be an inhibitor against skin 
cancer protein thus providing promising potential for future cancer drug development. 
Furthermore, linoleic acid is polyunsaturated fatty acids (PUFA) which is an essential 
lipid in human health and nutrition. Fish oils are the main marine source of PUFA, 
however in a bid to reduce the cost of production, microorganisms are now being 
explored as sources for the alternative production of PUFA to (Ruiz et al., 2007). The 
study by Ruiz et al. (2007) is similar to the present study which saw the isolation of 
linoleic acid from the marine derived fungi Trichoderma longibrachiatum. 
Linoleic acid and palmitic acid are also known to be common fatty acid 
constituents in essential oils (Tang et al., 2013). Linoleic acid especially is the second 
major fatty acid after oleic acid in argan oil (Benzaria et al., 2006). The composition of 
44.8% oleic acid and 33.7% of linoleic acid in argan oil has been proven to possess 
nutritional benefits in the reduction of atherosclerosis consequently preventing 
occurances of cardiovascular diseases in humans (Cherki et al., 2006). Studies by 
Cherki et al. (2006) have stated that linoleic acid, an essential acid that cannot be 
synthesized by the human body, is a precursor for the synthesis of arachidonic acid 
which is a precursor of prostaglandin E1, prostacyclin and thromboxane; all of which 
are known to possess platelet anti-aggregator and vasodilator activities thereby 
justifying the anti-hypertensive effect of linoleic acid. Arachidonic acid by itself is 
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known for its hypocholecterolemic effect thus being the reason why oils rich in 
arachidonic acid derived fatty acids particularly linoleic acid are recommended to 
reduced total cholesterol (Cherki et al., 2006). Linoleic acid and palmitic acid are also 
the second major fatty acid component after oleic acid in olive oil with linoleic acid at 
5.3-21.0% and palmitic acid at 7.5-20.0% (Mendoza et al., 2013). Olive oil is one of the 
most commonly consumed cooking oils in Mediterranean countries mainly due to its 
health benefits especially in prevention of cardiovascular diseases, a similar trait 
observed in argan oil (Maggio et al., 2009). Palmitic acid, being a saturated fatty acid 
holds less nutritional values in comparison to the unsaturated omega-6 linoleic acid thus 
justifying as to why food oils higher in linoleic acid is commonly proven beneficial 
(Benzaria et al., 2006). 
 The demand for fatty acid methyl esters (FAMEs) as diesel fuel (biodiesel) is on 
the rise due to the instability of petroleum prices (Vicente et al., 2009). Biodiesel is fast 
becoming the favoured alternative choice of fuel in comparison with conventional diesel 
fuels especially in countries such as European Union, America, Australia, Japan, China, 
and Malaysia among others (Zhu et al., 2008). Fatty acids are known to be ubiquitously 
found in most living organisms such as animals and plants. Although vegetable oils and 
animal fats are the main sources of fatty acids but their sustainability is mostly 
environmental dependant and varies with climates and seasons, thus forcing scientist to 
explore alternative sources of fatty acids in order to meet the demands of the biodiesel 
industry (Zhu et al., 2008; Khot et al., 2012). Currently lipids from oleaginous 
microorganisms may prove to possess significant potential as feedstock for biodiesel 
production as its resource requirements are basic and therefore may prove economical 
(Zhu et al., 2008).. Microalgae have been known to be the most prolific source for fatty 
acids among all microorganisms (Dominguez et al., 2012).  
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The production of fatty acids by fungi and its application have been studied 
since the late nineteenth century and fungi have also been known to be good producers 
of commercially important fatty acids (De et al., 2011). For instance, the fungus Mucor 
circinelloides produces large quantities of fatty acids thus making it a suitable candidate 
for large scale commercial production (Vicente et al., 2009). Although there have been 
not as many reports of marine derived fungi as potential producers of fatt acids, Table 
5.2 shows several selected marine derived fungi strains reported as significant producers 
of the same fatty acids as reported in the present study.  
 
Table 5.2: Research done on selected marine derived fungi leading to the isolation of 
similar fatty acids as in the present study 
 
Fungi Fatty acids Reference 
Trichoderma sp. Linoleic acid Kandasamy et al. (2012) 
Orpinomyces sp. Palmitic acid Comlekcioglu et al. (2010) 
Paecilomyces sp. Linoleic acid Wang et al. (2010) 
Mortierella alpina Linoleic acid Sakuradani et al (2009) 
Ceriporiopsis subvermispora Linoleic & palmitic acid Enoki et al. (1999) 
Hypoxylon sp. Linoleic acid Le et al. (1999) 
Arthrobotrys conoides Linoleic acid Anke et al. (1995) 
Annulohypoxylon squamulosum Palmitic acid Cheng et al. (2012) 
Alternaria sp. M6 Palmitic acid Zhang et al. (2012) 
Gliomastix murorum & Pichia 
 guilliermondii  
Palmitic acid Zhao et al. (2009) 
Chaetomium fusiforme Palmitic acid Guo et al. (2008) 
Cunninghamella echinulata Linoleic acid Fakas et al. (2008) 
Leccinum extremiorientale Palmitic acid Gao et al. (2003) 
Julella avicenniae Palmitic acid Le et al. (1998) 
Clitocybe laccata, Lactarius 
 controversus, Phellinus 
 pomaceus, Stereum hirsutum 
Palmitic & linoleic acid Senatore et al. (1988) 
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5.7 Improvisations with respect to the present study and suggestions for future 
work 
 The endophytic fungi strains in the present study were identified based on the 
sequence of only one gene (ITS) whereby some fungal strains were only 
identified to genus level. Therefore future work should adopt multi-gene 
analysis to improvise the accuracy in identifying the endophytic fungi and also 
to conduct phylogenetic studies of endophytic fungi found in the two marine 
associated plants in the study. 
 The present study focused on endophytic fungi that were able to grow in given 
laboratory conditions. Proposed future work should focus also on the non-
culturable endophytic fungi strains from the given plants. 
 The present study only involved the chemical analysis of S. rhizophorae 
secondary metabolites. Therefore future work should focus on the other fungi 
strains especially the endophytic fungi strains that displayed promising 
antibacterial activities in the broth microdilution assay.  
 Studies by Ramos et al. (2011), Sood, (2011) and Kang et al. (2013) have 
reported differing production of secondary metabolites with respect to varying 
culture conditions. In the present study, culture conditions were manipulated 
only in accordance to basic experimental optimization. Therefore further studies 
should involve systematic manipulation of culture conditions to obtain standard 
curves of varying culture conditions in relation to secondary metabolite profiles. 
 In the bioassay guided fractionation, only the HS fraction was purified which led 
to the isolation the linoleic acid and palmitic acid. The DS fraction exhibited 
significant antibacterial activity mainly against the Gram positive bacteria 
strains. However the dichloromethane fraction could not be further purified due 
to small amount of the fraction. Thus future work should focus on the large scale 
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cultivation and extraction of fungal crude extract to ensure complete isolation 
and analysis of their secondary metabolite profiles including minor compounds. 
 This is a bioassay-guided fractionation study therefore the inactive fractions of 
the S. rhizophorae extract were not purified. Thus future studies should also 
focus on inactive fractions and sub-fractions; this is because although the 
fractions and sub-fractions may be inactive, there may be metabolites present 
that may possess activity in its purified form. 
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CHAPTER 6 
CONCLUSIONS 
 
The diversity of endophytic fungi in the marine associated plants Ipomoea pes-caprae 
and Vitex rotundifolia is noteworthy. Twenty-one endophytic fungi strains were isolated 
from I. pes-caprae comprising of fifteen genus/species. As for V. rotundifolia, thirteen 
endophytic fungi strains were isolated and identified comprising of eight genus or 
species. Certain endophytic fungi such as Bipolaris sp., Guignardia mangiferae and 
Phoma sp., are known plant pathogens thus suggesting that they may not be exclusively 
pathogenic but may have evolved into a symbiotic relationship with the plant. 
Endophytic fungi have long been associated with the production of pharmacologically 
active metabolites which is supported by the findings of this study. Ten and five of the 
endophytic fungi from I. pes-caprae and V. rotundifolia respectively exhibited 
antibacterial activity against the test bacteria in the study. However the majority of the 
endophytic fungi strains were active against Gram positive bacteria with only 11.76% of 
all fungi strains active against Gram negative bacteria. As suggested by hypothesis on 
the influence of the place of collection and ethobotanical significance of a plant on the 
bioactivities exhibited by their endophytic fungi, the antibacterial activities displayed by 
the fungi strains from I. pes-caprae were broader spectrum. A total of five endophytic 
fungi were chosen for further analysis through the broth microdilution assay and strains 
such as Bipolaris sp. (HQ631009.1) from I. pes-caprae and Paecilomyces sp. from V. 
rotundifolia exhibited the strongest antibacterial potential with the lowest MIC values. 
 The manglicolous fungi in the study exhibited moderate antibacterial 
activities overall with the majority of them active against the Gram positive test 
bacteria; a trait common to that displayed by the endophytic fungi in the present study. 
Out of the eleven manglicolous fungi, ten or 90.9% of them exhibited antibacterial 
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activity. However out of this 90.9%, only 20% were active against Gram negative 
bacteria. The results obtained from the preliminary plug assay were in sync with those 
obtained from the broth microdilution assay. 
 The chemical elucidation of metabolites from the crude extract of 
Saccardoella rhizophorae revealed the presence of fatty acids linoleic acid and palmitic 
acid. These fatty acids although considered ubiquitious and simple, may prove 
beneficial as important constituents of essential oils and also possesses nutritional 
values as suggested by the role of linoleic acid in particular. Besides this, the fungal 
strain S. rhizophorae may prove to be a potential candidate to be explored for its role in 
the sustainable production of raw materials for biodiesel fuel. 
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APPENDIX 1 
Preparation of media and chemicals 
Luria Broth agar (LB) 
37 g of powder was dissolved with 1 L distilled water in a Schott bottle. The medium 
was then sterilized by autoclave at 121°C for 15 minutes.  
 
Mueller-Hinton broth (MHB)  
21 g of powder was dissolved with 1 L distilled water in a Schott bottle. The medium 
was then sterilized by autoclave at 121°C for 15 minutes.  
 
Potato Dextrose agar (PDA) 
39 g of powder was dissolved in 1 L distilled water in a Schott bottle. The medium was 
then sterilized by autoclave at 121°C for 15 minutes. 
 
Potato Dextrose broth (PDB) 
24 g of powder was dissolved in 1 L distilled water in a Schott bottle. The medium was 
then sterilized by autoclave at 121°C for 15 minutes. 
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Preparation of antibiotics 
For the preparation of antibiotics chloramphenicol and penicillin, 2.0 mg of powder was 
dissolved in 1ml of distilled water respective for both antibiotics. It was then sterilized 
using 0.45 μm syringe filter. After sterilization, the antibiotic solution was stored in a -
20°C freezer.  
 
Preparation of INT  
20 mg of INT was dissolved in 50 ml of distilled water. It was then sterilized using 0.45 
μm syringe filter. After sterilization, the INT solution was stored in a -20°C freezer.  
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APPENDIX 2 
 
List of aligned ITS sequence by NCBI BLAST of marine derived endophytic fungi 
 
Bipolaris sp. KH00278 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1 and 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 
2, partial sequence 
Sequence ID: gi|294471397|gb|GU017499.1|Length: 577Number of Matches: 1 
Score Expect Identities Gaps Strand 
1066 bits(577) 0.0 577/577(100%) 0/577(0%) Plus/Plus 
Query  19   AACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAATACAATATGAAGGCTG  78 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    AACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAATACAATATGAAGGCTG  60 
Query  79   TCCGCAGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGTTGTTTCCTGGGCGGG  138 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TCCGCAGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGTTGTTTCCTGGGCGGG  120 
Query  139  TTCGCTCGCCACCAGGACCACCAAATAAACCTTTTTTATGCAGTTGCAATCAGCGTCAGT  198 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  TTCGCTCGCCACCAGGACCACCAAATAAACCTTTTTTATGCAGTTGCAATCAGCGTCAGT  180 
Query  199  ACAAACAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATG  258 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  ACAAACAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATG  240 
Query  259  AAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATC  318 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  AAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATC  300 
Query  319  TTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGTCATTTG  378 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGTCATTTG  360 
Query  379  TACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTGTCTTTGGTCGCCCAAAGACTCGCCT  438 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  TACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTGTCTTTGGTCGCCCAAAGACTCGCCT  420 
Query  439  TAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGCAGCGCAGCACATTTTTGCGCTTGCCA  498 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  TAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGCAGCGCAGCACATTTTTGCGCTTGCCA  480 
Query  499  TCAGCAAAACGGCAATCCATCAAGCCTCCTTCTCACGTTTGACCTCGGATCAGGTAGGGA  558 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  TCAGCAAAACGGCAATCCATCAAGCCTCCTTCTCACGTTTGACCTCGGATCAGGTAGGGA  540 
Query  559  TACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA                         595 
            ||||||||||||||||||||||||||||||||||||| 
Sbjct  541  TACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA                         577 
 
Bipolaris sp. 1 TMS-2011 voucher SC9d100p9-2 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383330|gb|HQ631009.1|Length: 609Number of Matches: 1 
Score Expect Identities Gaps Strand 
1068 bits(578) 0.0 589/594(99%) 2/594(0%) Plus/Plus 
Query  2    GGAAGTAAAAGTCGTAACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAAT  61 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAAT  75 
Query  62   ACAATATGAAGGCTGTCCGCAGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTG-  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  76   ACAATATGAAGGCTGTCCGCAGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGA  135 
Query  121  TTGTTTCCTGGGCGGGTTCGCTCGCCACCAGGACCACCAAACAAACCTTTTTTATGCAGT  180 
            ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Sbjct  136  TTGTTTCCTGGGCGGGTTCGCTCGCCACCAGGACCACCAAATAAACCTTTTTTATGCAGT  195 
Query  181  TGCAATCAGCGTCAGTACAAACAATGTAAATCATTTACAACTTTCAACAACGGATCTCTT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  196  TGCAATCAGCGTCAGTACAAACAATGTAAATCATTTACAACTTTCAACAACGGATCTCTT  255 
Query  241  GGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  256  GGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTC  315 
Query  301  AGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  316  AGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCT  375 
Query  361  GTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTGTCTTTGGTC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  376  GTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTGTCTTTGGTC  435 
Query  421  GCCCAAAGACTCGCCTTAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGCAGCGCAGCAC  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  436  GCCCAAAGACTCGCCTTAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGCAGCGCAGCAC  495 
Query  481  ATTTTTGCGCTTGCCATCAGCAAAACGGCAATCCATCAAGCCTCCTTCTCACGTTTGACC  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  496  ATTTTTGCGCTTGCCATCAGCAAAACGGCAATCCATCAAGCCTCCTTCTCACGTTTGACC  555 
Query  541  TCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAG-CGGAGGAA        593 
            ||||||||||||||||||||||||||||||||||||||  ||||| |||||||| 
Sbjct  556  TCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATATATAAGGCGGAGGAA        609 
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Bipolaris sp. CC06-23-3_DCPA 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|478432585|gb|JX960589.1|Length: 570Number of Matches: 1 
Score Expect Identities Gaps Strand 
1037 bits(561) 0.0 568/571(99%) 2/571(0%) Plus/Plus 
Query  15   TCGTAACAAGGTCTCCGTTAAGGTGAACCTGCGGAGGGATCATTACACAATACAATATGA  74 
            ||||||||||||||||||  |||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCGTAACAAGGTCTCCGT--AGGTGAACCTGCGGAGGGATCATTACACAATACAATATGA  58 
Query  75   AGGCTGTCCGCAGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGTTGTTTCCTG  134 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  59   AGGCTGTCCGCAGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGTTGTTTCCTG  118 
Query  135  GGCGGGTTCGCTCGCCACCAGGACCACCAAACAAACCTTTTTTATGCAGTTGCAATCAGC  194 
            ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
Sbjct  119  GGCGGGTTCGCTCGCCACCAGGACCACCAAATAAACCTTTTTTATGCAGTTGCAATCAGC  178 
Query  195  GTCAGTACAAACAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCA  254 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  179  GTCAGTACAAACAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCA  238 
Query  255  TCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCAT  314 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  239  TCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCAT  298 
Query  315  CGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGT  374 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  299  CGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGT  358 
Query  375  CATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTGTCTTTGGTCGCCCAAAGAC  434 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  359  CATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTGTCTTTGGTCGCCCAAAGAC  418 
Query  435  TCGCCTTAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGCAGCGCAGCACATTTTTGCGC  494 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  419  TCGCCTTAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGCAGCGCAGCACATTTTTGCGC  478 
Query  495  TTGCCATCAGCAAAACGGCAATCCATCAAGCCTCCTTCTCACGTTTGACCTCGGATCAGG  554 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  479  TTGCCATCAGCAAAACGGCAATCCATCAAGCCTCCTTCTCACGTTTGACCTCGGATCAGG  538 
Query  555  TAGGGATACCCGCTGAACTTAAGCATATCAA                               585 
            ||||||||||||||||||||||||||||||| 
Sbjct  539  TAGGGATACCCGCTGAACTTAAGCATATCAA                               569 
 
Bipolaris sp. SLP1 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA 
gene, complete sequence; and internal transcribed spacer 2, partial sequence 
Sequence ID: gb|JX949177.1|Length: 974Number of Matches: 1 
Score Expect Identities Gaps Strand 
1799 bits(974) 0.0 974/974(100%) 0/974(0%) Plus/Plus 
Query  1    GGGGAAAACATTAAATATGAAGGCTGTCCGCAGCTGGAGTATTTTATTACCCTTGTCTTT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GGGGAAAACATTAAATATGAAGGCTGTCCGCAGCTGGAGTATTTTATTACCCTTGTCTTT  60 
Query  61   TGCGCACTTGTTGTTTCCTGGGCGGGTTCGCTCGCCACCAGGACCACCAAATAAACCTTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TGCGCACTTGTTGTTTCCTGGGCGGGTTCGCTCGCCACCAGGACCACCAAATAAACCTTT  120 
Query  121  TTTATGCAGTTGCAATCAGCGTCAGTACAAACAATGTAAATCATTTACAACTTTCAACAA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  TTTATGCAGTTGCAATCAGCGTCAGTACAAACAATGTAAATCATTTACAACTTTCAACAA  180 
Query  181  CGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAAT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  CGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAAT  240 
Query  241  TGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAA  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  TGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAA  300 
 
Query  301  GGGCATGCCTGTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  GGGCATGCCTGTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTT  360 
Query  361  GTCTTTGGTCGCCCAAAGACTCGCCTTAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GTCTTTGGTCGCCCAAAGACTCGCCTTAAAGTGATTGGCAGCCGGCCTTTCTGGTTTCGC  420 
Query  421  AGCGCAGCACATTTTTGCGCTTGCCATCAGCAAAACGGCAATCCATCAAGCCTCCTTCTC  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  AGCGCAGCACATTTTTGCGCTTGCCATCAGCAAAACGGCAATCCATCAAGCCTCCTTCTC  480 
Query  481  ACGTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAGACGGA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  ACGTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAGACGGA  540 
Query  541  GGAATACGTCTAGCAACTAACCCAACCCTTCCCTTCTTTCTTCTTTAGATAATAAACGAA  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  GGAATACGTCTAGCAACTAACCCAACCCTTCCCTTCTTTCTTCTTTAGATAATAAACGAA  600 
Query  601  ATCAAAGCACACTTGCATTTCCCGAACCACAGTACAGTAGACCATGTATCACTTATTGTC  660 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601  ATCAAAGCACACTTGCATTTCCCGAACCACAGTACAGTAGACCATGTATCACTTATTGTC  660 
Query  661  CTGAGTCTTCCGCGCCACGCTACTCGCGAGATAAGACACACTAATCAAATAGAACCTACA  720 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  661  CTGAGTCTTCCGCGCCACGCTACTCGCGAGATAAGACACACTAATCAAATAGAACCTACA  720 
Query  721  TCTCAAAAGCTCGCCGACCTCATCAAACTCGCAAAAAGCCAGATTAAAATATGCAACTCA  780 
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            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  721  TCTCAAAAGCTCGCCGACCTCATCAAACTCGCAAAAAGCCAGATTAAAATATGCAACTCA  780 
Query  781  ACTTCATGAAGTTGGAATCGCTAATAATCGCTGATCATAATGCCACTGCCAAGACGTTCC  840 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  781  ACTTCATGAAGTTGGAATCGCTAATAATCGCTGATCATAATGCCACTGCCAAGACGTTCC  840 
Query  841  CAGACCTTGTACCACCCCCCGTCACATCATGCGGATTGAGTCGGAGTAGAATTATTTTCC  900 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  841  CAGACCTTGTACCACCCCCCGTCACATCATGCGGATTGAGTCGGAGTAGAATTATTTTCC  900 
Query  901  CTAACCTTCGGGAAGACGCTTAATATTGATGCATTCTTACTGGGGTACAGTCCACAAATT  960 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  901  CTAACCTTCGGGAAGACGCTTAATATTGATGCATTCTTACTGGGGTACAGTCCACAAATT  960 
Query  961  GTTTTATTCTACAA                                                974 
            |||||||||||||| 
Sbjct  961  GTTTTATTCTACAA                                                974 
 
Cladosporium cladosporioides strain F28b 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|169639302|gb|EU497957.1|Length: 574Number of Matches: 1 
Score Expect Identities Gaps Strand 
1061 bits(574) 0.0 574/574(100%) 0/574(0%) Plus/Plus 
Query  1    GGAAGTAAAAGTCGTAACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACAAGTG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GGAAGTAAAAGTCGTAACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACAAGTG  60 
Query  61   ACCCCGGTTTACCACCGGGATGTTCATAACCCTTTGTTGTCCGACTCTGTTGCCTCCGGG  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   ACCCCGGTTTACCACCGGGATGTTCATAACCCTTTGTTGTCCGACTCTGTTGCCTCCGGG  120 
Query  121  GCGACCCTGCCTTCGGGCGGGGGCTCCGGGTGGACACTTCAAACTCTTGCGTAACTTTGC  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  GCGACCCTGCCTTCGGGCGGGGGCTCCGGGTGGACACTTCAAACTCTTGCGTAACTTTGC  180 
Query  181  AGTCTGAGTAAACTTAATTAATAAATTAAAACTTTTAACAACGGATCTCTTGGTTCTGGC  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  AGTCTGAGTAAACTTAATTAATAAATTAAAACTTTTAACAACGGATCTCTTGGTTCTGGC  240 
Query  241  ATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCA  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  ATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCA  300 
Query  301  TCGAATCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGGGGCATGCCTGTTCGAGCG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TCGAATCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGGGGCATGCCTGTTCGAGCG  360 
Query  361  TCATTTCACCACTCAAGCCTCGCTTGGTATTGGGCAACGCGGTCCGCCGCGTGCCTCAAA  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  TCATTTCACCACTCAAGCCTCGCTTGGTATTGGGCAACGCGGTCCGCCGCGTGCCTCAAA  420 
Query  421  TCGACCGGCTGGGTCTTCTGTCCCCTAAGCGTTGTGGAAACTATTCGCTAAAGGGTGCTC  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  TCGACCGGCTGGGTCTTCTGTCCCCTAAGCGTTGTGGAAACTATTCGCTAAAGGGTGCTC  480 
Query  481  GGGAGGCTACGCCGTAAAACAACCCCATTTCTAAGGTTGACCTCGGATCAGGTAGGGATA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GGGAGGCTACGCCGTAAAACAACCCCATTTCTAAGGTTGACCTCGGATCAGGTAGGGATA  540 
Query  541  CCCGCTGAACTTAAGCATATCAATAAGCGGAGGA                            574 
            |||||||||||||||||||||||||||||||||| 
Sbjct  541  CCCGCTGAACTTAAGCATATCAATAAGCGGAGGA                            574 
 
Cochliobolus eragrostidis strain NBRC 100188 internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, 
partial sequence 
Sequence ID: gi|363544572|gb|JN943412.1|Length: 572Number of Matches: 1 
Score Expect Identities Gaps Strand 
1057 bits(572) 0.0 572/572(100%) 0/572(0%) Plus/Plus 
Query  27   TCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAAAAAATATGAAGGCTGCAACCGCC  86 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAAAAAATATGAAGGCTGCAACCGCC  60 
Query  87   AGTTTTGGCGGGGAAGCTGAATTATTTTTCACCCATGTCTTTTGCGCACTTGTTGTTTCC  146 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   AGTTTTGGCGGGGAAGCTGAATTATTTTTCACCCATGTCTTTTGCGCACTTGTTGTTTCC  120 
Query  147  TGGGCGGGTTCGCCCGCCACCAGGACCACACCATAAACCTTTTTTATGCAGTTGCAATCA  206 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  TGGGCGGGTTCGCCCGCCACCAGGACCACACCATAAACCTTTTTTATGCAGTTGCAATCA  180 
Query  207  GCGTCAGTATAACAAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGG  266 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCGTCAGTATAACAAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGG  240 
Query  267  CATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATC  326 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATC  300 
Query  327  ATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGC  386 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  ATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGC  360 
Query  387  GTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTGTCTTTGGCTTTTGCCCCA  446 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTGTCTTTGGCTTTTGCCCCA  420 
Query  447  AAGACTCGCCTTAAAACGATTGGCAGCCGGCCTACTGGTTTCGGAGCGCAGCACATTTTT  506 
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            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  AAGACTCGCCTTAAAACGATTGGCAGCCGGCCTACTGGTTTCGGAGCGCAGCACATTTTT  480 
Query  507  GCGCTTGCAACCAGCTAAAGAGGCCAGCAATCCATCAAGACCTTCTTCTCACTTTTGACC  566 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GCGCTTGCAACCAGCTAAAGAGGCCAGCAATCCATCAAGACCTTCTTCTCACTTTTGACC  540 
Query  567  TCGGATCAGGTAGGGATACCCGCTGAACTTAA                              598 
            |||||||||||||||||||||||||||||||| 
Sbjct  541  TCGGATCAGGTAGGGATACCCGCTGAACTTAA                              572 
 
Cochliobolus eragrostidis strain NBRC 32566 internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, 
partial sequence 
Sequence ID: gi|363544608|gb|JN943448.1|Length: 572Number of Matches: 1 
Score Expect Identities Gaps Strand 
1057 bits(572) 0.0 572/572(100%) 0/572(0%) Plus/Plus 
Query  26   TCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAAAAAATATGAAGGCTGCAACCGCC  85 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAAAAAATATGAAGGCTGCAACCGCC  60 
Query  86   AGTTTTGGCGGGGAAGCTGAATTATTTTTCACCCATGTCTTTTGCGCACTTGTTGTTTCC  145 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   AGTTTTGGCGGGGAAGCTGAATTATTTTTCACCCATGTCTTTTGCGCACTTGTTGTTTCC  120 
Query  146  TGGGCGGGTTCGCCCGCCACCAGGACCACACCATAAACCTTTTTTATGCAGTTGCAATCA  205 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  TGGGCGGGTTCGCCCGCCACCAGGACCACACCATAAACCTTTTTTATGCAGTTGCAATCA  180 
Query  206  GCGTCAGTATAACAAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGG  265 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCGTCAGTATAACAAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGG  240 
Query  266  CATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATC  325 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CATCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATC  300 
Query  326  ATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGC  385 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  ATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGC  360 
Query  386  GTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTGTCTTTGGCTTTTGCCCCA  445 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTGTCTTTGGCTTTTGCCCCA  420 
Query  446  AAGACTCGCCTTAAAACGATTGGCAGCCGGCCTACTGGTTTCGGAGCGCAGCACATTTTT  505 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  AAGACTCGCCTTAAAACGATTGGCAGCCGGCCTACTGGTTTCGGAGCGCAGCACATTTTT  480 
Query  506  GCGCTTGCAACCAGCTAAAGAGGCCAGCAATCCATCAAGACCTTCTTCTCACTTTTGACC  565 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GCGCTTGCAACCAGCTAAAGAGGCCAGCAATCCATCAAGACCTTCTTCTCACTTTTGACC  540 
Query  566  TCGGATCAGGTAGGGATACCCGCTGAACTTAA                              597 
            |||||||||||||||||||||||||||||||| 
Sbjct  541  TCGGATCAGGTAGGGATACCCGCTGAACTTAA                              572 
 
Cochliobolus lunatus isolate CATAS-CL01 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|241912467|gb|GQ169765.1|Length: 562Number of Matches: 1 
Score Expect Identities Gaps Strand 
1038 bits(562) 0.0 562/562(100%) 0/562(0%) Plus/Plus 
Query  25   TCCGTAGGTGAACCTGCGGAGGGATCATTACACAAATACAATATGAAGGCTTCGGCTGGA  84 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCCGTAGGTGAACCTGCGGAGGGATCATTACACAAATACAATATGAAGGCTTCGGCTGGA  60 
Query  85   TTATTTATTTCACCCTTGTCTTTTGCGCACTTGTTGTTTCCTGGGCGGGTTCGCCCGCCA  144 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTATTTATTTCACCCTTGTCTTTTGCGCACTTGTTGTTTCCTGGGCGGGTTCGCCCGCCA  120 
Query  145  CCAGGACCACACCATAAACCTTTTTTGTTAATGCAGTCAGCGTCAGTACAACAAATGTAA  204 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CCAGGACCACACCATAAACCTTTTTTGTTAATGCAGTCAGCGTCAGTACAACAAATGTAA  180 
Query  205  ATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGA  264 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  ATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGA  240 
Query  265  AATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACAT  324 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  AATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACAT  300 
Query  325  TGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGTCATTTGTACCCTCAAGCTT  384 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGTCATTTGTACCCTCAAGCTT  360 
Query  385  TGCTTGGTGTTGGGCGTTTTGTCTTTGCTCGCCAAAGACTCGCCTTAAAACGATTGGCAG  444 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  TGCTTGGTGTTGGGCGTTTTGTCTTTGCTCGCCAAAGACTCGCCTTAAAACGATTGGCAG  420 
Query  445  CCGACCTCTTGGTTTCGCAGCGCAGCACAATTTTGCGCTTGCAAATCAGCAAGTTGGCAC  504 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  CCGACCTCTTGGTTTCGCAGCGCAGCACAATTTTGCGCTTGCAAATCAGCAAGTTGGCAC  480 
Query  505  TCCATCAAGAACATTTTCTTACGTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTT  564 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  TCCATCAAGAACATTTTCTTACGTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTT  540 
Query  565  AAGCATATCAATAAGCGGAGGA                                        586 
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            |||||||||||||||||||||| 
Sbjct  541  AAGCATATCAATAAGCGGAGGA                                        562 
 
Colletotrichum hippeastri strain CBS241.78 small subunit ribosomal RNA gene, partial 
sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal 
transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|399223736|gb|JX010293.1|Length: 612Number of Matches: 1 
Score Expect Identities Gaps Strand 
1096 bits(593) 0.0 603/608(99%) 0/608(0%) Plus/Plus 
Query  7    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACTGAGT  66 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  5    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACTGAGT  64 
Query  67   TACCGCTCTATAACCCTTTGTGAACATACCTACAACTGTTGCTTCGGCGGGTAGGCCGTC  126 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  65   TACCGCTCTATAACCCTTTGTGAACATACCTACAACTGTTGCTTCGGCGGGTAGGCCGTC  124 
Query  127  CCGTGAAAAGGACGCCTCCCGGCCCGGCCCGGACCCCTCGCGGGAACGGACCCGGCGCCC  186 
            |||||||||||||||||||||||||||||||||||||  ||||| ||||||||||||||| 
Sbjct  125  CCGTGAAAAGGACGCCTCCCGGCCCGGCCCGGACCCCCAGCGGGGACGGACCCGGCGCCC  184 
Query  187  GCCGGAGGATAACCAAACTCTGTTTTAACGACGTTTCTTCTGAGTGGCATAAGCAAAATA  246 
            |||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||| 
Sbjct  185  GCCGGAGGATAACCAAACCCTGTTTTAACGACGTTTCTTCTGAGTGGCATAAGCAAAATA  244 
Query  247  ATCAAAACTTTTAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATG  306 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  245  ATCAAAACTTTTAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATG  304 
Query  307  CGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCG  366 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  305  CGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCG  364 
Query  367  CCCGCCAGCATTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCT  426 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  365  CCCGCCAGCATTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCT  424 
Query  427  TGGTGTTGGGGCTCTACGGTTGACGTAGGCCCCCAAAGGTAGTGGCGGACCCTCCCGGAG  486 
            |||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||| 
Sbjct  425  TGGTGTTGGGGCTCTACGGTCGACGTAGGCCCCCAAAGGTAGTGGCGGACCCTCCCGGAG  484 
Query  487  CCTCCTTTGCGTAGTAACATTTCGTCTCGCACTGGGATCCGGAGGGACTCTTGCCGTAAA  546 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  485  CCTCCTTTGCGTAGTAACATTTCGTCTCGCACTGGGATCCGGAGGGACTCTTGCCGTAAA  544 
Query  547  ACCCCCCAATTTTTCAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCA  606 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  545  ACCCCCCAATTTTTCAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCA  604 
Query  607  TATCAATA                                                      614 
            |||||||| 
Sbjct  605  TATCAATA                                                      612 
 
Colletotrichum sp. NFCCI 1611 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gb|JN390940.1|Length: 595Number of Matches: 1 
Score Expect Identities Gaps Strand 
1099 bits(595) 0.0 595/595(100%) 0/595(0%) Plus/Plus 
Query  1    TAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACTGAGTTACCGCTCTATAAC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACTGAGTTACCGCTCTATAAC  60 
Query  61   CCTTTGTGAACATACCTACAACTGTTGCTTCGGCGGGTAGGCCGTCCCCTGAAAAGGACG  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   CCTTTGTGAACATACCTACAACTGTTGCTTCGGCGGGTAGGCCGTCCCCTGAAAAGGACG  120 
Query  121  CCTcccggcccggaccggaccccccgcgggaccggacccggcgcccgccggaGGATAACC  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CCTCCCGGCCCGGACCGGACCCCCCGCGGGACCGGACCCGGCGCCCGCCGGAGGATAACC  180 
Query  181  AAACTCTATTGTAACGACGTTTCTTCTGAGTGGCATAAGCAAAATAATCAAAACTTTTAA  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  AAACTCTATTGTAACGACGTTTCTTCTGAGTGGCATAAGCAAAATAATCAAAACTTTTAA  240 
Query  241  CAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTG  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTG  300 
Query  301  AATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGCATTCT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  AATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGCATTCT  360 
Query  361  GGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCTTGGTGTTGGGGCTC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCTTGGTGTTGGGGCTC  420 
Query  421  TACGGTCGACGTAGGCCCTCAAAGGTAGTGGCGGACCCTCCCGGAGCCTCCTTTGCGTAG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  TACGGTCGACGTAGGCCCTCAAAGGTAGTGGCGGACCCTCCCGGAGCCTCCTTTGCGTAG  480 
Query  481  TAACATTTCGTCTCGCACTGGGATCCGGAGGGACTCTTGCCGTAAAACCCCCCAATTTTC  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  TAACATTTCGTCTCGCACTGGGATCCGGAGGGACTCTTGCCGTAAAACCCCCCAATTTTC  540 
Query  541  CAAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAATA       595 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  CAAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAATA       595 
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Curvularia sp. TMS-2011 voucher SC16d1p11-2 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383382|gb|HQ631061.1|Length: 629Number of Matches: 1 
Score Expect Identities Gaps Strand 
1129 bits(611) 0.0 614/615(99%) 1/615(0%) Plus/Plus 
Query  3    GGAAGTAAAAAGTCGTAACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAA  62 
            |||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  16   GGAAGT-AAAAGTCGTAACAAGGTCTCCGTAGGTGAACCTGCGGAGGGATCATTACACAA  74 
Query  63   TAAACATATGAAGGCTGCACCGCCAACAGGCGGCAAGGCTGGAGTATTTTATTACCCTTG  122 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  75   TAAACATATGAAGGCTGCACCGCCAACAGGCGGCAAGGCTGGAGTATTTTATTACCCTTG  134 
Query  123  TCTTTTGCGCACTTGTTGTTTCCTGGGCGGGTTCGCCCGCCTCCAGGACCACATGATAAA  182 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  135  TCTTTTGCGCACTTGTTGTTTCCTGGGCGGGTTCGCCCGCCTCCAGGACCACATGATAAA  194 
Query  183  CCTTTTTTATGCAGTTGCAATCAGCGTCAGTACAACAAATGTAAATCATTTACAACTTTC  242 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  195  CCTTTTTTATGCAGTTGCAATCAGCGTCAGTACAACAAATGTAAATCATTTACAACTTTC  254 
Query  243  AACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATACGTAGTG  302 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  255  AACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATACGTAGTG  314 
Query  303  TGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATT  362 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  315  TGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATT  374 
Query  363  CCAAAGGGCATGCCTGTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCG  422 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  375  CCAAAGGGCATGCCTGTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCG  434 
Query  423  TTTTTTGTCTTTGGTTTTGTCCAAAGACTCGCCTTAAAACGATTGGCAGCCGGCCTACTG  482 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  435  TTTTTTGTCTTTGGTTTTGTCCAAAGACTCGCCTTAAAACGATTGGCAGCCGGCCTACTG  494 
Query  483  GTTTCGCAGCGCAGCACATTTTTGCGCTTGCAATCAGCAAAAGAGGACGGCACTCCATCA  542 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  495  GTTTCGCAGCGCAGCACATTTTTGCGCTTGCAATCAGCAAAAGAGGACGGCACTCCATCA  554 
Query  543  AGACTCTATATCACTTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATAT  602 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  555  AGACTCTATATCACTTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATAT  614 
Query  603  CAATAAGCGGAGGAA                                               617 
            ||||||||||||||| 
Sbjct  615  CAATAAGCGGAGGAA                                               629 
 
Curvularia sp. HSAUP074064 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|239586345|gb|GQ184733.1|Length: 589Number of Matches: 1 
Score Expect Identities Gaps Strand 
1088 bits(589) 0.0 589/589(100%) 0/589(0%) Plus/Plus 
Query  28   TCCGTAGGTGAACCTGCGGAGGGATCATTACACAATAAACATATGAAGGCTGCACCGCCA  87 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCCGTAGGTGAACCTGCGGAGGGATCATTACACAATAAACATATGAAGGCTGCACCGCCA  60 
Query  88   ACAGGCGGCAAGGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGTTGTTTCCTG  147 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   ACAGGCGGCAAGGCTGGAGTATTTTATTACCCTTGTCTTTTGCGCACTTGTTGTTTCCTG  120 
Query  148  GGCGGGTTCGCCCGCCTCCAGGACCACATGATAAACCTTTTTTATGCAGTTGCAATCAGC  207 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  GGCGGGTTCGCCCGCCTCCAGGACCACATGATAAACCTTTTTTATGCAGTTGCAATCAGC  180 
Query  208  GTCAGTACAACAAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCA  267 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GTCAGTACAACAAATGTAAATCATTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCA  240 
Query  268  TCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCAT  327 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  TCGATGAAGAACGCAGCGAAATGCGATACGTAGTGTGAATTGCAGAATTCAGTGAATCAT  300 
Query  328  CGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGT  387 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  CGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGCCTGTTCGAGCGT  360 
Query  388  CATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTTGTCTTTGGTTTTGTCCAAA  447 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  CATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTTTTTTGTCTTTGGTTTTGTCCAAA  420 
Query  448  GACTCGCCTTAAAACGATTGGCAGCCGGCCTACTGGTTTCGCAGCGCAGCACATTTTTGC  507 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GACTCGCCTTAAAACGATTGGCAGCCGGCCTACTGGTTTCGCAGCGCAGCACATTTTTGC  480 
Query  508  GCTTGCAATCAGCAAAAGAGGACGGCACTCCATCAAGACTCTATATCACTTTTGACCTCG  567 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GCTTGCAATCAGCAAAAGAGGACGGCACTCCATCAAGACTCTATATCACTTTTGACCTCG  540 
Query  568  GATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGA             616 
 
Dothideomycetes sp. TMS-2011 voucher SC10d50p8-8 18S ribosomal RNA gene, partial 
sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal 
transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383329|gb|HQ631008.1| 
Score Expect Identities Gaps Strand 
156 
 
896 bits(485) 0.0 581/627(93%) 8/627(1%) Plus/Plus 
Query  4    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTGTG  63 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTTTG  75 
Query  64   GCCGCCGTGAACGCTCCGGCGCGAGCGACGGCCATTCTCTAGCGACGCCTCCACGTCCGG  123 
            || ||||||| |||| ||||| ||||||| | |||||| |||||| ||||||  |||||| 
Sbjct  76   GCTGCCGTGAGCGCTTCGGCGTGAGCGACAGTCATTCTATAGCGATGCCTCCGTGTCCGG  135 
Query  124  GAAACCGGC-TGGGGCTGACCTAACCCTTCTCTACGCGTACCTCTG-TTCTCCTTCGGCG  181 
            |||||||||  ||||||||||||||||||||||||| |||||| |  ||||||||||||| 
Sbjct  136  GAAACCGGCGCGGGGCTGACCTAACCCTTCTCTACGAGTACCTATCATTCTCCTTCGGCG  195 
Query  182  GGCTCGTCTCGCCGCTGGAACTCACGAACCAACTTGCATTTAGCATTATCTGTTCTGATA  241 
            ||  |  | ||||||||||||| | ||||||||||||||||||||||| ||||||||||| 
Sbjct  196  GGG-CAACCCGCCGCTGGAACTTAAGAACCAACTTGCATTTAGCATTACCTGTTCTGATA  254 
Query  242  ACAATCAATTGTTACAACTTTCAACAATGGATCTCTTGGCTCTGGCATCGATGAAGAACG  301 
            ||||| |||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  255  ACAATTAATTATTACAACTTTCAACAATGGATCTCTTGGCTCTGGCATCGATGAAGAACG  314 
Query  302  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  361 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  315  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  374 
Query  362  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTACACCCTC  421 
            |||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||| 
Sbjct  375  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATCTACACCCTC  434 
Query  422  AAGCACTGCTTGGTGTTGGGCGTCTGTCCCGCCG-CGCGCGTGGACTCGCCCCAAAGGCA  480 
            |||||||||||||||||||||||||||||||||  |||||||||||||||||||||| || 
Sbjct  435  AAGCACTGCTTGGTGTTGGGCGTCTGTCCCGCCTTCGCGCGTGGACTCGCCCCAAAGTCA  494 
Query  481  TTGGCAGCGGTCTCTGGCACCTCAACGCGCAGTACATTGCGTACGTTGGG-TGCTGCAGG  539 
            |||||||||||||||||||||||||||||||||||| ||||| | ||||| ||| |  || 
Sbjct  495  TTGGCAGCGGTCTCTGGCACCTCAACGCGCAGTACAATGCGTTCATTGGGGTGCCGTGGG  554 
Query  540  ACGCAACCACAAAGCTAATCACCGTCTTTGACCTCGGATCAGGTAGGGATACCCGCTGAA  599 
             |||  |||  |||||| | |||||||||||||||||||||||||||||||||||||||| 
Sbjct  555  -CGCGTCCAT-AAGCTATTTACCGTCTTTGACCTCGGATCAGGTAGGGATACCCGCTGAA  612 
Query  600  CTTAAGCATATCAATAAGCCGGAGGAA                                   626 
            ||||||||||||||||||| ||||||| 
Sbjct  613  CTTAAGCATATCAATAAGC-GGAGGAA                                   638 
 
Dothideomycetes sp. genotype 189 isolate FL0014 internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|387352752|gb|JQ759890.1|Length: 1134Number of Matches: 1 
Score Expect Identities Gaps Strand 
1101 bits(596) 0.0 596/596(100%) 0/596(0%) Plus/Plus 
Query  52   GATCATTACAAGTTGAAACGGTTGCCCTCGCGGTGACCGGTTCTTCAAACCTCTGCGTAC  111 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GATCATTACAAGTTGAAACGGTTGCCCTCGCGGTGACCGGTTCTTCAAACCTCTGCGTAC  60 
Query  112  CAAACCTTTCAGTTGCCTCCGGCGGCCCTGGGCCGACGCGGCGCGCGACCTCCCCGTTCG  171 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   CAAACCTTTCAGTTGCCTCCGGCGGCCCTGGGCCGACGCGGCGCGCGACCTCCCCGTTCG  120 
Query  172  CgggggggCCGCTCCTCGCGGCGGACCACCCGCCGGGCGGTCATAAACAAAACCTTTTGT  231 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CGGGGGGGCCGCTCCTCGCGGCGGACCACCCGCCGGGCGGTCATAAACAAAACCTTTTGT  180 
Query  232  CGAGATGGCATCGTCTAATTTCTTCATAACACAATATGAAATACAACTTTTAACAATGGA  291 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  CGAGATGGCATCGTCTAATTTCTTCATAACACAATATGAAATACAACTTTTAACAATGGA  240 
Query  292  TCTCTTGGCTCCGGCATCGATGAAGAACGCAGCGAAATGCGATAACTAGTGTGAATTGCA  351 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  TCTCTTGGCTCCGGCATCGATGAAGAACGCAGCGAAATGCGATAACTAGTGTGAATTGCA  300 
Query  352  GATTTCAGTGAATCATCGAGTCTTTGAACGCACATTGCGCCTCTTGGTATTCCTCGAGGC  411 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  GATTTCAGTGAATCATCGAGTCTTTGAACGCACATTGCGCCTCTTGGTATTCCTCGAGGC  360 
Query  412  ATGCCTGTTCGAGCGTCGTTACGCCCCTCAAGCGCAAGCTTGGTGTTGGGGATCGCCCCT  471 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  ATGCCTGTTCGAGCGTCGTTACGCCCCTCAAGCGCAAGCTTGGTGTTGGGGATCGCCCCT  420 
Query  472  GAGATACGGCGGCGGCCCTTAAATGCATCGGCGGTGCTGGTGTCAGCCCGGAGCGCAGCA  531 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GAGATACGGCGGCGGCCCTTAAATGCATCGGCGGTGCTGGTGTCAGCCCGGAGCGCAGCA  480 
Query  532  GACATGCGGCTTCCAGGCGACCACGCGCCCGCCGGACAACGACCCGACTTTCAAACGTCG  591 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GACATGCGGCTTCCAGGCGACCACGCGCCCGCCGGACAACGACCCGACTTTCAAACGTCG  540 
Query  592  ACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA      647 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  ACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA      596 
 
Fungal endophyte sp. g88 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|300872433|gb|HM537063.1|Length: 573Number of Matches: 1 
Score Expect Identities Gaps Strand 
994 bits(538) 0.0 552/559(99%) 0/559(0%) Plus/Plus 
Query  2    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACATTCA  61 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
157 
 
Sbjct  15   GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACATTCA  74 
Query  62   GTAGCCTAGCTACTTGTTTACACCCTTGTTTTTTGGCGTACCTATCGTTTCCTCGGCAGG  121 
            |||||| ||||||||||||||||||||||||||| |||||||||||||||||||||| || 
Sbjct  75   GTAGCCCAGCTACTTGTTTACACCCTTGTTTTTTTGCGTACCTATCGTTTCCTCGGCGGG  134 
Query  122  CTTGCCTGCCGGCTGGACACCTTTATAACCTTTTTAAATCTTCAATCAGCGTCTGAATAA  181 
            |||||||||||| |||||| ||||||||||||||||||||||||||||||||||||| || 
Sbjct  135  CTTGCCTGCCGGTTGGACAACTTTATAACCTTTTTAAATCTTCAATCAGCGTCTGAACAA  194 
Query  182  TATACAATAATTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGC  241 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  195  TATACAATAATTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGC  254 
Query  242  AGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACG  301 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  255  AGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACG  314 
Query  302  CACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTCA  361 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  315  CACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTCA  374 
Query  362  AGCTTTGCTTGGTGTTGGGTGCTTGTCTTTTTGTGAAGACTCACCTCAAAGTCATTGGCA  421 
            |||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||| 
Sbjct  375  AGCTTTGCTTGGTGTTGGGTGCTTGTCTTTTTGTTAAGACTCACCTCAAAGTCATTGGCA  434 
Query  422  GCCAGTGTTTTGGTAGTAAGCGCAGCACATTTTGCGTCTTGGTCCCTCAACAGCGGCATC  481 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  435  GCCAGTGTTTTGGTAGTAAGCGCAGCACATTTTGCGTCTTGGTCCCTCAACAGCGGCATC  494 
Query  482  CATCAAGCCATTTTCTCACTTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAG  541 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  495  CATCAAGCCATTTTCTCACTTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAG  554 
Query  542  CATATCAATAAGCGGAGGA                                           560 
            ||||||||||||||||||| 
Sbjct  555  CATATCAATAAGCGGAGGA                                           573 
 
Fungal sp. ARIZ B233 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|223006334|gb|FJ612966.1|Length: 563Number of Matches: 1 
Score Expect Identities Gaps Strand 
1037 bits(561) 0.0 561/561(100%) 0/561(0%) Plus/Plus 
Query  1    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTAAAGAGT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTAAAGAGT  62 
Query  61   TATAACAACTCCCAAACCCCTGTGAACATACCTCATGTTGCCTCGGCAGGTCGCGCCTCG  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  63   TATAACAACTCCCAAACCCCTGTGAACATACCTCATGTTGCCTCGGCAGGTCGCGCCTCG  122 
Query  121  GTGCCCTGCCGGCGGCCCACGAAACTCTGTTTAGCATTAAATTCTGAACTTATAACTAAA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  123  GTGCCCTGCCGGCGGCCCACGAAACTCTGTTTAGCATTAAATTCTGAACTTATAACTAAA  182 
Query  181  TCAGTTAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAA  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  183  TCAGTTAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAA  242 
Query  241  ATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATT  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  243  ATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATT  302 
Query  301  GCGCCCATTAGTATTCTAGTGGGCATGCCTGTTCGAGCGTCATTTCAACCCTTAAGCCCT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  303  GCGCCCATTAGTATTCTAGTGGGCATGCCTGTTCGAGCGTCATTTCAACCCTTAAGCCCT  362 
Query  361  CGTTGCTTAGCGTTGGGAGCCTACAAGCACTGTAGCTCCCCAAAGTTAGTGGCGGAGTCG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  363  CGTTGCTTAGCGTTGGGAGCCTACAAGCACTGTAGCTCCCCAAAGTTAGTGGCGGAGTCG  422 
Query  421  GTTCACACCCCAGACGTAGTAAGATTTCACCTCGCCTGTAGTTGGACCGGTCCCCTGCCG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  423  GTTCACACCCCAGACGTAGTAAGATTTCACCTCGCCTGTAGTTGGACCGGTCCCCTGCCG  482 
Query  481  TAAAACACATAATTTTCTCAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  483  TAAAACACATAATTTTCTCAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTA  542 
Query  541  AGCATATCAATAAGCGGAGGA                                         561 
            ||||||||||||||||||||| 
Sbjct  543  AGCATATCAATAAGCGGAGGA                                         563 
 
Fusarium equiseti isolate H02-765S 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|192758036|gb|EU595566.1|Length: 1156Number of Matches: 1 
Score Expect Identities Gaps Strand 
1059 bits(573) 0.0 573/573(100%) 0/573(0%) Plus/Plus 
Query  4    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACCGAGT  63 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACCGAGT  60 
Query  64   TTACAACTCCCAAACCCCTGTGAACATACCTATACGTTGCCTCGGCGGATCAGCCCGCGC  123 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTACAACTCCCAAACCCCTGTGAACATACCTATACGTTGCCTCGGCGGATCAGCCCGCGC  120 
Query  124  CCCGTAAAACGGGACGGCCCGCCCGAGGACCCCTAAACTCTGTTTTTAGTGGAACTTCTG  183 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
158 
 
Sbjct  121  CCCGTAAAACGGGACGGCCCGCCCGAGGACCCCTAAACTCTGTTTTTAGTGGAACTTCTG  180 
Query  184  AGTAAAACAAACAAATAAATCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGAT  243 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  AGTAAAACAAACAAATAAATCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGAT  240 
Query  244  GAAGAACGCAGCAAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAAT  303 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  GAAGAACGCAGCAAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAAT  300 
Query  304  CTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGGCATGCCTGTTCGAGCGTCATTT  363 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  CTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGGCATGCCTGTTCGAGCGTCATTT  360 
Query  364  CAACCCTCAAGCTCAGCTTGGTGTTGGGACTCGCGGTAACCCGCGTTCCCCAAATCGATT  423 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  CAACCCTCAAGCTCAGCTTGGTGTTGGGACTCGCGGTAACCCGCGTTCCCCAAATCGATT  420 
Query  424  GGCGGTCACGTCGAGCTTCCATAGCGTAGTAATCATACACCTCGTTACTGGTAATCGTCG  483 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GGCGGTCACGTCGAGCTTCCATAGCGTAGTAATCATACACCTCGTTACTGGTAATCGTCG  480 
Query  484  CGGCCACGCCGTAAAACCCCAACTTCTGAATGTTGACCTCGGATCAGGTAGGAATACCCG  543 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  CGGCCACGCCGTAAAACCCCAACTTCTGAATGTTGACCTCGGATCAGGTAGGAATACCCG  540 
Query  544  CTGAACTTAAGCATATCAATAAGCGGAGGAAAA                             576 
            ||||||||||||||||||||||||||||||||| 
Sbjct  541  CTGAACTTAAGCATATCAATAAGCGGAGGAAAA                             573 
 
Guignardia mangiferae isolate MFUCC120015 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|528747898|gb|KC686598.1|Length: 882Number of Matches: 1 
Score Expect Identities Gaps Strand 
1190 bits(644) 0.0 659/666(99%) 1/666(0%) Plus/Plus 
Query  5    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACTGTGA  64 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||  | 
Sbjct  122  GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACTGAAA  181 
Query  65   TGTAATAACTTCTATTGTAAGGTTCCAGAGTAGGCGCTACAACGCCGAAATGACCTTCTC  124 
            ||||||||||||||||| |||||||||||||||||||||||||||||||||||||||||| 
Sbjct  182  TGTAATAACTTCTATTGAAAGGTTCCAGAGTAGGCGCTACAACGCCGAAATGACCTTCTC  241 
Query  125  ACCCTTGTGTACTCACTATGTTGTTTTGGCGGGTCGACCTGGTTCCGACCCATGCGGCCG  184 
            |||| |||||||||||||||||| |||||||||||||||||||||||||||| ||||||| 
Sbjct  242  ACCCCTGTGTACTCACTATGTTGCTTTGGCGGGTCGACCTGGTTCCGACCCAGGCGGCCG  301 
Query  185  GCGCCCCCAGCCTTAACTGGCCAGGACGCCCGGCTAAGTGCCCGCCAGTATACAAAACTC  244 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  302  GCGCCCCCAGCCTTAACTGGCCAGGACGCCCGGCTAAGTGCCCGCCAGTATACAAAACTC  361 
Query  245  AAGAATTCATATTGTGAAGTCCTGATATATCATTTAATTGATTTAAAACTTTCAACAACG  304 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  362  AAGAATTCATATTGTGAAGTCCTGATATATCATTTAATTGATTTAAAACTTTCAACAACG  421 
Query  305  GATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTG  364 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  422  GATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTG  481 
Query  365  CAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTCTGGTATTCCGGAGG  424 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  482  CAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTCTGGTATTCCGGAGG  541 
Query  425  GCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCTTGGTATTGGGCAACGTCCG  484 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  542  GCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCTTGGTATTGGGCAACGTCCG  601 
Query  485  CTGCCGGACGTGCCTTGAAGACCTCGGCGACGGCGTCCTAGCCTCGAGCGTAGTAGTAAA  544 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  602  CTGCCGGACGTGCCTTGAAGACCTCGGCGACGGCGTCCTAGCCTCGAGCGTAGTAGTAAA  661 
Query  545  ATATCTCGCTTTGGAGTGCTGGGCGACGGCCGCCGGACAATCGACCTTCGGTCTATTTTT  604 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  662  ATATCTCGCTTTGGAGTGCTGGGCGACGGCCGCCGGACAATCGACCTTCGGTCTATTTTT  721 
Query  605  CCAAGGTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAG-CG  663 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  722  CCAAGGTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAAGGCG  781 
Query  664  GAGGAA                                                        669 
            |||||| 
Sbjct  782  GAGGAA                                                        787 
 
Guignardia mangiferae isolate XSD-43 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gb|EU273524.1|Length: 663Number of Matches: 1 
Score Expect Identities Gaps Strand 
1192 bits(645) 0.0 647/648(99%) 0/648(0%) Plus/Plus 
Query  117  GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACTGAAA  176 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACTGAAA  60 
Query  177  TGTAATAACTTCTATTGAAAGGTTCCAGAGTAGGCGCTACAACGCCGAAATGACCTTCTC  236 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TGTAATAACTTCTATTGAAAGGTTCCAGAGTAGGCGCTACAACGCCGAAATGACCTTCTC  120 
Query  237  ACCCTTGTGTACTCACTATGTTGCTTTGGCGGGTCGACCTGGTTCCGACCCAGGCGGCCG  296 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
159 
 
Sbjct  121  ACCCTTGTGTACTCACTATGTTGCTTTGGCGGGTCGACCTGGTTCCGACCCAGGCGGCCG  180 
Query  297  GCGCCCCCAGCCTTAACTGGCCAGGACGCCCGGCTAAGTGCCCGCCAGTATACAAAACTC  356 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCGCCCCCAGCCTTAACTGGCCAGGACGCCCGGCTAAGTGCCCGCCAGTATACAAAACTC  240 
Query  357  AAGAATTCATTTTGTGAAGTCCTGATATATCATTTAATTGATTAAAACTTTCAACAACGG  416 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  AAGAATTCATTTTGTGAAGTCCTGATATATCATTTAATTGATTAAAACTTTCAACAACGG  300 
Query  417  ATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGC  476 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  ATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGC  360 
Query  477  AGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTCTGGTATTCCGGAGGG  536 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  AGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTCTGGTATTCCGGAGGG  420 
Query  537  CATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCTTGGTATTGGGCAACGTCCGC  596 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  CATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCTCTGCTTGGTATTGGGCAACGTCCGC  480 
Query  597  TGCCGGACGTGCCTTGAAGACCTCGGCGACGGCGTCCTAGCCTCGAGCGTAGTAGTAAAA  656 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  TGCCGGACGTGCCTTGAAGACCTCGGCGACGGCGTCCTAGCCTCGAGCGTAGTAGTAAAA  540 
Query  657  TATCTCGCTTTGGAGTGCTGGGCGACGGCTGCCGGACAATCGACCTTCGGTCTATTTTTC  716 
            ||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||| 
Sbjct  541  TATCTCGCTTTGGAGTGCTGGGCGACGGCCGCCGGACAATCGACCTTCGGTCTATTTTTC  600 
Query  717  CAAGGTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATA              764 
            |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601  CAAGGTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATA              648 
 
Letendraea helminthicola strain F158 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|406780888|gb|JQ026217.1|Length: 724Number of Matches: 1 
Score Expect Identities Gaps Strand 
1221 bits(661) 0.0 667/670(99%) 0/670(0%) Plus/Plus 
Query  14   CGTAACAAGGTTTTCGTAGGGGAACCTGCGGAAGGATCATTACATTTTCACAACAACGAT  73 
            ||||||||||||| |||||| ||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    CGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACATTTTCACAACAACGAT  60 
Query  74   GGCGTCGTCCTTAGAACCGTCTCCGTGCGGCTCGGGGCGGCGTTTCATCAGCGGGCACGT  133 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   GGCGTCGTCCTTAGAACCGTCTCCGTGCGGCTCGGGGCGGCGTTTCATCAGCGGGCACGT  120 
Query  134  CGCGGCTTCCTGTTTTCAGGAAGTAATCCCATCTAGAATGGACTCACGCGGGGTCGTCTG  193 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CGCGGCTTCCTGTTTTCAGGAAGTAATCCCATCTAGAATGGACTCACGCGGGGTCGTCTG  180 
Query  194  AATCCTTAACTTTACGAGAACTCCCCATACTCCTTCGGTGGGGTGACCTGCCGTTGGAAC  253 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  AATCCTTAACTTTACGAGAACTCCCCATACTCCTTCGGTGGGGTGACCTGCCGTTGGAAC  240 
Query  254  CAACAAAAACCtttttttGCATCTAGCATTACCTGTTCTGATACAAACAATCGTTACAAC  313 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CAACAAAAACCTTTTTTTGCATCTAGCATTACCTGTTCTGATACAAACAATCGTTACAAC  300 
Query  314  TTTCAACAATGGATCTCTTGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGT  373 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TTTCAACAATGGATCTCTTGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGT  360 
Query  374  AGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTTGG  433 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  AGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTTGG  420 
Query  434  TATTCCATGGGGCATGCCTGTTCGAGCGTCATCTACACCCTCAAGCTCTGCTTGGTGTTG  493 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  TATTCCATGGGGCATGCCTGTTCGAGCGTCATCTACACCCTCAAGCTCTGCTTGGTGTTG  480 
Query  494  GGCGTCTGTCCCGCCTCCGCGCGTGGACTCGCCCCAAATTCATTGGCAGCGGTCTTCTTG  553 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GGCGTCTGTCCCGCCTCCGCGCGTGGACTCGCCCCAAATTCATTGGCAGCGGTCTTCTTG  540 
 
Query  554  CCCCCTCTCGCGCAGCACATTGCGTTTCTCGAGGGTGGCGGGCCGCGTCCACGAAGCAAC  613 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  CCCCCTCTCGCGCAGCACATTGCGTTTCTCGAGGGTGGCGGGCCGCGTCCACGAAGCAAC  600 
Query  614  ATTCACCGTCTTTGACCTCGGATCAGGTAGGGATACCCGCTGAAATTAAGCATATCAATA  673 
            |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||| 
Sbjct  601  ATTCACCGTCTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATA  660 
Query  674  AGCGGAGGAA                                                    683 
            |||||||||| 
Sbjct  661  AGCGGAGGAA                                                    670 
 
Minimidochium sp. TMS-2011 voucher MS3p_50-45 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383295|gb|HQ630974.1|Length: 581Number of Matches: 1 
Score Expect Identities Gaps Strand 
909 bits(492) 0.0 551/577(95%) 13/577(2%) Plus/Plus 
Query  5    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACAGGAC  64 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACAGGAC  75 
Query  65   GTCACACTCCCGTAATACCACTGTGAATCTTACCTACCGTCGTTGCCTCGGCGGGGTCGG  124 
160 
 
            |||| ||||||||||||||||||||||||||||||||||||||||||||||||||  | | 
Sbjct  76   GTCATACTCCCGTAATACCACTGTGAATCTTACCTACCGTCGTTGCCTCGGCGGG--C-G  132 
Query  125  TCCCCCTCGGGGGGCGCCCGCCGGCGGCCCGCATACTCTGTCTCAGCGTGTTGGCATCTC  184 
                 |||   | ||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  133  -----CTC--CGCGCGCCCGCCGGCGGCCCGCATACTCTGTCTCAGCGTGTTGGCATCTC  185 
Query  185  CGAGTACAATACAAACGAGTCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGAT  244 
            ||||||  |||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  186  CGAGTATTATACAAACGAGTCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGAT  245 
Query  245  GAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAAT  304 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  246  GAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAAT  305 
Query  305  CTTTGAACGCACATTGCGCCCGCCAGTATCCTGGCGGGCATGCCTGTTCGAGCGTCATTT  364 
            |||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||| 
Sbjct  306  CTTTGAACGCACATTGCGCCCGCCAGCATCCTGGCGGGCATGCCTGTTCGAGCGTCATTT  365 
Query  365  CAACCCTCAAGCCCCCGCGGCTTGGTGTTGGAGGCCTGCGCACCGCAGCCTCCCAAAGAC  424 
            ||||||||||||||||||||||||||||||| | |||||||||||||||| || |||||| 
Sbjct  366  CAACCCTCAAGCCCCCGCGGCTTGGTGTTGGGGACCTGCGCACCGCAGCCCCCTAAAGAC  425 
Query  425  AGCGGCGGGCGTGGCCTGGCACCGAACGTAGTAGACTCTCTCTCGTTCGCGGTCCAGGGC  484 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||  | 
Sbjct  426  AGCGGCGGGCGTGGCCTGGCACCGAACGTAGTAGACTCTCTCTCGTTCGCGGTCCAGTTC  485 
Query  485  GCGCTTCCGGCCGGTAAACCCCCATCTTTTA-CG-TGGTTGACCTCGGATCAGGTAGGAA  542 
            |||| |||||||||||||||||||||||||| |  ||||||||||||||||||||||||| 
Sbjct  486  GCGC-TCCGGCCGGTAAACCCCCATCTTTTAACAATGGTTGACCTCGGATCAGGTAGGAA  544 
Query  543  TACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA                         579 
            ||||||||||||||||||||||||||||||||||||| 
Sbjct  545  TACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA                         581 
 
Montagnulaceae sp. HJ15H 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|485185712|gb|KC291642.1|Length: 721Number of Matches: 1 
Score Expect Identities Gaps Strand 
1325 bits(717) 0.0 720/721(99%) 1/721(0%) Plus/Plus 
Query  40   TGCGGAGGGATCATTATTCATTACAGTAAGCCTATGGCTTCGGGGGCGAACAAGCCAGGC  99 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2    TGCGGAGGGATCATTATTCATTACAGTAAGCCTATGGCTTCGGGGGCGAACAAGCCAGGC  61 
Query  100  GCGGTCGACCCTTCGGGGCGTGGCAGCGTCGCGGCTCCCCGAATCGTTATGCTTTAGCGG  159 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  62   GCGGTCGACCCTTCGGGGCGTGGCAGCGTCGCGGCTCCCCGAATCGTTATGCTTTAGCGG  121 
Query  160  GTGTGTTGCGGCCCTCGAGGCCCCGGACCGGCTCGACAGTGGTCAGCCGGCACGGGAACC  219 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  122  GTGTGTTGCGGCCCTCGAGGCCCCGGACCGGCTCGACAGTGGTCAGCCGGCACGGGAACC  181 
Query  220  AGCTCCGGGAGGTGTAGGGCTCCTCGTGGAGCCCTTTCACGCGCACATGACTGAATCCTT  279 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  182  AGCTCCGGGAGGTGTAGGGCTCCTCGTGGAGCCCTTTCACGCGCACATGACTGAATCCTT  241 
Query  280  ACTCTACTCGTACCTCTCGTTCTCCCTCGGCGGGGCGACCTGCCGTGGGAACCGCAAAAC  339 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  242  ACTCTACTCGTACCTCTCGTTCTCCCTCGGCGGGGCGACCTGCCGTGGGAACCGCAAAAC  301 
Query  340  GAACCCTTCTTTGCATCTAGCATTACCTGTTCCGATACCCACAATCGTTACAACTTTCAA  399 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  302  GAACCCTTCTTTGCATCTAGCATTACCTGTTCCGATACCCACAATCGTTACAACTTTCAA  361 
Query  400  CAATGGATCTCTTGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAGTGTG  459 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  362  CAATGGATCTCTTGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAGTGTG  421 
Query  460  AATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTCGGTATTCC  519 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  422  AATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTCGGTATTCC  481 
Query  520  GTGGGGCATGCCTGTTCGAGCGTCATCTACACCCTCAAGCTCTGCTTGGTGTTGGGCGTC  579 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  482  GTGGGGCATGCCTGTTCGAGCGTCATCTACACCCTCAAGCTCTGCTTGGTGTTGGGCGTC  541 
Query  580  TGTCCCGCCTCCTTCGCGCGCGGACTCGCCCCAAATCCATTGGCGGCGGCCCTTGCCTCC  639 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  542  TGTCCCGCCTCCTTCGCGCGCGGACTCGCCCCAAATCCATTGGCGGCGGCCCTTGCCTCC  601 
Query  640  CTCTCGCGCAGCACATTGCGCTTCTCGAGGCGCGGCGGACCGCGTCCAGCAAGCAACCGT  699 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  602  CTCTCGCGCAGCACATTGCGCTTCTCGAGGCGCGGCGGACCGCGTCCAGCAAGCAACCGT  661 
Query  700  CACACCGTCTTTGACCTCGGATGCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATA  759 
            |||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||| 
Sbjct  662  CACACCGTCTTTGACCTCGGAT-CAGGTAGGGATACCCGCTGAACTTAAGCATATCAATA  720 
Query  760  A                                                             760 
            | 
Sbjct  721  A                                                             721 
 
Myrothecium sp. 2 TMS-2011 voucher SC8d10p9-5 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383388|gb|HQ631067.1|Length: 622Number of Matches: 1 
Score Expect Identities Gaps Strand 
1094 bits(592) 0.0 602/607(99%) 0/607(0%) Plus/Plus 
Query  4    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACCGAGT  63 
161 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACCGAGT  75 
Query  64   TTACAAACTCCCAACCCTATGTGAACCTTACCTATCGTTGCTTCGGCGGGCTTAGCCCCC  123 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  76   TTACAAACTCCCAACCCTATGTGAACCTTACCTATCGTTGCTTCGGCGGGCTTAGCCCCC  135 
Query  124  GCGCCCTCGCCGGCGCCGGGAAACAGGCGCCCGCCGGAGACCCAAACTCAATGTTTTTCA  183 
            ||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  136  GCGCCTTCGCCGGCGCCGGGAAACAGGCGCCCGCCGGAGACCCAAACTCAATGTTTTTCA  195 
Query  184  TGCAGTATTATCTGAGTGGCAAACGCAAAAATAAATCAAAACTTTTAACAACGGATCTCT  243 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  196  TGCAGTATTATCTGAGTGGCAAACGCAAAAATAAATCAAAACTTTTAACAACGGATCTCT  255 
Query  244  TGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATT  303 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  256  TGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATT  315 
Query  304  CAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCGAGTATTCTCGCGGGCATGCC  363 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  316  CAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCGAGTATTCTCGCGGGCATGCC  375 
Query  364  TGTTCGAGCGTCATTTCAACCCTCAGAGCCCGTCTGCTTGTTCAGGCGCGGCGCTGGTGT  423 
            ||| ||||||||||||||||||||||||| || ||||||||||||||||||||||||||| 
Sbjct  376  TGTCCGAGCGTCATTTCAACCCTCAGAGCTCGCCTGCTTGTTCAGGCGCGGCGCTGGTGT  435 
Query  424  TGGGGATCGGCCTAAACGCCGTCCCCCAAATACAGTGGCGGTCTCGCTGCAGCCTCCCCT  483 
            ||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  436  TGGGGATCGGCCTAACCGCCGTCCCCCAAATACAGTGGCGGTCTCGCTGCAGCCTCCCCT  495 
Query  484  GCGTAGTAGCAACACTCGCATGCGGAGCGCGGCGCGGCCACGCCGTAAAACCCCCGACTT  543 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  496  GCGTAGTAGCAACACTCGCATGCGGAGCGCGGCGCGGCCACGCCGTAAAACCCCCGACTT  555 
Query  544  TCTGAACGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAATAAGC  603 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  556  TCTGAACGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAATAAGC  615 
Query  604  GGAGGAA                                                       610 
            ||||||| 
Sbjct  616  GGAGGAA                                                       622 
 
Nemania primolutea isolate 91102001 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|122935533|gb|EF026121.1|Length: 582Number of Matches: 1 
Score Expect Identities Gaps Strand 
1064 bits(576) 0.0 580/582(99%) 0/582(0%) Plus/Plus 
Query  28   TCCGTTGGTGAACCAGCGGAGGGATCATTAAAGAGTTTTCTACAACTCCCAAACCCCTGT  87 
            ||||| |||||||| ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCCGTAGGTGAACCTGCGGAGGGATCATTAAAGAGTTTTCTACAACTCCCAAACCCCTGT  60 
Query  88   GAACATACCTTCTGTTGCCTCGGCAGGCCTCGCCTACCCTCGTAGCCCCCTACACCGTAG  147 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   GAACATACCTTCTGTTGCCTCGGCAGGCCTCGCCTACCCTCGTAGCCCCCTACACCGTAG  120 
Query  148  GGCCTACGCCGGGTGGTGCGCGGACCCTGCCGGCGGCCCGCGAAACTCTGTTTAGCACTG  207 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  GGCCTACGCCGGGTGGTGCGCGGACCCTGCCGGCGGCCCGCGAAACTCTGTTTAGCACTG  180 
Query  208  AATCTCTGAACATATAACTAAATAAGTTAAAACTTTCAACAACGGATCTCTTGGTTCTGG  267 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  AATCTCTGAACATATAACTAAATAAGTTAAAACTTTCAACAACGGATCTCTTGGTTCTGG  240 
Query  268  CATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATC  327 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATC  300 
Query  328  ATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGCATGCCTGTTCGAGC  387 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  ATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGCATGCCTGTTCGAGC  360 
Query  388  GTCATTTCAACCCTTAAGCCCCTGTTGCTTAGCGTTGGGAGCCTACGGCAGCGTAGCTCC  447 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GTCATTTCAACCCTTAAGCCCCTGTTGCTTAGCGTTGGGAGCCTACGGCAGCGTAGCTCC  420 
Query  448  CCAAAGTTAGTGGCGTGGTCGGTTCACACTCCAGACGTAGTAGATTTTCGTCTCGCCTGT  507 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  CCAAAGTTAGTGGCGTGGTCGGTTCACACTCCAGACGTAGTAGATTTTCGTCTCGCCTGT  480 
Query  508  AGTTGGACCGGTCCCCTGCCGTAAAACACCCCAATTCTAAAAGGTTGACCTCGGATCAGG  567 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  AGTTGGACCGGTCCCCTGCCGTAAAACACCCCAATTCTAAAAGGTTGACCTCGGATCAGG  540 
Query  568  TAGGAATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGA                    609 
            |||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  TAGGAATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGA                    582 
 
Nemania primolutea isolate FG9 internal transcribed spacer 1, partial sequence; 5.8S 
ribosomal RNA gene and internal transcribed spacer 2, complete sequence; and 28S 
ribosomal RNA gene, partial sequence 
Sequence ID: gb|KC845930.1|Length: 511Number of Matches: 1 
Score Expect Identities Gaps Strand 
944 bits(511) 0.0 511/511(100%) 0/511(0%) Plus/Plus 
Query  1    TGAACATACCTTCTGTTGCCTCGGCAGGCCTCGCCTACCCTCGTAGCCCCCTACACCGTA  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TGAACATACCTTCTGTTGCCTCGGCAGGCCTCGCCTACCCTCGTAGCCCCCTACACCGTA  60 
Query  61   GGGCCTACGCCGGGTGGTGCGCGGACCCTGCCGGCGGCCCGCGAAACTCTGTTTAGCACT  120 
162 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   GGGCCTACGCCGGGTGGTGCGCGGACCCTGCCGGCGGCCCGCGAAACTCTGTTTAGCACT  120 
Query  121  GAATCTCTGAACATATAACTAAATAAGTTAAAACTTTCAACAACGGATCTCTTGGTTCTG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  GAATCTCTGAACATATAACTAAATAAGTTAAAACTTTCAACAACGGATCTCTTGGTTCTG  180 
Query  181  GCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAAT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAAT  240 
Query  241  CATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGCATGCCTGTTCGAG  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGCATGCCTGTTCGAG  300 
Query  301  CGTCATTTCAACCCTTAAGCCCCTGTTGCTTAGCGTTGGGAGCCTACGGCAGCGTAGCTC  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  CGTCATTTCAACCCTTAAGCCCCTGTTGCTTAGCGTTGGGAGCCTACGGCAGCGTAGCTC  360 
Query  361  CCCAAAGTTAGTGGCGTGGTCGGTTCACACTCCAGACGTAGTAGATTTTCGTCTCGCCTG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  CCCAAAGTTAGTGGCGTGGTCGGTTCACACTCCAGACGTAGTAGATTTTCGTCTCGCCTG  420 
Query  421  TAGTTGGACCGGTCCCCTGCCGTAAAACACCCCAATTCTAAAAGGTTGACCTCGGATCAG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  TAGTTGGACCGGTCCCCTGCCGTAAAACACCCCAATTCTAAAAGGTTGACCTCGGATCAG  480 
Query  481  GTAGGAATACCCGCTGAACTTAAGCATATCA                               511 
            ||||||||||||||||||||||||||||||| 
Sbjct  481  GTAGGAATACCCGCTGAACTTAAGCATATCA                               511 
 
Paecilomyces sp. TMS-2011 voucher BGd1p19-17 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383362|gb|HQ631041.1|Length: 606Number of Matches: 1 
Score Expect Identities Gaps Strand 
902 bits(488) 0.0 566/601(94%) 15/601(2%) Plus/Plus 
Query  2    GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGTTTGGAACCAGCGGAGGGATCATTACAG  61 
            |||||||||||||||||||||||||||||||||   |||||||||||||||||||||||| 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTCTCCGTTGGT---GAACCAGCGGAGGGATCATTACAG  72 
Query  62   AGTTGAAAAACTCCCCCAACCATTGTGAACC-TACCTTCCACCGTTGCTTCGGCGGGCGG  120 
            ||||| |||||||||| |||||||||||||| ||||||| |||||||||||||||||||| 
Sbjct  73   AGTTGCAAAACTCCCCAAACCATTGTGAACCTTACCTTCAACCGTTGCTTCGGCGGGCGG  132 
Query  121  GCCCCAGCGccccccccggccccccccGGGGGGCGCCCGCCGGAGGATGCACAAACTCTT  180 
            ||| ||||| |||||||||||||||| | ||||||||||||||||||| | ||||||||| 
Sbjct  133  GCCACAGCG-CCCCCCCGGCCCCCCCAGCGGGGCGCCCGCCGGAGGATACCCAAACTCTT  191 
Query  181  TGT-CATTAGCGGCCTCTCTGAGTCTT---TACTGAATAAGTCAAAACTTTCAACAACGG  236 
              | | |||  ||||||||||||||||   |||||||||||||||||||||||||||||| 
Sbjct  192  GATACTTTAT-GGCCTCTCTGAGTCTTCTGTACTGAATAAGTCAAAACTTTCAACAACGG  250 
Query  237  ATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGC  296 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  251  ATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGC  310 
Query  297  AGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGTACTCTGGCGGG  356 
            |||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||| 
Sbjct  311  AGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGG  370 
Query  357  CATGCCTGTTCGAGCGTCATTTCAACCATCAAGCCCCCGGGCTTGTGTTGGGGACCTGCG  416 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  371  CATGCCTGTTCGAGCGTCATTTCAACCATCAAGCCCCCGGGCTTGTGTTGGGGACCTGCG  430 
Query  417  GCTGCCCGCAGGCCCTGAAAAGCAGTGGCGGGCTCGCCGTCACGCCGAGCGTAGTAGCAA  476 
            ||||||||||||||||||||| ||||||||||||||| ||||| |||||||||||||| | 
Sbjct  431  GCTGCCCGCAGGCCCTGAAAACCAGTGGCGGGCTCGCTGTCACACCGAGCGTAGTAGC-A  489 
Query  477  TCATCTCGCTCAGGGCGTGCTGCGGGCTCCGGCCGTTAAACAACAGCCTCTCAGGCCCAA  536 
            |||||||||||||||||||||||||| |||||||||||||    ||||||| |  ||||| 
Sbjct  490  TCATCTCGCTCAGGGCGTGCTGCGGGTTCCGGCCGTTAAA----AGCCTCTAATACCCAA  545 
Query  537  GGTTGACCTCGGATCAGGTAGGAAGACCCGCTGAACTTAAGCATATCAATAAGCGGAGGA  596 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  546  GGTTGACCTCGGATCAGGTAGGAAGACCCGCTGAACTTAAGCATATCAATAAGCGGAGGA  605 
Query  597  A                                                             597 
            | 
Sbjct  606  A                                                             606 
 
Penicillium sp. HF12230 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|392514877|gb|JQ889696.1|Length: 580Number of Matches: 1 
Score Expect Identities Gaps Strand 
1018 bits(551) 0.0 567/574(99%) 4/574(0%) Plus/Plus 
Query  1    GAAGT-AAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCGAGT  59 
            ||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3    GAAGTAAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCGAGT  62 
Query  60   GCGGGCCCTCGCGGCCCAACCTCCCACCCGTGTCTCTCTCTACCTGTTGCTTTGGCGGGC  119 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  63   GCGGGCCCTCGCGGCCCAACCTCCCACCCGTGTCTCTCTCTACCTGTTGCTTTGGCGGGC  122 
Query  120  CCACCGGGGCCACCCGGTCGCCGGGGGACGT-CGTCCCCGGGCCCGCGCCCGCCGAAGCG  178 
            ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
Sbjct  123  CCACCGGGGCCACCCGGTCGCCGGGGGACGTCCGTCCCCGGGCCCGCGCCCGCCGAAGCG  182 
Query  179  CTCTGTGAACCCTGATGAAGATGGGCTGTCTGAGTCGAATGAAAATTGTCAAAACTTTCA  238 
163 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  183  CTCTGTGAACCCTGATGAAGATGGGCTGTCTGAGTCGAATGAAAATTGTCAAAACTTTCA  242 
Query  239  ACAATGGATCTCTTGGTTCCGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGT  298 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  243  ACAATGGATCTCTTGGTTCCGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGT  302 
Query  299  GAATTGCAGAATTCCGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCCTGGCATTC  358 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  303  GAATTGCAGAATTCCGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCCTGGCATTC  362 
Query  359  CGGGGGGCATGCCTGTCCGAGCGTCATTTCTGCCCTCAAGCCCGGCTTGTGTGTTGGGCG  418 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  363  CGGGGGGCATGCCTGTCCGAGCGTCATTTCTGCCCTCAAGCCCGGCTTGTGTGTTGGGCG  422 
Query  419  TGGTCCCCCCGGGGACCTGCCCGAAAGGCAGCGGCGACGTCCGTCTGGTCCTCGAGCGTA  478 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  423  TGGTCCCCCCGGGGACCTGCCCGAAAGGCAGCGGCGACGTCCGTCTGGTCCTCGAGCGTA  482 
Query  479  TGGGGCTCTGTCACTCGCT-CGGGACGGATCGGCGGAGGTTGGTCACCACCACAGTTTTA  537 
            ||||||| ||||||||||| |||||||||||||||||||||||||||||||||||||||| 
Sbjct  483  TGGGGCTTTGTCACTCGCTACGGGACGGATCGGCGGAGGTTGGTCACCACCACAGTTTTA  542 
Query  538  CCACGGTTGACCTCGGATCAGGTAGGAGTTACCC                            571 
            |||||| |||||||||||||||||||| || ||| 
Sbjct  543  CCACGG-TGACCTCGGATCAGGTAGGATTTCCCC                            575 
 
Phoma sp. TMS-2011 voucher MS5p50-9 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383284|gb|HQ630963.1|Length: 574Number of Matches: 1 
Score Expect Identities Gaps Strand 
1026 bits(555) 0.0 557/558(99%) 0/558(0%) Plus/Plus 
Query  1    GAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  17   GAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAG  76 
Query  61   TTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGGT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  77   TTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGGT  136 
Query  121  GGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTGAAAA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  137  GGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTGAAAA  196 
Query  181  AACTCAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGC  240 
            |||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  197  AACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGC  256 
Query  241  AGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACG  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  257  AGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACG  316 
Query  301  CACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTCA  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  317  CACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTCA  376 
Query  361  AGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGCC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  377  AGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGCC  436 
Query  421  GGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCCA  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  437  GGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCCA  496 
Query  481  AAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  497  AAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCA  556 
Query  541  TATCAATAAGCGGAGGAA                                            558 
            |||||||||||||||||| 
Sbjct  557  TATCAATAAGCGGAGGAA                                            574 
 
Phoma sp. TMS-2011 voucher MS5p50-9 18S ribosomal RNA gene, partial sequence; internal 
transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, 
complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383284|gb|HQ630963.1|Length: 574Number of Matches: 1 
Score Expect Identities Gaps Strand 
1033 bits(559) 0.0 559/559(100%) 0/559(0%) Plus/Plus 
Query  2    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGA  61 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGA  75 
Query  62   GTTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGG  121 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  76   GTTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGG  135 
Query  122  TGGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTGAAA  181 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  136  TGGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTGAAA  195 
Query  182  AAACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  241 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  196  AAACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  255 
Query  242  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  301 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  256  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  315 
Query  302  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  361 
164 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  316  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  375 
Query  362  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGC  421 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  376  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGC  435 
Query  422  CGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCC  481 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  436  CGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCC  495 
Query  482  AAAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGC  541 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  496  AAAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGC  555 
Query  542  ATATCAATAAGCGGAGGAA                                           560 
            ||||||||||||||||||| 
Sbjct  556  ATATCAATAAGCGGAGGAA                                           574 
 
Phoma sp. P14E4 18S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, 
5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28S 
ribosomal RNA gene, partial sequence 
Sequence ID: gi|346654886|gb|JN207285.1|Length: 562Number of Matches: 1 
Score Expect Identities Gaps Strand 
1035 bits(560) 0.0 560/560(100%) 0/560(0%) Plus/Plus 
Query  4    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGA  63 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  3    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGA  62 
Query  64   GTTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTTCGTTTCCTCGG  123 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  63   GTTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTTCGTTTCCTCGG  122 
Query  124  CGGGTCCGCCCGCCGATTGGACACATTCAAACCCTTTGCAGTTGCAATCAGCGTCTGAAA  183 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  123  CGGGTCCGCCCGCCGATTGGACACATTCAAACCCTTTGCAGTTGCAATCAGCGTCTGAAA  182 
Query  184  AAACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  243 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  183  AAACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  242 
Query  244  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  303 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  243  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  302 
Query  304  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  363 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  303  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  362 
Query  364  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCGCCTCTGCGCGCAGACTCGCCTCAAAACAA  423 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  363  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCGCCTCTGCGCGCAGACTCGCCTCAAAACAA  422 
Query  424  TTGGCAGCCGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGA  483 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  423  TTGGCAGCCGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGA  482 
Query  484  CGACGATCCAAAAGTACATTTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCT  543 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  483  CGACGATCCAAAAGTACATTTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCT  542 
Query  544  GAACTTAAGCATATCAATAA                                          563 
            |||||||||||||||||||| 
Sbjct  543  GAACTTAAGCATATCAATAA                                          562 
 
Phoma sp. CPO 10.003 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|378750663|gb|JQ388280.1|Length: 557Number of Matches: 1 
Score Expect Identities Gaps Strand 
1020 bits(552) 0.0 557/559(99%) 2/559(0%) Plus/Plus 
Query  5    GAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAG  64 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAG  60 
Query  65   TTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGGT  124 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGGT  120 
Query  125  GGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTGaaaa  184 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||| 
Sbjct  121  GGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTG-AAA  179 
Query  185  aaaCTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  244 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  180  AAACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  239 
Query  245  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  304 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  240  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  299 
Query  305  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  364 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  300  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  359 
Query  365  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGC  424 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  360  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGC  419 
Query  425  CGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCC  484 
165 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  420  CGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCC  479 
Query  485  AAAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGC  544 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  480  AAAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGC  539 
Query  545  ATATCAATAAGCCGGAGGA                                           563 
            |||||||||||| |||||| 
Sbjct  540  ATATCAATAAGC-GGAGGA                                           557 
 
Phoma sp. CPO 10.003 18S ribosomal RNA gene, partial sequence; internal transcribed 
spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; 
and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|378750663|gb|JQ388280.1|Length: 557Number of Matches: 1 
Score Expect Identities Gaps Strand 
1024 bits(554) 0.0 557/558(99%) 1/558(0%) Plus/Plus 
Query  6    GAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAG  65 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAG  60 
Query  66   TTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGGT  125 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTGTAGGCTTTGCCTGCTATCTCTTACCCATGTCTTTTGAGTACCTTACGTTTCCTCGGT  120 
Query  126  GGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTGaaaa  185 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||| 
Sbjct  121  GGGTTCGCCCACCGATTGGACAAATTTAAACCCTTTGCAGTTGAAATCAGCGTCTG-AAA  179 
Query  186  aaaCTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  245 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  180  AAACTTAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACG  239 
Query  246  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  305 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  240  CAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC  299 
Query  306  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  365 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  300  GCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTC  359 
Query  366  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGC  425 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  360  AAGCTCTGCTTGGTGTTGGGTGTTTGTCTCCTGTAGACTCGCCTTAAAACAATTGGCAGC  419 
Query  426  CGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCC  485 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  420  CGGCGTATTGATTTCGGAGCGCAGTACATCTCGCGCTTTGCACTCATAACGACGACATCC  479 
Query  486  AAAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGC  545 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  480  AAAAGTACATTTTTACACTCTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGC  539 
Query  546  ATATCAATAAGCGGAGGA                                            563 
            |||||||||||||||||| 
Sbjct  540  ATATCAATAAGCGGAGGA                                            557 
 
Pleosporales sp. 3 TMS-2011 voucher SC8d10p9-6 18S ribosomal RNA gene, partial sequence; 
internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 
2, complete sequence; and 28S ribosomal RNA gene, partial sequence 
Sequence ID: gi|317383336|gb|HQ631015.1|Length: 588Number of Matches: 1 
Score Expect Identities Gaps Strand 
1087 bits(565) 0.0 567/568(99%) 0/568(0%) Plus/Plus 
Query  3    GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACATTCA  62 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  16   GGAAGTAAAAGTCGTAACAAGGTTTCCGTAGGTGAACCTGCGGAAGGATCATTACATTCA  75 
Query  63   GTAGCCTAGCTACTTGTTTACACCCTTGttttttttGCGCACTTCATTGTATCCCTCGGC  122 
            |||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||| 
Sbjct  76   GTAGCCTAGCTACTTGTTTACACCCTTGTTTTTTTTGCGCACTTCACTGTATCCCTCGGC  135 
Query  123  GGGCTTGCTCGCCGGTTGGACAACATTTATAACCTTTTTTAATCTTCAATCAGCGTCTGA  182 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  136  GGGCTTGCTCGCCGGTTGGACAACATTTATAACCTTTTTTAATCTTCAATCAGCGTCTGA  195 
Query  183  ATTATATTTAATAATTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGA  242 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  196  ATTATATTTAATAATTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGA  255 
Query  243  ACGCAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTG  302 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  256  ACGCAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTG  315 
Query  303  AACGCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACC  362 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  316  AACGCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACC  375 
Query  363  CTCAAGCTTTGCTTGGTGTTGGGCGTCTTGTCTACCTCTTTAGCGGGTAGACTCGCCTTA  422 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  376  CTCAAGCTTTGCTTGGTGTTGGGCGTCTTGTCTACCTCTTTAGCGGGTAGACTCGCCTTA  435 
Query  423  AAGTAATTGGCAGCCAGTGTTTTTGGCAGTAAGCGCAGCACATTTTGCGTCTTAGTCCCT  482 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  436  AAGTAATTGGCAGCCAGTGTTTTTGGCAGTAAGCGCAGCACATTTTGCGTCTTAGTCCCT  495 
Query  483  AAACAGTGGCATCCACAAAGCCTCTTTCTCACTTTTGACCTCGGATCAGGTAGGGATACC  542 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  496  AAACAGTGGCATCCACAAAGCCTCTTTCTCACTTTTGACCTCGGATCAGGTAGGGATACC  555 
Query  543  CGCTGAACTTAAGCATATCAATAAGCGG                                  570 
166 
 
            |||||||||||||||||||||||||||| 
Sbjct  556  CGCTGAACTTAAGCATATCAATAAGCGG                                  583 
 
Xylaria sp. P055 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA 
gene, complete sequence; and internal transcribed spacer 2, partial sequence 
Sequence ID: gi|126131223|gb|EF423534.1|Length: 589Number of Matches: 1 
Score Expect Identities Gaps Strand 
883 bits(478) 0.0 561/599(94%) 13/599(2%) Plus/Plus 
Query  15   TCGTAACAAGGTCTCCGTTGGTGAACCAGCGGAGGGATCATTACAGAGTTTATCATAACT  74 
            |||||||||||||||||||||||||| |||||||||| ||||| |||| || | |||||| 
Sbjct  1    TCGTAACAAGGTCTCCGTTGGTGAAC-AGCGGAGGGA-CATTAAAGAG-TTCT-ATAACT  56 
Query  75   CCCAAACCCATGTGAACATACCTTACGTTGCCTCGGCAGGACGTGCTTACCCCGTAGCGC  134 
            |||||||||||||||||||||| ||||||||||||||||| || || ||||||||||||  
Sbjct  57   CCCAAACCCATGTGAACATACCATACGTTGCCTCGGCAGGTCGCGCCTACCCCGTAGCGT  116 
Query  135  CCTACCCTGTAGGGCCTACCCGGGAAGGC-CGGGTAACCCTGCCAATGGCCCACGAAACT  193 
            |||||||| |||| |||||||||  || | ||||||| ||||||   |||||| |||||| 
Sbjct  117  CCTACCCTATAGGACCTACCCGG-TAGACGCGGGTAAGCCTGCCGGCGGCCCAAGAAACT  175 
Query  194  CTGTTTAGTATTGAATTCTGAACTTATAACTAAATAAAGTTAAAACTTTCAACAACGGAT  253 
            ||||||||||||||||||||||| ||||||||||| |||||||||||||||||||||||| 
Sbjct  176  CTGTTTAGTATTGAATTCTGAACCTATAACTAAAT-AAGTTAAAACTTTCAACAACGGAT  234 
Query  254  CTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAG  313 
            ||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||| 
Sbjct  235  CTCTTGGTTCTGGCATCGATGAAGAAC-CAGCGAAATGCGATAAGTAATGTGAATTGCAG  293 
Query  314  AATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGCA  373 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  294  AATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGCA  353 
Query  374  TGCCTGTTCGAGCGTCATTTCAACCCTTAAGCCCTCGTTGCTTAGTGTTGGGAGCCTACG  433 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  354  TGCCTGTTCGAGCGTCATTTCAACCCTTAAGCCCTCGTTGCTTAGTGTTGGGAGCCTACG  413 
Query  434  GTGCT-GTAGCTCTTCAAAGTTAGTGGCGGAGTCGGTTCACACTCTAGACGTAGTAAATT  492 
            || |  ||||||| ||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  414  GTACCCGTAGCTCCTCAAAGTTAGTGGCGGAGTCGGTTCACACTCTAGACGTAGTAA-TT  472 
Query  493  TTCACCTCGCCTGT-AGTTGGACCGGTCCCTTGCCGTAAAACACCTTAATTATCTAAAGG  551 
            || | ||||||| | ||||||||||||||| ||||||||||||||  |||| |||||||| 
Sbjct  473  TT-ATCTCGCCTATCAGTTGGACCGGTCCCCTGCCGTAAAACACCCCAATT-TCTAAAGG  530 
Query  552  TTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA   610 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  531  TTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAATAAGCGGAGGAA   589 
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APPENDIX 3 
Zone of inhibition values demonstrated by marine derived fungi against test bacteria in the plug assay 
Table 1: Zone of inhibition values demonstrated by endophytic fungi from Vitex rotundifolia against test bacteria in plug assay 
 
Endophytic fungi Test bacteria (zone of inhibition in mm) 
SA BC BS ML EF EC PA 
Cochliobolus eragrostidis - 14.00±0.00 14.83±0.29 - - - - 
Cochliobolus eragrostidis - - - - - - - 
Curvularia sp. 16.17±0.29 14.83±0.29 13.00±0.00 - - - - 
Curvularia sp. - - - - - - - 
Fungal sp. ARIZ B233 - - - - - - - 
Guignardia mangiferae  - 12.33±0.58 14.00±0.00 - - - - 
Letendraea helminthicola  - - - - - - - 
Nemania primolutea  - - - - - - - 
Nemania primolutea - - - - - - - 
Paecilomyces sp. 16.00±0.00 16.17±0.29 15.00±0.00 - - - - 
Phoma sp. - - - - - - - 
Phoma sp. - 8.00±0.00 - - - - - 
Phoma sp. - - - - - - - 
Mean ± standard deviation, n=3; “-“ = no activity against all test bacteria 
SA: Staphylococcus aureus; BC: Bacillus cereus; BS: Bacillus subtilis; EF: Enterococcus faecalis; ML: Micrococcus luteus; EC: Escherichia coli; PA: Pseudomonas aeruginosa 
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Table 2: Zone of inhibition values demonstrated by endophytic fungi from Ipomoea pes-caprae against test bacteria in plug assay 
 
Endophytic fungi Test bacteria (zone of inhibition in mm) 
SA BC BS ML EF EC PA 
Bipolaris sp. - - 10.17±0.29 25.00±0.00 - - - 
Bipolaris sp. 21.00±0.00 14.83±0.29 10.00±0.00 18.67±0.29 15.67±0.58 8.00±0.00 - 
Bipolaris sp. - - - - - - - 
Bipolaris sp. - - - - - - - 
Cladosporium cladosporioides  - - - - - - - 
Cochliobolus lunatus - - - - - - - 
Colletotrichum hippeastri  - - - - - - - 
Colletotrichum sp. - - - - - - - 
Dothideomycete sp. 10.17±0.29 11.17±0.29 - 10.00±0.00 - - 8.00±0.00 
Dothideomycete sp. - - - - - - - 
Fungal endophyte sp g88 - - - - - - - 
Fusarium equiseti 27.33±0.58 24.00±0.00 22.00±0.00 26.00±0.00 - - - 
Guignardia mangiferae - - - - - - - 
Minimidochium sp. 8.33±0.47 8.33±0.24 13.33±0.58 10.83±0.29 - 8.67±0.24 - 
Montagnulaceae sp. 24.67±0.29 27.33±0.58 19.83±0.29 24.00±0.00 - - - 
Myrothecium sp. 8.33±0.47 8.33±0.47 8.33 ±0.24 - - - - 
Penicillium sp. 8.00±0.00 8.00±0.00 - - - 8.67±0.24 - 
Phoma sp. - - - 8.00±0.00 - - - 
Phoma sp. 10.83±0.29 - - 10.17±0.29 - - - 
Pleosporales sp. - - - - - - - 
Xylaria sp. - - - - - - - 
Mean ± standard deviation, n=3; “-“ = no activity against all test bacteria 
SA: Staphylococcus aureus; BC: Bacillus cereus; BS: Bacillus subtilis; EF: Enterococcus faecalis; ML: Micrococcus luteus; EC: Escherichia coli; PA: Pseudomonas aeruginosa 
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Table 3: Zone of inhibition values demonstrated by manglicolous fungi against test bacteria in plug assay 
 
Manglicolous fungi Test bacteria (zone of inhibition in mm) 
SA BC BS ML EF EC PA 
Corollospora maritima - 10.33±0.236 10.167±0.24 - - - - 
Dactylospora haliotrepha (ISB001) 10.83±0.24 - 10.33±0.24 - - - - 
Dactylospora haliotrepha (ISB002) 11.00±0.41 - 10.83±0.24 - - - - 
Dactylospora haliotrepha (ISB003) 13.00±0.41 13.83±0.236 14.33±0.24 10.83±0.24 - - - 
Dactylospora haliotrepha (ISB004) 13.00±0.41 14.33±0.236 13.83±0.24 - - - - 
Fusarium sp. - - - - - - - 
Henningsomyces sp. 14.67±0.24 14.33±0.236 13.67±0.24 10.33±0.24 - - - 
MF 28 14.83±0.24 15.00±0.408 14.67±0.24 - - 8.00±0.00 - 
Saccardoella rhizophorae 15.83±0.24 16.17±0.236 15.00±0.41 14.67±0.24 - 8.00±0.00 - 
Verruculina enalia (ISB005) 11.00±0.41 13.83±0.236 12.17±0.24 - - - - 
Verruculina enalia (ISB006) 10.83±0.24 12.17±0.236 11.00±0.41 - - - - 
Mean ± standard deviation, n=3; “-“ = no activity 
SA: Staphylococcus aureus; BC: Bacillus cereus; BS: Bacillus subtilis; EF: Enterococcus faecalis; ML: Micrococcus luteus; EC: Escherichia coli; PA: Pseudomonas aeruginosa 
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APPENDIX 4 
 
2-Dimensional NMR spectrum of linoleic acid in CDCl3 
 
Correlation spectroscopy (COSY) spectrum 
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COSY spectrum (continued) 
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Distortionless enhancement by polarization transfer (DEPT) spectrum 
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DEPT spectrum (continued) 
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Heteronuclear single-quantum correlation spectroscopy (HSQC) spectrum 
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HSQC spectrum (continued) 
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HSQC spectrum (continued) 
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Heteronuclear multiple-bond correlation spectroscopy (HMBC) spectrum 
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HMBC spectrum (continued) 
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HMBC spectrum (continued) 
 
 
 
 
 
 
 
 
180 
 
APPENDIX 5 
 
2-Dimensional NMR spectrum of palmitic acid in CDCl3 
 
COSY spectrum 
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DEPT spectrum 
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HSQC spectrum 
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HMBC spectrum 
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HMBC spectrum (continued) 
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Majority of drugs today are derived from plants and microorganism. The harsh 
environment of the marine ecosystem offers promising potential for new bioactive 
compounds. A total of 11 saprophytic and 46 endophytic fungi were evaluated for their 
antibacterial activity. The saprophytic fungi were isolated from various manglicolous 
materials in Malaysia while the endophytic fungi were isolated from two marine 
associated plants, Ipomoea pes-caprae and Vitex rotundifolia. These two plants were 
found along the shoreline from west and east coastal regions in Malaysia. The minimum 
inhibitory concentration (MIC) of all saprophytes and preliminary screening of all 46 
endophytes collected were evaluated against 7 bacterial strains consisting of 2 Gram 
negative and 5 Gram positive bacteria. Results for MIC displayed potent antibacterial 
activity of 4 saprophytic fungi strains; Dactylospora haliotrepha (tioman), Sacardoella 
rhizophorae, Henningsomyces sp. and an unidentified species, MF 28 against 4 Gram 
positive bacteria namely Staphylococcus aureus, Bacillus cereus, Micrococcus luteus 
and Bacillus subtilis. The endophytic fungi were screened using the plug assay method 
and the bacterial susceptibility index was evaluated for all 7 bacteria. Results obtained 
showed that Bacillus cereus had the highest susceptibility index at 0.3696% followed by 
Staphylococcus aureus at 0.3043%, Bacillus subtilis at 0.2609% and Micrococcus 
luteus at 0.2391%. The lowest bacterial susceptibility index was recorded by 
Escherichia coli at 0.0217%. Further work will be focussing on the species 
identification of all isolated endophytes through molecular sequencing of their ITS 
sequences and the chemical characterization and elucidation of pure compounds from 
the active fungi strains. 
 
 
 
 
 
 
186 
 
Paliany, A.S., Sivasothy, Y., Alias, S.A., Awang, K. (2013). The antibacterial activity 
of marine derived fungi from Peninsular Malaysia. Abstract in book, International 
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3
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Over the past 2 decades, scientist have come to acknowledge the growing importance of 
marine and marine-related resources such as plants, sponges, algae and microbes, for 
new drugs, pesticides and anti-fouling substances.  Marine fungi have been recognized 
as a rich of novel bioactive metabolites with potential biomedical use. In our study, we 
explored the antibacterial activity of marine derived endophytic and saprophytic fungi. 
The endophytic fungi in this study was isolated from 2 marine associated plants; Vitex 
rotundifolia L. f. and Ipomoea pes-caprae (L.) R.Br., from the coastlines of Peninsular 
Malaysia. The saprophytic fungi in this study were from the mangrove habitat. A total 
of 12 and 21 endophytic fungi were isolated from Vitex rotundifolia and Ipomoea pes-
caprae respectively while 10 saprophytic fungi were isolated from the mangrove 
environment. The plug assay and broth microdilution assay were adopted as 
antibacterial screening methods of the fungi strains. Results showed that the endophytes 
from Ipomoea pes-caprae exhibited a broader spectrum of antibacterial activity 
covering both Gram positive and negative bacteria in comparison to the endophytes 
from Vitex rotundifolia. The saprophytic fungi, Saccardoella sp. showed a broad 
spectrum antibacterial activity against both Gram positive and negative bacteria. The 
chemical analyses of the secondary metabolites from Saccardoella sp. revealed 2 
chemical compounds with antibacterial activity. The search for novel metabolites of 
fungal origin in Malaysia is still at its preliminary stages with very few reports 
published. Thus this study may prove crucial to pave the way for further discovery of 
novel fungal metabolites with pharmacological values. 
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Antibacterial Potential of Marine Derived Fungi from Peninsular Malaysia and 
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2
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3
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Abstract: 
The past 2 decades has seen the discovery of numerous new and novel fungal 
metabolites of promising pharmacological significance. Marine fungi in particular, have 
now been recognized as good harbors of important novel bioactive metabolites with 
potential biomedical applications. In an effort to tap into natural products harboured by 
marine derived fungi in Malaysia, selected marine derived endophytic and manglicolous 
fungi from the coastlines of Peninsular Malaysia were investigated for their antibacterial 
potential. A total of 12 and 21 endophytic fungi were isolated from the marine 
associated plants, Vitex rotundifolia and Ipomoea pes-caprae respectively while 10 
manglicolous fungi were isolated from various decaying mangrove wood of Peninsular 
Malaysia. In preliminary experiments, the plug assay was employed to study the 
antibacterial activities of all 33 fungi isolates. Fifteen or 45.45% of the endophytic fungi 
isolates and 9 or 90% of the manglicolous fungi isolated displayed antibacterial 
activities against at least one of the test bacteria. The endophytic fungi from I. pes-
caprae displayed higher antibacterial potential in comparison to the endophytic fungi 
from V. rotundifolia especially the strains, Minimidochium sp. and Bipolaris sp. which 
displayed antibacterial activities against 5 or more test bacteria. The fungi isolates that 
exhibited good antibacterial activities in the plug assay was further analysed through the 
broth microdilution assay where the fungi strains Minimidochium sp and Saccardoella 
rhizophorae exhibited promising antibacterial activities with minimum inhibitory 
concentrations not higher than 0.5mg/ml. Bioactivity-guided fractionation of S. 
rhizophorae extract resulted in the isolation of high concentrations of palmitic and 
linoleic acid thereby suggesting Saccardoella rhizophorae to be a promising biodiesel 
source. The search for novel metabolites of fungal origin in Malaysia is still at its 
preliminary stages with very few reports published thereby this study may prove crucial 
to pave the way for further discovery of fungal metabolites with commercial values. 
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Abstract 
In an effort to tap into natural products harboured by marine derived fungi in Malaysia, 
selected marine derived endophytic and manglicolous fungi from the coastlines of 
Peninsular Malaysia were investigated for their antibacterial potential. Forty-one strains 
were isolated from marine associated plants, comprised  and comprised 11 and 18 
endophytic strains  from Vitex rotundifolia and Ipomoea pes-caprae respectively, while 
10 manglicolous strains were from decaying mangrove wood collected in Peninsular 
Malaysia. In preliminary experiments, a plug assay was employed to study the 
antibacterial activities of all 39 fungi isolates. Fifteen of the endophytic isolates and 
nine of the manglicolous isolates displayed antibacterial activities against at least one of 
the test bacteria. Based on the plug assay, the endophytic fungi from Ipomoea pes-
caprae were shown to display higher antibacterial potential in comparison to the 
endophytic fungi from Vitex rotundifolia. In particular, Minimidochium sp. and 
Bipolaris sp. (ISB0014) displayed antibacterial activities against 5 or more test bacteria. 
Potential fungi isolates with good antibacterial activities were further analysed through 
a broth microdilution assay. Minimidochium sp. and Dyfrolomyces rhizophorae 
exhibited promising antibacterial activities with minimum inhibitory concentrations not 
higher than 0.5 mg/ml. Bioactivity-guided fractionation of D. rhizophorae extracts 
resulted in the isolation of fatty acids, palmitic and linoleic acid. Though ubiquitous in 
nature, linoleic acid is known as an essential health supplement and both fatty acids are 
used as biodiesel replacing conventional fuels. 
Keywords: Natural products, Antibiotics, Manglicolous fungi, Endophytic fungi, 
Bioactivity. 
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Abstract 
The rhizomes of Alpinia pahangensis Ridley yielded a new bis-labdanic diterpene for 
which the name pahangensin A (1) was proposed along with a new labdane diterpene, 
pahangensin B (2). Their structures were elucidated by spectroscopic methods 
including, 1D and 2D NMR techniques and LCMS-IT-TOF analysis. Pahangensin A (1) 
was found to be an antibacterial agent against Staphylococcus aureus, Bacillus cereus 
and Bacillus subtilis with MIC values less than 100 µg/mL, respectively. Pahangensin B 
(2) exhibited antibacterial activity (MIC < 100 µg/mL) against Bacillus cereus.  
 
Keywords: Alpinia pahangensis Ridley, Zingiberaceae, bis-labdanic diterpene, labdane  
                  diterpene, pahangensin A, pahangensin B, antibacterial agent 
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Abstract 
The rhizomes of Alpinia pahangensis Ridley yielded a new bis-labdanic diterpene for 
which the name pahangensin C (1) was proposed along with twelve known analogues 
(2-13). The structure of 1 was elucidated via spectroscopic methods including, 1D and 
2D NMR techniques and LCMS-IT-TOF analysis. Compounds 2 and 12 were isolated 
for the first time from the genus Alpinia. This is the second occurrence of compounds 2 
and 12 in the Zingiberaceae. Selected analogues exhibited moderate to strong inhibitory 
activity against Staphylococcus aureus and Bacillus cereus. 
 
Keywords: Alpinia pahangensis Ridley, Zingiberaceae, bis-labdanic diterpene, labdane  
                  diterpene, pahangensin C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
